FedInvent™ Patents

Patent Details for Tuesday, January 02, 2018 

This page was updated on Monday, March 27, 2023 at 05:27 AM GMT

Department of Health and Human Services (HHS) 

US 09854970 Dana et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Eye Institute (NEI)
APPLICANT(S) Massachusetts Eye and Ear Infirmary (Boston, Massachusetts)
ASSIGNEE(S) Massachusetts Eye and Ear Infirmary (Boston, Massachusetts)
INVENTOR(S) Reza Dana (Newton, Massachusetts);  Francisco L. Amparo Pulido (Cambridge, Massachusetts);  Haobing Wang (Newton, Massachusetts)
ABSTRACT The present application includes methods, systems and computer readable storage devices for determining a color score for at least a portion of a biological tissue. The subject matter of the application is embodied in a method that includes obtaining a digital image of the biological tissue, and receiving a selection of a portion of the image as an evaluation area. The method also includes determining for each of a plurality of pixels within the evaluation area, a plurality of color components that are based on a Cartesian color space, and determining, from the color components, a hue value in a polar coordinate based color space. The method further includes determining a color value based on the hue value for each of the plurality of pixels, and assigning a color score to the evaluation area based on an average of the color values of the plurality of pixels.
FILED Thursday, February 21, 2013
APPL NO 13/773310
ART UNIT 3779 — SELECT * FROM codes_techcenter;
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 3/14 (20130101) Original (OR) Class

Image Data Processing or Generation, in General
G06T 7/0012 (20130101)
G06T 7/90 (20170101)
G06T 2207/30041 (20130101)

Pictorial Communication, e.g Television
H04N 1/628 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09855217 Brinker et al.
FUNDED BY
Department of Energy (DOE)
National Nuclear Security Administration (NNSA)
Sandia National Laboratories (SNL)
Federally Funded Research and Development Center (FFRDC)
Operated by National Technology and Engineering Solutions of Sandia, LLC (NTESS) at Albuquerque, NM
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
APPLICANT(S) STC.UNM (Albuquerque, New Mexico);  National Technology and Engineering Solutions of Sandia, LLC (Albuquerque, New Mexico)
ASSIGNEE(S) STC. UNM (Albuquerque, New Mexico);  National Technology and Engineering Solutions of Sandia, LLC (Albuquerque, New Mexico)
INVENTOR(S) C. Jeffrey Brinker (Albuquerque, New Mexico);  Yu-Shen Lin (Albuquerque, New Mexico)
ABSTRACT In one aspect, the invention provides novel monodisperse, colloidally-stable, toroidal mesoporous silica nanoparticles (TMSNPs) which are synthesized from ellipsoid-shaped mesoporous silica nanoparticles (MSNPs) which are prepared using an ammonia basecatalyzed method under a low surfactant conditions. Significantly, the TMSNPs can be loaded simultaneously with a small molecule active agent, a siRNA, a mRNA, a plasmid and other cargo and can be used in the diagnosis and/or treatment of a variety of disorders, including a cancer, a bacterial infection and/or a viral infection, among others. Related protocells, pharmaceutical compositions and therapeutic and diagnostic methods are also provided.
FILED Thursday, September 18, 2014
APPL NO 15/023110
ART UNIT 1616 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/14 (20130101)
A61K 9/1271 (20130101) Original (OR) Class
A61K 9/5115 (20130101)
A61K 9/5123 (20130101)
A61K 31/7088 (20130101)
A61K 38/16 (20130101)
A61K 38/43 (20130101)
A61K 39/395 (20130101)

Specific Uses or Applications of Nanostructures; Measurement or Analysis of Nanostructures; Manufacture or Treatment of Nanostructures
B82Y 5/00 (20130101)
B82Y 15/00 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/88 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09855233 Rahbar et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
U.S. State Government
State of California
California Breast Cancer Research Program (CBCRP)
APPLICANT(S) CITY OF HOPE (Duarte, California);  Mahin Rahbar (Beverly Hills, California)
ASSIGNEE(S) CITY OF HOPE (Duarte, California)
INVENTOR(S) Samuel Rahbar (Beverly Hills, California);  Timothy W. Synold (Monrovia, California);  John Termini (Altadena, California)
ABSTRACT Methods of quantifying a N2-carboxyethyl-2′-deoxyguanosine (CEdG) levels in biological samples and comparing those levels to known normal levels can diagnose a number of disorders, including diabetes and cancer. Methods can also determine whether therapies for disorders are effective by measuring CEdG levels before and after treatment. Measurement of CEdG levels occurs using liquid chromatography electrospray ionization tandem mass spectrometry.
FILED Friday, November 07, 2014
APPL NO 14/536299
ART UNIT 1634 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/195 (20130101) Original (OR) Class
A61K 45/06 (20130101)

Electrotherapy; Magnetotherapy; Radiation Therapy; Ultrasound Therapy
A61N 5/10 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 30/7233 (20130101)
G01N 30/7266 (20130101)
G01N 2030/045 (20130101)
G01N 2030/8827 (20130101)
G01N 2030/8868 (20130101)
G01N 2800/042 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09855239 Maeda et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Eye Institute (NEI)
APPLICANT(S) University of Washington (Seattle, Washington)
ASSIGNEE(S) University of Washington (Seattle, Washington)
INVENTOR(S) Tadao Maeda (Mayfield Heights, Ohio);  David Saperstein (Seattle, Washington);  Krzysztof Palczewski (Bay Village, Ohio)
ABSTRACT A method of treating or preventing age-related retinal dysfunction involves administering to a patient a pharmaceutically effective amount of a synthetic retinal derivative repeatedly over a duration of at least about 3 months. Effective synthetic retinal derivatives include 9-cis-retinyl esters, 11-cis-retinyl esters, derivatives and congeners thereof, and combinations thereof. Suitable ester substituents include carboxylates of C1-C10 monocarboxylic acids and C2-C22 polycarboxylic acids.
FILED Tuesday, July 26, 2016
APPL NO 15/220315
ART UNIT 1621 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/0053 (20130101)
A61K 31/07 (20130101)
A61K 31/22 (20130101)
A61K 31/215 (20130101) Original (OR) Class
A61K 31/4709 (20130101)

Technical Subjects Covered by Former USPC Cross-reference Art Collections [XRACs] and Digests
Y10S 514/912 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09855266 Laberge et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute on Aging (NIA)
APPLICANT(S) Buck Institute for Research on Aging (Novato, California);  Unity Biotechnology, Inc. (Brisbane, California);  Mayo Foundation for Medical Education and Research (Rochester, Minnesota);  The Johns Hopkins University (Baltimore, Maryland)
ASSIGNEE(S) Unity Biotechnology, Inc. (San Francisco, California);  Buck Institute for Research on Aging (Novato, California);  Mayo Foundation for Medical Education and Research (Rochester, Minnesota);  The John Hopkins University (Baltimore, Maryland)
INVENTOR(S) Remi-Martin Laberge (San Francisco, California);  Judith Campisi (Berkeley, California);  Albert Davalos (San Rafael, California);  Marco Demaria (Groningen, Netherlands);  Nathaniel David (San Francisco, California);  Alain Philippe Vasserot (Carlsbad, California);  James L. Kirkland (Rochester, Minnesota);  Tamar Tchkonia (Rochester, Minnesota);  Jennifer Elisseeff (Baltimore, Maryland);  Chaekyu Kim (Pikesville, Maryland);  Okhee Jeon (Baltimore, Maryland);  Yi Zhu (Rochester, Minnesota)
ABSTRACT Methods are provided herein for selectively killing senescent cells and for treating senescence-associated diseases and disorders by administering a senolytic agent. Senescence-associated diseases and disorders treatable by the methods using the senolytic agents described herein include cardiovascular diseases and disorders associated with or caused by arteriosclerosis, such as atherosclerosis; idiopathic pulmonary fibrosis; chronic obstructive pulmonary disease; osteoarthritis; senescence-associated ophthalmic diseases and disorders; and senescence-associated dermatological diseases and disorders.
FILED Thursday, March 23, 2017
APPL NO 15/467129
ART UNIT 1628 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/496 (20130101) Original (OR) Class
A61K 31/4178 (20130101)
A61K 47/36 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09855273 Starczynowski et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) Children's Hospital Medical Center (Cincinnati, Ohio)
ASSIGNEE(S) Children's Hospital Medical Center (Cincinnati, Ohio)
INVENTOR(S) Daniel Starczynowski (Cincinnati, Ohio);  Garrett W. Rhyasen (Cincinnati, Ohio)
ABSTRACT Disclosed are compositions and methods for the treatment of disorders such as myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). The disclosed methods include administering to an individual in need of such treatment a composition that may include an IRAK1/4 inhibitor. In other aspects, the method may include administration of a BLC2 inhibitor.
FILED Friday, October 07, 2016
APPL NO 15/288402
ART UNIT 1674 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/404 (20130101)
A61K 31/495 (20130101)
A61K 31/496 (20130101)
A61K 31/519 (20130101)
A61K 31/4184 (20130101)
A61K 31/4375 (20130101)
A61K 31/5377 (20130101) Original (OR) Class
A61K 45/06 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09855290 Devi et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute on Drug Abuse (NIDA)
APPLICANT(S) Icahn School of Medicine at Mount Sinai (New York, New York)
ASSIGNEE(S) Icahn School of Medicine at Mount Sinai (New York, New York)
INVENTOR(S) Lakshmi A. Devi (New Rochelle, New York);  Raphael Rozenfeld (New York, New York)
ABSTRACT Compounds and compositions useful for the treatment of liver diseases and methods of treating liver diseases are disclosed. The compounds of the invention specifically interact with heteromers of cannabinoid receptors as compared to monomers or homodimers. The invention also relates to methods of screening for compounds useful for the treatment of liver diseases and to methods of screening for diacylglycerol lipase inhibitors.
FILED Tuesday, December 01, 2015
APPL NO 14/955586
ART UNIT 1647 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/454 (20130101)
A61K 31/7076 (20130101) Original (OR) Class

Peptides
C07K 16/44 (20130101)
C07K 16/286 (20130101)
C07K 16/2869 (20130101)
C07K 2317/31 (20130101)
C07K 2317/32 (20130101)
C07K 2317/76 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09855298 Bot et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Kite Pharma, Inc. (Santa Monica, California);  The United States of America, as Represented by the Secretary, Department of Health and Human Services (Washington, District of Columbia)
ASSIGNEE(S) Kite Pharma, Inc. (Santa Monica, California);  The United States of America, as Represented by the Secretary, Department of Health and Human Services (Washington, District of Columbia)
INVENTOR(S) Adrian Bot (Santa Monica, California);  Jeffrey S. Wiezorek (Santa Monica, California);  William Go (Santa Monica, California);  Rajul Jain (Santa Monica, California);  James N. Kochenderfer (Bethesda, Maryland);  Steven A. Rosenberg (Bethesda, Maryland)
ABSTRACT The invention provides methods of increasing the efficacy of a T cell therapy in a patient in need thereof. The invention includes a method of conditioning a patient prior to a T cell therapy, wherein the conditioning involves administering a combination of cyclophosphamide and fludarabine.
FILED Friday, May 27, 2016
APPL NO 15/167977
ART UNIT 1642 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/664 (20130101)
A61K 31/675 (20130101)
A61K 31/675 (20130101)
A61K 31/7076 (20130101)
A61K 31/7076 (20130101)
A61K 35/17 (20130101) Original (OR) Class
A61K 38/2013 (20130101)
A61K 38/2013 (20130101)
A61K 45/06 (20130101)
A61K 2300/00 (20130101)
A61K 2300/00 (20130101)
A61K 2300/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09855312 Schally et al.
FUNDED BY
Department of Veterans Affairs (DVA)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) UNIVERSITY OF MIAMI (Miami, Florida);  THE UNITED STATES OF AMERICA, REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS (Washington, District of Columbia)
ASSIGNEE(S) UNIVERSITY OF MIAMI (Miami, Florida);  THE UNITED STATES OF AMERICA, REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS (Washington, District of Columbia)
INVENTOR(S) Andrew V. Schally (Miami Beach, Florida);  Joshua M. Hare (Miami Beach, Florida);  Norman L. Block (Hollywood, Florida);  Samirah A. Gomes (Miami Beach, Florida);  Rosemeire M. Kanashiro-Takeuchi (Miami, Florida)
ABSTRACT Disclosed herein are compositions of GHRH agonists and peptides, and methods to treat disorders, such as ischemia and reperfusion injury. In one embodiment, a method of treating a reperfusion injury in a subject in need may involve administering a therapeutically effective amount of at least one GHRH agonist peptide to the subject. In additional embodiment, a method of promoting vasculogenesis in a mammal may involve administering a therapeutically effective amount of at least one GHRH agonist peptide to the subject. In a further embodiment, a method of promoting differentiation of mesenchymal stem cells into endothelial cells may involve contacting mesenchymal stem cells with at least one GHRH agonist peptide.
FILED Monday, December 23, 2013
APPL NO 14/138391
ART UNIT 1675 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/16 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09855313 Ghatnekar et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) MUSC Foundation for Research Development (Charleston, South Carolina)
ASSIGNEE(S) MUSC Foundation for Research Development (Charleston, South Carolina)
INVENTOR(S) Gautam Ghatnekar (Charleston, South Carolina);  Robert Gourdie (Charleston, South Carolina);  Jane Jourdan (Charleston, South Carolina)
ABSTRACT Provided herein are compositions and methods for use in promoting wound healing and tissue regeneration following tissue injury in a subject.
FILED Thursday, June 23, 2016
APPL NO 15/190810
ART UNIT 1656 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/177 (20130101) Original (OR) Class
A61K 38/1767 (20130101)

Peptides
C07K 14/705 (20130101)
C07K 14/43581 (20130101)
C07K 2319/10 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09855314 Haider
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Eye Institute (NEI)
APPLICANT(S) The Schepens Eye Research Institute, Inc. (Boston, Massachusetts)
ASSIGNEE(S) The Schepens Eye Research Insititute, Inc. (Boston, Massachusetts)
INVENTOR(S) Neena B. Haider (Brookline, Massachusetts)
ABSTRACT The present invention relates to compositions and methods comprising administering gene modifiers for treating ocular disease.
FILED Monday, March 03, 2014
APPL NO 14/772039
ART UNIT 1674 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/13 (20130101)
A61K 38/1783 (20130101) Original (OR) Class
A61K 48/00 (20130101)
A61K 48/005 (20130101)
A61K 48/0083 (20130101)

Peptides
C07K 14/4705 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09855329 Korber et al.
FUNDED BY
Department of Energy (DOE)
Los Alamos National Security, LLC (LANS)
National Nuclear Security Administration (NNSA)
Los Alamos National Laboratory (LANL)
Federally Funded Research and Development Center (FFRDC)
Operated by Triad National Security, LLC (TRIAD) at Los Alamos, NM
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) Los Alamos National Security, LLC (Los Alamos, New Mexico);  Duke University (Durham, North Carolina);  Dana-Farber Cancer Institute, Inc. (, None)
ASSIGNEE(S) Los Alamos National Security, LLC (Los Alamos, New Mexico);  Dana-Farber Cancer Institute (Brookline, Massachusetts);  Duke University (Durham, North Carolina)
INVENTOR(S) Bette T. M. Korber (Los Alamos, New Mexico);  S. Gnanakaran (Los Alamos, New Mexico);  Simon Perkins (Boulder, Colorado);  Joseph Sodroski (Boston, Massachusetts);  Barton Haynes (Durham, North Carolina)
ABSTRACT Disclosed herein are mosaic HIV envelope (Env) polypeptides that can elicit an immune response to HIV (such as cytotoxic T cell (CTL), helper T cell, and/or humoral responses). Also disclosed are sets of the disclosed mosaic Env polypeptides, which include two or more (for example, three) of the polypeptides. Also disclosed herein are methods for treating or inhibiting HIV in a subject including administering one or more of the disclosed immunogenic polypeptides or compositions to a subject infected with HIV or at risk of HIV infection. In some embodiments, the methods include inducing an immune response to HIV in a subject comprising administering to the subject at least one (such as two, three, or more) of the immunogenic polypeptides or at least one (such as two, three, or more) nucleic acids encoding at least one of the immunogenic polypeptides disclosed herein.
FILED Tuesday, September 30, 2014
APPL NO 15/025806
ART UNIT 1648 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 39/12 (20130101)
A61K 39/21 (20130101) Original (OR) Class
A61K 45/06 (20130101)
A61K 2039/57 (20130101)

Peptides
C07K 14/005 (20130101)
C07K 14/162 (20130101)
C07K 16/1063 (20130101)
C07K 2317/34 (20130101)
C07K 2317/76 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 7/00 (20130101)
C12N 2740/16034 (20130101)
C12N 2740/16122 (20130101)
C12N 2740/16134 (20130101)
C12N 2740/16171 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09855330 Krensky et al.
FUNDED BY
Department of Health and Human Services (HHS)
APPLICANT(S) The United States of America, as represented by the Secretary, Dept. of Health and Human Services (Washington, District of Columbia)
ASSIGNEE(S) The United States of America, as represented by the Secretary, Department of Health and Human Services (Washington, District of Columbia)
INVENTOR(S) Alan M. Krensky (Chicago, Illinois);  Carol Clayberger (Chicago, Illinois)
ABSTRACT Methods of stimulating or enhancing an immune response in a host are disclosed. The methods include contacting a monocyte with 15 kD granulysin thereby producing a monocyte-derived dendritic cell. In one example, the method further includes contacting the monocyte or monocyte-derived dendritic cell with a target antigen, such as a tumor antigen or an autoimmune antigen. In another embodiment, the method includes contacting the monocyte with an additional agent that enhances maturation of dendritic cells or induces immunological tolerance. The methods are of use in vivo, in vitro and ex vivo. In another aspect, the disclosure relates to compositions and methods for the treatment of tumors.
FILED Monday, June 06, 2016
APPL NO 15/174402
ART UNIT 1656 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/0014 (20130101)
A61K 31/727 (20130101)
A61K 35/15 (20130101)
A61K 35/15 (20130101)
A61K 35/17 (20130101)
A61K 35/17 (20130101)
A61K 38/19 (20130101)
A61K 38/19 (20130101)
A61K 38/1729 (20130101)
A61K 38/1729 (20130101)
A61K 38/2026 (20130101)
A61K 39/39 (20130101) Original (OR) Class
A61K 45/06 (20130101)
A61K 2039/55516 (20130101)
A61K 2039/55522 (20130101)
A61K 2039/55527 (20130101)
A61K 2300/00 (20130101)
A61K 2300/00 (20130101)
A61K 2300/00 (20130101)
A61K 2300/00 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 5/064 (20130101)
C12N 5/0639 (20130101)
C12N 2501/23 (20130101)
C12N 2501/052 (20130101)
C12N 2501/998 (20130101)
C12N 2506/11 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09855341 Li et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) University of Pittsburgh Of the Commonwealth System of Higher Education (Pittsburgh, Pennsylvania)
ASSIGNEE(S) University of Pittsburgh Of the Commonwealth System of Higher Education (Pittsburgh, Pennsylvania)
INVENTOR(S) Song Li (Wexford, Pennsylvania);  Yixian Huang (Pittsburgh, Pennsylvania);  Xiaolan Zhang (Pittsburgh, Pennsylvania);  Xiang Gao (Pittsburgh, Pennsylvania)
ABSTRACT A method of forming or creating a formulation for a compound to be delivered includes creating a carrier agent by conjugating at least one hydrophobic domain or hydrophobic compound with at least one hydrophilic domain or hydrophilic compound and associating the compound to be delivered with the carrier agent to create the formulation. The at least one hydrophobic compound has the formula:
wherein R1 is a farnesyl group, a geranyl group or geranyl-geranyl group, X is O, S, SO, SO2, NH or Se, Z is C—R2 or N, R2 is H, CN, CO2R7, SO3R7, CONR7R8 or SO2NR7R8, wherein R7 and R8 are each independently H, an alkyl group, an alkenyl group, CO2M or SO3M, wherein M is a cation and R3, R4, and R5 are independently H, a carboxyl group, an alkyl group, an alkenyl group, an aminoalkyl group, a nitroalkyl group, a nitro group, a halo atom, an amino group, a mono-alkylamino group, a di-alkylamino group, mercapto group, a mercaptoalkyl group, an azido group or a thiocyanato group. A plurality of the carrier agents are adapted to assemble into a structure. The hydrophobic compound is cleavably conjugated to the at least one hydrophilic compound via a linkage which is labile in vivo.
FILED Thursday, February 19, 2015
APPL NO 14/625873
ART UNIT 1613 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/0019 (20130101)
A61K 9/1075 (20130101)
A61K 31/235 (20130101)
A61K 31/337 (20130101)
A61K 31/704 (20130101)
A61K 47/48215 (20130101) Original (OR) Class

Macromolecular Compounds Obtained Otherwise Than by Reactions Only Involving Unsaturated Carbon-to-carbon Bonds
C08G 65/331 (20130101)
C08G 65/334 (20130101)
C08G 65/3311 (20130101)
C08G 65/3344 (20130101)
C08G 65/33306 (20130101)
C08G 65/33396 (20130101)

Compositions of Macromolecular Compounds
C08L 2203/02 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09855342 Frank et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) The Brigham and Women's Hospital, Inc. (Boston, Massachusetts)
ASSIGNEE(S) The Brigham and Women's Hospital, Inc. (Boston, Massachusetts)
INVENTOR(S) Markus H. Frank (Cambridge, Massachusetts);  Natasha Y. Frank (Cambridge, Massachusetts);  Mohamed H. Sayegh (Westwood, Massachusetts)
ABSTRACT The invention relates to methods for treating a subject by manipulating ABCB5 on a cell as well as related products. The methods include methods of treating cancer using ABCB5 binding molecules such as antibodies and fragments thereof.
FILED Monday, January 25, 2016
APPL NO 15/005364
ART UNIT 1643 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/713 (20130101)
A61K 38/47 (20130101)
A61K 47/6851 (20170801)
A61K 47/48569 (20130101) Original (OR) Class
A61K 2039/505 (20130101)

Peptides
C07K 16/18 (20130101)
C07K 2317/56 (20130101)
C07K 2317/565 (20130101)
C07K 2317/732 (20130101)
C07K 2317/734 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/1135 (20130101)
C12N 2310/14 (20130101)
C12N 2310/3513 (20130101)
C12N 2320/32 (20130101)

Enzymes
C12Y 302/02022 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/57492 (20130101)
G01N 2333/705 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09855349 Konstantopoulos et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Konstantinos Konstantopoulos (Ellicott City, Maryland);  Susan Napier Thomas (Baltimore, Maryland)
ASSIGNEE(S) Konstantinos Konstantopoulos (Ellicott City, Maryland);  Susan Napier Thomas (Baltimore, Maryland)
INVENTOR(S) Konstantinos Konstantopoulos (Ellicott City, Maryland);  Susan Napier Thomas (Baltimore, Maryland)
ABSTRACT The present invention provides methods and compositions useful in the diagnosis and treatment of cancer. More specifically, the present invention provides compositions and methods of use comprising a targeting composition comprising a solid substrate, an antibody composition, and optionally a chemotherapeutic agent.
FILED Tuesday, September 29, 2015
APPL NO 14/868626
ART UNIT 1678 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 39/3955 (20130101)
A61K 39/3955 (20130101)
A61K 39/39558 (20130101)
A61K 39/39558 (20130101)
A61K 47/48561 (20130101)
A61K 47/48576 (20130101)
A61K 47/48876 (20130101)
A61K 51/1027 (20130101)
A61K 51/1048 (20130101)
A61K 51/1063 (20130101) Original (OR) Class
A61K 51/1093 (20130101)
A61K 2300/00 (20130101)
A61K 2300/00 (20130101)

Specific Uses or Applications of Nanostructures; Measurement or Analysis of Nanostructures; Manufacture or Treatment of Nanostructures
B82Y 5/00 (20130101)

Peptides
C07K 16/18 (20130101)
C07K 16/2896 (20130101)
C07K 16/3046 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09855368 Murray et al.
FUNDED BY
Department of Veterans Affairs (DVA)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
APPLICANT(S) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (Oakland, California)
ASSIGNEE(S) The Regents of the University of California (Oakland, California);  Department of Veterans Affairs (Washington, District of Columbia)
INVENTOR(S) Samuel S. Murray (Saugus, California);  Elsa J. Murray (Saugus, California);  Jeffrey C. Wang (Sherman Oaks, California);  Keyvan Behnam (Simi Valley, California)
ABSTRACT A cyclized peptide designated BMP Binding Peptide (BBP) is a synthetic peptide that avidly binds rhBMP-2, as do endogenous forms of BBP, and sequence conservation between species results in a variety of useful BBP compositions. BBP increases the over-all osteogenic activity of rhBMP-2, increases the rate at which rhBMP-2 induces bone formation, and BBP induces calcification alone. Compositions and substrates including BBP, and methods of using BBP are useful in therapeutic, diagnostic and clinical applications requiring calcification and osteogenesis.
FILED Friday, March 06, 2015
APPL NO 14/640451
ART UNIT 1647 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 35/28 (20130101)
A61K 38/12 (20130101)
A61K 38/1841 (20130101)
A61K 38/1841 (20130101)
A61K 38/1875 (20130101)
A61K 38/1875 (20130101)
A61K 2300/00 (20130101)
A61K 2300/00 (20130101)

Methods or Apparatus for Sterilising Materials or Objects in General; Disinfection, Sterilisation, or Deodorisation of Air; Chemical Aspects of Bandages, Dressings, Absorbent Pads, or Surgical Articles; Materials for Bandages, Dressings, Absorbent Pads, or Surgical Articles
A61L 27/54 (20130101)
A61L 27/227 (20130101) Original (OR) Class
A61L 27/3821 (20130101)
A61L 27/3834 (20130101)
A61L 2400/18 (20130101)
A61L 2430/02 (20130101)

Peptides
C07K 7/08 (20130101)
C07K 14/51 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 5/0668 (20130101)
C12N 2501/15 (20130101)
C12N 2501/155 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09855370 Breuer et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) Christopher Breuer (Bethany, Connecticut);  Themis Kyriakides (Branford, Connecticut);  Jason Roh (Boston, Massachusetts)
ASSIGNEE(S) Yale University (New Haven, Connecticut)
INVENTOR(S) Christopher Breuer (Bethany, Connecticut);  Themis Kyriakides (Branford, Connecticut);  Jason Roh (Boston, Massachusetts)
ABSTRACT Methods for increasing the patency of biodegradable, synthetic vascular grafts are provided. The methods include administering one or more cytokines and/or chemokines that promote outward tissue remodeling of the vascular grafts and vascular neotissue formation. The disclosed methods do not require cell seeding of the vascular grafts, thus avoiding many problems associated with cell seeding. Biodegradable, polymeric vascular grafts which provide controlled release of cytokines and/or chemokines at the site of vascular graft implantation are also provided.
FILED Thursday, January 08, 2009
APPL NO 12/811676
ART UNIT 1647 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Filters Implantable into Blood Vessels; Prostheses; Devices Providing Patency To, or Preventing Collapsing Of, Tubular Structures of the Body, e.g Stents; Orthopaedic, Nursing or Contraceptive Devices; Fomentation; Treatment or Protection of Eyes or Ears; Bandages, Dressings or Absorbent Pads; First-aid Kits
A61F 2/06 (20130101)

Preparations for Medical, Dental, or Toilet Purposes
A61K 38/195 (20130101)

Methods or Apparatus for Sterilising Materials or Objects in General; Disinfection, Sterilisation, or Deodorisation of Air; Chemical Aspects of Bandages, Dressings, Absorbent Pads, or Surgical Articles; Materials for Bandages, Dressings, Absorbent Pads, or Surgical Articles
A61L 27/18 (20130101)
A61L 27/18 (20130101)
A61L 27/54 (20130101)
A61L 27/507 (20130101) Original (OR) Class
A61L 2300/426 (20130101)
A61L 2300/604 (20130101)

Compositions of Macromolecular Compounds
C08L 67/04 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09855376 Bluvshtein et al.
FUNDED BY
Department of Health and Human Services (HHS)
U.S. Public Health Service (USPHS)
Small Business Administration (SBA)
Small Business Innovation Research (SBIR)
APPLICANT(S) Minnetronix, Inc. (Saint Paul, Minnesota)
ASSIGNEE(S) MINNETRONIX, INC. (Saint Paul, Minnesota)
INVENTOR(S) Vlad Bluvshtein (Plymouth, Minnesota);  Lori Lucke (Rosemount, Minnesota);  William Weiss (Mechanicsburg, Pennsylvania)
ABSTRACT Disclosed are systems and methods for measuring and calculating parameters to control and monitor a power transfer in an implanted medical device, including operating the device in a plurality of scalable power modes and/or coupling modes. The system may shift between or among power and/or coupling modes based on input such as data received over system communication lines, programmable timers, or electrical loading information. The system may also shift between or among power and/or coupling modes based on calculated amounts of coupling, levels of detected heat flux, and/or amounts of estimated temperature changes.
FILED Friday, July 24, 2015
APPL NO 14/808540
ART UNIT 3766 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Devices for Introducing Media Into, or Onto, the Body; Devices for Transducing Body Media or for Taking Media From the Body; Devices for Producing or Ending Sleep or Stupor
A61M 1/12 (20130101)
A61M 1/101 (20130101)
A61M 1/122 (20140204)
A61M 1/127 (20130101) Original (OR) Class
A61M 1/1086 (20130101)
A61M 2205/3368 (20130101)
A61M 2205/8243 (20130101)

Magnets; Inductances; Transformers; Selection of Materials for Their Magnetic Properties
H01F 38/14 (20130101)

Circuit Arrangements or Systems for Supplying or Distributing Electric Power; Systems for Storing Electric Energy
H02J 7/025 (20130101)
H02J 50/12 (20160201)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09855421 Garai et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
Fogarty International Center (FIC)
APPLICANT(S) Ellis Garai (Sherman Oaks, California);  Aravind Swaminathan (Palo Alto, California)
ASSIGNEE(S) THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (Palo Alto, California)
INVENTOR(S) Ellis Garai (Sherman Oaks, California);  Aravind Swaminathan (Palo Alto, California)
ABSTRACT A device for positioning an electrode in tissue includes: a lead body having a distal portion; an electrode array coupled to the lead distal portion; an anchoring element having an anchor tip and being operable in a first configuration in which the anchor tip is retracted within the lead and in a second configuration in which the anchor tip is extended outside the lead and configured to fixate within the tissue; and a displacement mechanism that is actuated to bias the electrode array or the anchoring element toward the tissue. A method for positioning an electrode in tissue includes: navigating, to the tissue, a lead with an electrode array, an anchoring element with a distal anchor tip, and a displacement mechanism; biasing the electrode array and anchoring element towards the tissue with the displacement mechanism; and deploying the anchoring element, and verifying fixation of the anchor tip within the tissue.
FILED Monday, August 29, 2011
APPL NO 13/219874
ART UNIT 3731 — Sheet Container Making, Package Making, Receptacles, Shoes, Apparel, and Tool Driving or Impacting
CURRENT CPC
Electrotherapy; Magnetotherapy; Radiation Therapy; Ultrasound Therapy
A61N 1/057 (20130101) Original (OR) Class
A61N 1/0558 (20130101)
A61N 1/0573 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09855442 Deisseroth et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
NIH Office of the Director (NIHOD)
APPLICANT(S) The Board of Trustees of the Leland Stanford Junior University (Stanford, California)
ASSIGNEE(S) The Board of Trustees of the Leland Stanford Junior University (Stanford, California)
INVENTOR(S) Karl Deisseroth (Stanford, California);  Feng Zhang (Cambridge, Massachusetts);  Viviana Gradinaru (Menlo Park, California)
ABSTRACT Stimulation of target cells using light, e.g., in vivo or in vitro, is implemented using a variety of methods and devices. One example involves a vector for delivering a light-activated NpHR-based molecule comprising a nucleic acid sequence that codes for light-activated NpHR-based molecule and a promoter. Either a high expression of the molecule manifests a toxicity level that is less than about 75%, or the light-activated NpHR-based proteins are expressed using at least two NpHR-based molecular variants. Each of the variants characterized in being useful for expressing a light-activated NpHR-based molecule that responds to light by producing an inhibitory current to dissuade depolarization of the neuron. Other aspects and embodiments are directed to systems, methods, kits, compositions of matter and molecules for ion pumps or for controlling inhibitory currents in a cell (e.g., in in vivo and in vitro environments).
FILED Monday, March 07, 2016
APPL NO 15/063296
ART UNIT 1632 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Animal Husbandry; Care of Birds, Fishes, Insects; Fishing; Rearing or Breeding Animals, Not Otherwise Provided For; New Breeds of Animals
A01K 67/0333 (20130101)
A01K 2217/052 (20130101)
A01K 2227/703 (20130101)
A01K 2267/0356 (20130101)

Preparations for Medical, Dental, or Toilet Purposes
A61K 38/00 (20130101)
A61K 48/005 (20130101)
A61K 48/0058 (20130101)
A61K 48/0083 (20130101)

Electrotherapy; Magnetotherapy; Radiation Therapy; Ultrasound Therapy
A61N 5/062 (20130101) Original (OR) Class
A61N 5/0613 (20130101)
A61N 5/0622 (20130101)

Peptides
C07K 14/00 (20130101)
C07K 14/195 (20130101)
C07K 14/215 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 13/00 (20130101)
C12N 15/86 (20130101)
C12N 2710/10343 (20130101)
C12N 2710/16643 (20130101)
C12N 2740/16043 (20130101)
C12N 2740/16071 (20130101)
C12N 2750/14143 (20130101)
C12N 2830/002 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09856214 Messick et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Neurological Disorders and Stroke (NINDS)
APPLICANT(S) THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY (Philadelphia, Pennsylvania)
ASSIGNEE(S) THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY (Philadelphia, Pennsylvania)
INVENTOR(S) Troy E. Messick (Upper Darby, Pennsylvania);  Garry R. Smith (Royersford, Pennsylvania);  Allen B. Reitz (Lansdale, Pennsylvania);  Paul M. Lieberman (Wynnewood, Pennsylvania);  Mark E. McDonnell (Lansdale, Pennsylvania);  Yan Zhang (Fort Washington, Pennsylvania);  Venkata Velvadapu (Ankeny, Iowa)
ABSTRACT The invention provides EBNA1 inhibitors, and pharmaceutical compositions comprising the same, that are useful for the treatment of diseases caused by EBNA1 activity such as, but not limited to, cancer, infectious mononucleosis, chronic fatigue syndrome, multiple sclerosis, systemic lupus erythematosus and/or rheumatoid arthritis. The compounds and compositions of the invention are further useful for the treatment of diseases caused by latent Epstein-Barr Virus (EBV) infection. The compounds and compositions of the invention are further useful for the treatment of diseases caused by lytic EBV infection.
FILED Friday, November 14, 2014
APPL NO 15/036211
ART UNIT 1627 — Organic Chemistry
CURRENT CPC
Acyclic or Carbocyclic Compounds
C07C 53/18 (20130101)
C07C 63/66 (20130101)
C07C 65/19 (20130101)
C07C 65/28 (20130101)
C07C 211/27 (20130101)
C07C 217/84 (20130101)
C07C 229/56 (20130101)
C07C 229/64 (20130101)
C07C 233/11 (20130101)
C07C 233/64 (20130101)
C07C 233/65 (20130101)
C07C 235/58 (20130101)
C07C 255/54 (20130101)
C07C 255/55 (20130101)
C07C 311/08 (20130101)
C07C 311/16 (20130101)
C07C 311/17 (20130101)
C07C 317/14 (20130101)
C07C 317/44 (20130101)
C07C 2601/02 (20170501)

Heterocyclic Compounds
C07D 207/08 (20130101)
C07D 207/12 (20130101)
C07D 207/14 (20130101)
C07D 207/16 (20130101)
C07D 207/327 (20130101) Original (OR) Class
C07D 209/08 (20130101)
C07D 211/70 (20130101)
C07D 213/55 (20130101)
C07D 213/64 (20130101)
C07D 213/74 (20130101)
C07D 215/14 (20130101)
C07D 231/12 (20130101)
C07D 235/06 (20130101)
C07D 239/26 (20130101)
C07D 249/06 (20130101)
C07D 277/30 (20130101)
C07D 295/155 (20130101)
C07D 307/79 (20130101)
C07D 333/54 (20130101)
C07D 401/04 (20130101)
C07D 401/10 (20130101)
C07D 403/10 (20130101)
C07D 409/10 (20130101)
C07D 417/10 (20130101)
C07D 471/04 (20130101)
C07D 487/04 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09856223 Treon et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Dana-Farber Cancer Institute, Inc. (Boston, Massachusetts)
ASSIGNEE(S) Dana-Farber Cancer Institute, Inc. (Boston, Massachusetts)
INVENTOR(S) Steven P. Treon (Jamaica Plain, Massachusetts);  Sara Jean Buhrlage (Somerville, Massachusetts);  Nathanael S. Gray (Boston, Massachusetts);  Li Tan (Boston, Massachusetts);  Guang Yang (Natick, Massachusetts)
ABSTRACT The present invention provides compounds of any one of Formulae (A), (I-11), (II), and (V) (e.g., compounds of Formula (A-1)-(A-18)), and methods for treating Waldenström's macroglobulinemia (WM) and other B cell neoplasm in a subject using the compounds. The methods comprise administering to a subject in need thereof an effective amount of the compounds. Also provided are methods to treat B cell neoplasms using the compounds in combination with inhibitors of Bruton's tyrosine kinase (BTK), interleukin-1 receptor-associated kinase 1 (IRAK1), interleukin-1 receptor-associated kinase 4 (IRAK4), bone marrow on X chromosome kinase (BMX), phosphoinositide 3-kinase (PI3K), transforming growth factor b-activated kinase-1 (TAK1), and/or a Src family kinase.
FILED Friday, December 12, 2014
APPL NO 15/104132
ART UNIT 1624 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/506 (20130101)
A61K 45/06 (20130101)

Heterocyclic Compounds
C07D 239/47 (20130101) Original (OR) Class
C07D 403/12 (20130101)
C07D 405/12 (20130101)
C07D 413/12 (20130101)
C07D 417/04 (20130101)
C07D 487/04 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09856231 Silverman et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute on Drug Abuse (NIDA)
APPLICANT(S) Northwestern University (Evanston, Illinois)
ASSIGNEE(S) Northwestern University (Evanston, Illinois)
INVENTOR(S) Richard B. Silverman (Winnetka, Illinois);  Hoang V. Le (Evanston, Illinois);  Dustin D. Hawker (Evanston, Illinois)
ABSTRACT Tetrahydrothiophene and related heterocyclic analogs and related methods for GABA aminotransferase inactivation.
FILED Wednesday, March 09, 2016
APPL NO 15/065487
ART UNIT 1629 — Organic Chemistry
CURRENT CPC
Heterocyclic Compounds
C07D 333/40 (20130101) Original (OR) Class

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 9/99 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09856260 Fatatis et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
U.S. Army Medical Research and Materiel Command (USAMRMC)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute on Drug Abuse (NIDA)
APPLICANT(S) Drexel University (Philadelphia, Pennsylvania);  Alliance Discovery, Inc. (Doylestown, Pennsylvania)
ASSIGNEE(S) Drexel University (Philadelphia, Pennsylvania);  Alliance Discovery, Inc. (Doylestown, Pennsylvania)
INVENTOR(S) Alessandro Fatatis (Penn Valley, Pennsylvania);  Joseph M. Salvino (Chester Springs, Pennsylvania);  Olimpia Meucci (Penn Valley, Pennsylvania);  Whitney L. Gladney (Glenolden, Pennsylvania)
ABSTRACT The present invention includes compositions that are useful in preventing or treating metastasis in a subject diagnosed with cancer. The present invention also includes methods of preventing or treating metastasis in a subject diagnosed with cancer, wherein the method comprises administering to the subject in need thereof an effective amount of a pharmaceutical formulation comprising at least one pharmaceutically acceptable carrier and at least one CX3CR1 or fractalkine antagonist.
FILED Monday, June 06, 2016
APPL NO 15/174227
ART UNIT 1627 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/451 (20130101)
A61K 31/453 (20130101)
A61K 31/7088 (20130101)
A61K 39/3955 (20130101)

Heterocyclic Compounds
C07D 403/04 (20130101)
C07D 487/04 (20130101) Original (OR) Class

Peptides
C07K 16/28 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09856272 Echegoyen et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
National Science Foundation (NSF)
APPLICANT(S) Luis A. Echegoyen (El Paso, Texas);  Danisha M. Rivera-Nazario (El Paso, Texas);  Edison A. Castro Portillo (El Paso, Texas);  Zachary Martinez (El Paso, Texas);  Manuel Llano (El Paso, Texas)
ASSIGNEE(S) THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (Austin, Texas)
INVENTOR(S) Luis A. Echegoyen (El Paso, Texas);  Danisha M. Rivera-Nazario (El Paso, Texas);  Edison A. Castro Portillo (El Paso, Texas);  Zachary Martinez (El Paso, Texas);  Manuel Llano (El Paso, Texas)
ABSTRACT Certain embodiments useful as HIV-inhibitor agents are directed to fullerene derivatives tetrahydro-1H—C60-fulleropyrrolo[1,2-c][1,3]thiazine salts (Formula I) or tetrahydro-1H—C70-fulleropyrrolo[1,2-c][1,3]thiazine salts (Formula II), while further embodiments are directed to α, β, γ, and/or δ isomer of tetrahydro-1H—C70-fulleropyrrolo[1,2-c][1,3]thiazine salt.
FILED Friday, November 04, 2016
APPL NO 15/343631
ART UNIT 1624 — Organic Chemistry
CURRENT CPC
Heterocyclic Compounds
C07D 513/04 (20130101) Original (OR) Class
C07D 519/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09856273 Overman et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) City of Hope (Duarte, California);  The Regents of the University of California (Oakland, California)
ASSIGNEE(S) CITY OF HOPE (Duarte, California);  THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (Oakland, California)
INVENTOR(S) Larry Eugene Overman (Corona Del Mar, California);  Marcus Baumann (Durham, United Kingdom);  Sangkil Nam (Tijunga, California);  David Horne (Altadena, California);  Richard Jove (Pasadena, California);  Jun Xie (Duarte, California);  Claudia Kowolik (Redondo Beach, California)
ABSTRACT Provided herein, inter alia, is the synthesis of ETP derivatives. The uses of the ETP derivatives described herein include treatment of cancer.
FILED Friday, August 19, 2016
APPL NO 15/242318
ART UNIT 1625 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/44 (20130101)
A61K 31/44 (20130101)
A61K 31/548 (20130101)
A61K 31/548 (20130101)
A61K 31/706 (20130101)
A61K 31/706 (20130101)
A61K 31/7068 (20130101)
A61K 31/7068 (20130101)
A61K 45/06 (20130101)
A61K 2300/00 (20130101)
A61K 2300/00 (20130101)
A61K 2300/00 (20130101)
A61K 2300/00 (20130101)

Heterocyclic Compounds
C07D 487/04 (20130101)
C07D 513/18 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09856275 Molander et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) The Trustees of The University of Pennsylvania (Philadelphia, Pennsylvania)
ASSIGNEE(S) The Trustees of the University of Pennsylvania (Philadelphia, Pennsylvania)
INVENTOR(S) Gary Alan Molander (Broomall, Pennsylvania);  Oana Andreea Argintaru (Philadelphia, Pennsylvania)
ABSTRACT The invention is directed to the preparation of fluorinated compounds and their use in organic synthesis. In particular, the invention is directed to methods of reacting compounds of structure with Rf—CH═N2 or (CF3)2C═N2 to form a perfluoroalkylate or -arylated compounds, and products derived from these reactions, where X, YB, and Rf are described herein.
FILED Wednesday, February 12, 2014
APPL NO 14/767103
ART UNIT 1626 — Organic Chemistry
CURRENT CPC
General Methods of Organic Chemistry; Apparatus Therefor
C07B 39/00 (20130101)
C07B 2200/09 (20130101)

Acyclic or Carbocyclic Compounds
C07C 17/263 (20130101)
C07C 17/263 (20130101)
C07C 22/08 (20130101)
C07C 22/08 (20130101)
C07C 29/36 (20130101)
C07C 41/22 (20130101)
C07C 41/22 (20130101)
C07C 41/26 (20130101)
C07C 41/26 (20130101)
C07C 41/30 (20130101)
C07C 41/30 (20130101)
C07C 43/23 (20130101)
C07C 43/225 (20130101)
C07C 43/225 (20130101)
C07C 67/343 (20130101)
C07C 67/343 (20130101)
C07C 69/734 (20130101)

Heterocyclic Compounds
C07D 209/08 (20130101)

Acyclic, Carbocyclic or Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium or Tellurium
C07F 5/02 (20130101)
C07F 5/04 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09856283 Oscarson et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) The Regents of The University of California (Oakland, California);  University College Dublin (Dublin, Ireland)
ASSIGNEE(S) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (Oakland, California)
INVENTOR(S) Stefan Oscarson (Blackrock, Ireland);  John Vincent Fahy (San Francisco, California);  Shaopeng Yuan (San Francisco, California);  Stephen Carrington (Roundwood, Ireland)
ABSTRACT There are provided, inter alia, methods for decreasing mucus elasticity or decreasing mucus viscosity in a subject in need thereof, the methods including administering to the subject an effective amount of a thiosaccharide mucolytic agent, and compounds and pharmaceutical compositions useful for the methods.
FILED Tuesday, September 08, 2015
APPL NO 14/847439
ART UNIT 1673 — Organic Chemistry, Polymers, Compositions
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/70 (20130101)
A61K 31/702 (20130101)
A61K 31/7016 (20130101)
A61K 31/7028 (20130101)

Heterocyclic Compounds
C07D 309/10 (20130101)

Sugars; Derivatives Thereof; Nucleosides; Nucleotides; Nucleic Acids
C07H 5/04 (20130101)
C07H 13/04 (20130101)
C07H 15/04 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09856300 Yang et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) Marquette University (Milwaukee, Wisconsin)
ASSIGNEE(S) Marquette University (Milwaukee, Wisconsin)
INVENTOR(S) Pinfen Yang (Milwaukee, Wisconsin);  Priyanka Sivadas (Milwaukee, Wisconsin)
ABSTRACT Disclosed are compositions and methods for modulating Dpy-30 binding activity. The compositions may include peptides or peptidomimetics thereof that are related to radial spoke protein 3 (RSP3) or absent, small, homeotic discs 2-like protein (Ash2L) and that bind to Dumpy-30 protein (Dpy-30).
FILED Friday, June 17, 2016
APPL NO 15/185299
ART UNIT 1676 — Organic Chemistry, Polymers, Compositions
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/00 (20130101)

Peptides
C07K 7/06 (20130101)
C07K 7/08 (20130101)
C07K 14/47 (20130101) Original (OR) Class
C07K 14/405 (20130101)
C07K 14/415 (20130101)
C07K 2319/10 (20130101)
C07K 2319/21 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09856301 Leonard et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
APPLICANT(S) University of Massachusetts (Boston, Massachusetts)
ASSIGNEE(S) University of Massachusetts (Boston, Massachusetts)
INVENTOR(S) Jack L. Leonard (Shrewsbury, Massachusetts);  Deborah M. Leonard (Shrewsbury, Massachusetts);  Karl J. Simin (Princeton, Massachusetts)
ABSTRACT The invention relates to novel therapeutic approaches to cancer treatment that exploits tumor suppressor functions of DKK3b by site-specific delivery of DKK3b. Novel therapeutics and methods for treating tumors and cancers utilizing DKK3b tumor suppressor functions are disclosed.
FILED Friday, October 10, 2014
APPL NO 14/511667
ART UNIT 1633 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Animal Husbandry; Care of Birds, Fishes, Insects; Fishing; Rearing or Breeding Animals, Not Otherwise Provided For; New Breeds of Animals
A01K 67/0276 (20130101)
A01K 2217/15 (20130101)
A01K 2217/075 (20130101)
A01K 2217/203 (20130101)
A01K 2227/105 (20130101)
A01K 2267/0331 (20130101)
A01K 2267/0393 (20130101)

Preparations for Medical, Dental, or Toilet Purposes
A61K 35/76 (20130101)
A61K 38/00 (20130101)
A61K 38/1709 (20130101)

Peptides
C07K 14/00 (20130101)
C07K 14/82 (20130101)
C07K 14/4703 (20130101) Original (OR) Class
C07K 2319/10 (20130101)
C07K 2319/21 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 2740/15043 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09856303 Korsmeyer et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Stanley J. Korsmeyer (Weston, Massachusetts);  Anthony Letai (Medfield, Massachusetts)
ASSIGNEE(S) Dana-Farber Cancer Institute, Inc. (Boston, Massachusetts)
INVENTOR(S) Stanley J. Korsmeyer (Weston, Massachusetts);  Anthony Letai (Medfield, Massachusetts)
ABSTRACT The invention provides peptides and the nucleic acid sequences that encode them. The invention further provides therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of apoptosis associated disorders.
FILED Monday, December 13, 2010
APPL NO 12/966821
ART UNIT 1642 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Peptides
C07K 14/4747 (20130101) Original (OR) Class
C07K 2319/03 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09856313 Zheng et al.
FUNDED BY
Department of Health and Human Services (HHS)
APPLICANT(S) XIAMEN UNIVERSITY (Xiamen, China PRC);  THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (Washington, District of Columbia);  XIAMEN INNOVAX BIOTECH CO., LTD. (Xiamen, China PRC)
ASSIGNEE(S) XIAMEN UNIVERSITY (Xiamen, China PRC);  XIAMEN INNOVAX BIOTECH CO., LTD. (Xiamen, China PRC);  THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (Washington, District of Columbia)
INVENTOR(S) Zizheng Zheng (Xiamen, China PRC);  Jason S. McLellan (Hanover, New Hampshire);  Man Chen (Bethesda, Maryland);  Min Zhao (Xiamen, China PRC);  Liangmin Huang (Xiamen, China PRC);  Barney S. Graham (Bethesda, Maryland);  Ningshao Xia (Xiamen, China PRC)
ABSTRACT The present invention relates to an epitope peptide (or a variant thereof) which can be used in the prevention of respiratory syncytial virus (RSV) infection, a recombinant protein comprising the epitope peptide (or a variant thereof) and a carrier protein, and uses of the epitope peptide (or a variant thereof) and the recombinant protein. The present invention also relates to an antibody against the epitope peptide, a cell line for generating the antibody, and uses thereof. Furthermore, the present invention also relates to a vaccine or a pharmaceutical composition comprising the recombinant protein or the antibody according to the invention, for preventing one or more symptoms associated with RSV infection.
FILED Monday, March 17, 2014
APPL NO 14/777275
ART UNIT 1648 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/7084 (20130101)
A61K 39/12 (20130101)
A61K 39/155 (20130101)
A61K 2039/53 (20130101)

Peptides
C07K 14/005 (20130101)
C07K 16/1027 (20130101) Original (OR) Class
C07K 2317/20 (20130101)
C07K 2317/21 (20130101)
C07K 2317/24 (20130101)
C07K 2317/31 (20130101)
C07K 2317/34 (20130101)
C07K 2317/51 (20130101)
C07K 2317/54 (20130101)
C07K 2317/55 (20130101)
C07K 2317/56 (20130101)
C07K 2317/76 (20130101)
C07K 2317/565 (20130101)
C07K 2317/622 (20130101)
C07K 2317/626 (20130101)
C07K 2319/00 (20130101)
C07K 2319/35 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 7/00 (20130101)
C12N 2760/18522 (20130101)
C12N 2760/18534 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09856322 Campana et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
APPLICANT(S) St. Jude Children's Research Hospital, Inc. (Memphis, Tennessee)
ASSIGNEE(S) St Jude Children's Research Hospital, Inc. (Memphis, Tennessee)
INVENTOR(S) Dario Campana (Singapore, Singapore);  Chihaya Imai (Niigata, Japan)
ABSTRACT The present invention relates to a chimeric receptor capable of signaling both a primary and a co-stimulatory pathway, thus allowing activation of the co-stimulatory pathway without binding to the natural ligand. The cytoplasmic domain of the receptor contains a portion of the 4-1BB signaling domain. Embodiments of the invention relate to polynucleotides that encode the receptor, vectors and host cells encoding a chimeric receptor, particularly including T cells and natural killer (NK) cells and methods of use.
FILED Thursday, June 12, 2014
APPL NO 14/303331
ART UNIT 1644 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 39/0011 (20130101)

Peptides
C07K 14/7051 (20130101)
C07K 14/70517 (20130101)
C07K 14/70578 (20130101)
C07K 16/2803 (20130101)
C07K 16/2866 (20130101)
C07K 16/2878 (20130101)
C07K 16/2896 (20130101) Original (OR) Class
C07K 2317/569 (20130101)
C07K 2317/622 (20130101)
C07K 2319/00 (20130101)
C07K 2319/02 (20130101)
C07K 2319/03 (20130101)
C07K 2319/30 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 5/0646 (20130101)
C12N 2501/599 (20130101)
C12N 2501/2302 (20130101)
C12N 2501/2315 (20130101)
C12N 2502/99 (20130101)
C12N 2510/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09856453 Childs et al.
FUNDED BY
Department of Health and Human Services (HHS)
APPLICANT(S) The United States of America as Represented by the Secretary, Department of Health (Washington, District of Columbia)
ASSIGNEE(S) The United States of America, as represented by the Secretary, Department of Health and Human Services (Washington, District of Columbia)
INVENTOR(S) Richard William Wyatt Childs (Rockville, Maryland);  Yoshiyuki Takahashi (Nagoya, Japan);  Sachiko Kajigaya (Rockville, Maryland);  Nanae Harashima (Rockville, Maryland)
ABSTRACT Compositions and methods are provided for preventing or treating neoplastic disease in a mammalian subject. A composition is provided which comprises an enriched immune cell population reactive to a human endogenous retrovirus type E antigen on a tumor cell. A method of treating a neoplastic disease in a mammalian subject is provided which comprises administering to a mammalian subject a composition comprising an enriched immune cell population reactive to a human endogenous retrovirus type E antigen, in an amount effective to reduce or eliminate the neoplastic disease or to prevent its occurrence or recurrence.
FILED Thursday, November 20, 2014
APPL NO 14/549296
ART UNIT 1648 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 35/12 (20130101)
A61K 35/17 (20130101)
A61K 39/00 (20130101)
A61K 39/12 (20130101)
A61K 39/21 (20130101)
A61K 2039/585 (20130101)

Peptides
C07K 14/005 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 5/0638 (20130101) Original (OR) Class
C12N 2740/10022 (20130101)
C12N 2740/10034 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09856469 Lisowski et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (Palo Alto, California)
ASSIGNEE(S) The Board of Trustees of The Leland Stanford Junior University (Stanford, California)
INVENTOR(S) Leszek Lisowski (San Mateo, California);  Mark A. Kay (Los Altos, California)
ABSTRACT Recombinant adeno-associated viral (AAV) capsid proteins are provided. Methods for generating the recombinant adeno-associated viral capsid proteins and a library from which the capsids are selected are also provided.
FILED Monday, September 14, 2015
APPL NO 14/853552
ART UNIT 1636 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Peptides
C07K 14/005 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 7/00 (20130101)
C12N 15/1058 (20130101) Original (OR) Class
C12N 2750/14121 (20130101)
C12N 2750/14122 (20130101)
C12N 2750/14141 (20130101)
C12N 2750/14143 (20130101)
C12N 2750/14151 (20130101)
C12N 2750/14152 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09856472 Pierce et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) California Institute of Technology (Pasadena, California)
ASSIGNEE(S) CALIFORNIA INSTITUTE OF TECHNOLOGY (Pasadena, California)
INVENTOR(S) Niles A. Pierce (Pasadena, California);  Lisa Hochrein (Pasadena, California)
ABSTRACT The present subject matter relates to the use conditional hairpins, such as, but not limited to shRNAs. The conditional formation of these structures can allow for further events, such as gene silencing (in some embodiments).
FILED Monday, June 30, 2014
APPL NO 14/320479
ART UNIT 1634 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/111 (20130101) Original (OR) Class
C12N 2310/531 (20130101)
C12N 2320/50 (20130101)
C12N 2330/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09856474 Singh et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
APPLICANT(S) Iowa State University Research Foundation, Inc. (Ames, Iowa)
ASSIGNEE(S) Iowa State University Research Foundation, Inc. (Ames, Iowa)
INVENTOR(S) Ravindra N. Singh (Ames, Iowa);  Natalia N. Singh (Ames, Iowa)
ABSTRACT The present invention is directed to methods and compositions for blocking the effect of the intronic inhibitory splicing region of intron 7 of the SMN2 gene. The compositions and methods of the instant invention include short oligonucleotide reagents (e.g., oligoribonucleotides) that effectively target sites in the SMN2 pre-mRNA, thereby modulating the splicing of SMN2 pre-mRNA to include exon 7 in the processed transcript. The target regions include a unique RNA structure and a 6-nucleotide long sequence that is essential for initiating a long distance steric inhibitory interaction. The identified region provides a novel target deep within SMN2 intron 7. Intronic targets are highly desirable as annealing of an ASO to an intron does not interfere with translation and transport of mRNA. The invention also provides opportunity to employ a short antisense oligonucleotide or a small compound against the unique RNA structure responsible of SMN2 exon 7 skipping in SMA.
FILED Thursday, January 16, 2014
APPL NO 14/647952
ART UNIT 1674 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/113 (20130101) Original (OR) Class
C12N 2310/11 (20130101)
C12N 2310/113 (20130101)
C12N 2310/314 (20130101)
C12N 2310/315 (20130101)
C12N 2310/321 (20130101)
C12N 2310/345 (20130101)
C12N 2310/3231 (20130101)
C12N 2310/3233 (20130101)
C12N 2310/3521 (20130101)
C12N 2320/33 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09856478 Chang et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) Trustees of Dartmouth College (Hanover, New Hampshire)
ASSIGNEE(S) TRUSTEES OF DARTMOUTH COLLEGE (Hanover, New Hampshire)
INVENTOR(S) Ta-Yuan Chang (Etna, New Hampshire);  Catherine C. Y. Chang (Etna, New Hampshire);  Li-Hao Huang (West Lebanon, New Hampshire);  Elaina Melton (Hanover, New Hampshire);  Paul Sohn (Las Vegas, Nevada)
ABSTRACT The present invention features methods for preventing and treating three related diseases, diet-induced obesity, metabolic syndrome, and atherosclerosis, alone or in combination by inhibiting Acyl-CoA:Cholesterol Acyltransferase 1 (ACATI) activity or expression in myeloid cells.
FILED Wednesday, September 10, 2014
APPL NO 15/035780
ART UNIT 1674 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Animal Husbandry; Care of Birds, Fishes, Insects; Fishing; Rearing or Breeding Animals, Not Otherwise Provided For; New Breeds of Animals
A01K 67/0271 (20130101)
A01K 2207/12 (20130101)
A01K 2227/105 (20130101)
A01K 2267/0362 (20130101)
A01K 2267/0375 (20130101)

Preparations for Medical, Dental, or Toilet Purposes
A61K 9/127 (20130101)
A61K 31/713 (20130101)
A61K 31/7105 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/1137 (20130101) Original (OR) Class
C12N 2310/14 (20130101)
C12N 2310/141 (20130101)
C12N 2750/14143 (20130101)

Enzymes
C12Y 203/01009 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09856479 Lee et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) The General Hospital Corporation (Boston, Massachusetts)
ASSIGNEE(S) The General Hospital Corporation (Boston, Massachusetts)
INVENTOR(S) Jeannie T. Lee (Cambridge, Massachusetts);  Jing Zhao (San Diego, California);  Kavitha Sarma (Waltham, Massachusetts);  Mark Borowsky (Needham, Massachusetts);  Toshiro Kendrick Ohsumi (Cambridge, Massachusetts)
ABSTRACT This invention relates to long non-coding RNAs (lncRNAs), libraries of those ncRNAs that bind chromatin modifiers, such as Polycomb Repressive Complex 2, inhibitory nucleic acids and methods and compositions for targeting lncRNAs.
FILED Thursday, June 02, 2016
APPL NO 15/171860
ART UNIT 1674 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/1271 (20130101)
A61K 31/713 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/113 (20130101)
C12N 15/1135 (20130101)
C12N 15/1136 (20130101)
C12N 15/1137 (20130101) Original (OR) Class
C12N 2310/14 (20130101)
C12N 2310/113 (20130101)
C12N 2310/141 (20130101)
C12N 2310/314 (20130101)
C12N 2310/315 (20130101)
C12N 2310/321 (20130101)
C12N 2310/346 (20130101)
C12N 2310/3181 (20130101)
C12N 2310/3231 (20130101)
C12N 2310/3233 (20130101)
C12N 2320/30 (20130101)
C12N 2320/32 (20130101)
C12N 2330/31 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6876 (20130101)
C12Q 1/6881 (20130101)
C12Q 1/6886 (20130101)
C12Q 2600/136 (20130101)
C12Q 2600/158 (20130101)
C12Q 2600/178 (20130101)

Enzymes
C12Y 201/01043 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09856481 Harris et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) ANN AND ROBERT H. LURIE CHILDREN'S HOSPITAL OF CHICAGO (Chicago, Illinois)
ASSIGNEE(S) Ann and Robert H. Lurie Children's Hospital (Chicago, Illinois)
INVENTOR(S) Ann Harris (Chicago, Illinois);  Lindsay R. Stolzenburg (Chicago, Illinois)
ABSTRACT Provided herein are microRNAs that target transforming growth factor beta (TGF-β) receptors and attenuate pathways of fibrosis. In particular, microRNA-1343 reduces expression of TGFBR1 and TGFBR2, decreases TGF-β signaling, represses pathways of fibrosis, and treats fibrotic diseases.
FILED Friday, August 12, 2016
APPL NO 15/235682
ART UNIT 1674 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/1138 (20130101) Original (OR) Class
C12N 2310/141 (20130101)
C12N 2320/30 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09856513 Cerf et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute on Drug Abuse (NIDA)
APPLICANT(S) CORNELL UNIVERSITY (Ithaca, New York)
ASSIGNEE(S) CORNELL UNIVERSITY (Ithaca, New York)
INVENTOR(S) Aline Cerf (Toulous, France);  Harold G. Craighead (Ithaca, New York);  Harvey C. Tian (Fayetteville, Arkansas)
ABSTRACT The present invention relates to methods and arrays for use in high resolution imaging of individual nucleic acid molecules and chromatin fragments, including native chromatin fragments. In one aspect, the present invention relates to a chromatin array that includes a transfer platform having a support and a transfer surface layered on the support. The chromatin array also includes a plurality of elongated individual native chromatin fragments coupled to the transfer surface in an orderly pattern suitable for high resolution imaging of the plurality of native chromatin fragments. The native chromatin fragments of the chromatin array include both DNA and histones.
FILED Monday, January 28, 2013
APPL NO 14/374819
ART UNIT 1639 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6806 (20130101) Original (OR) Class
C12Q 1/6837 (20130101)
C12Q 1/6837 (20130101)
C12Q 2522/101 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 1/30 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09856521 Stevens et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Human Genome Research Institute (NHGRI)
APPLICANT(S) BioSpyder Technologies, Inc. (Carlsbad, California)
ASSIGNEE(S) BioSpyder Technologies, Inc. (Carlsbad, California)
INVENTOR(S) Anthony Stevens (San Diego, California);  Bruce Seligmann (Tuscon, Arizona);  Joanne M. Yeakley (Encinitas, California);  Joel McComb (Rancho Santa Fe, California)
ABSTRACT Ligation assays in liquid phase for detecting nucleic acid sequences.
FILED Tuesday, June 30, 2015
APPL NO 14/788670
ART UNIT 1634 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6827 (20130101) Original (OR) Class
C12Q 1/6827 (20130101)
C12Q 1/6827 (20130101)
C12Q 2521/307 (20130101)
C12Q 2521/325 (20130101)
C12Q 2521/325 (20130101)
C12Q 2525/155 (20130101)
C12Q 2525/155 (20130101)
C12Q 2525/161 (20130101)
C12Q 2525/161 (20130101)
C12Q 2525/185 (20130101)
C12Q 2525/185 (20130101)
C12Q 2525/186 (20130101)
C12Q 2525/186 (20130101)
C12Q 2533/101 (20130101)
C12Q 2533/101 (20130101)
C12Q 2533/107 (20130101)
C12Q 2533/107 (20130101)
C12Q 2535/122 (20130101)
C12Q 2535/122 (20130101)
C12Q 2565/629 (20130101)
C12Q 2565/629 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09856536 Sharifi et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) THE CLEVELAND CLINIC FOUNDATION (Cleveland, Ohio)
ASSIGNEE(S) THE CLEVELAND CLINIC FOUNDATION (Cleveland, Ohio)
INVENTOR(S) Nima Sharifi (Shaker Hts., Ohio);  Kai-Hsiung Chang (Cleveland, Ohio)
ABSTRACT Methods and kits for characterizing a subject having a steroid-dependent disease such as prostate cancer are described. A method of treating a steroid-dependent disease in a subject by obtaining a biological sample from the subject, determining if the HSD3B1(1245C) gene or 3βHSD1(367T) protein is expressed in the biological sample, and providing treatment other than or in addition to steroid ablation to the subject if the HSD3B1(1245C) gene or 3βHSD1(367T) protein is expressed is also described.
FILED Monday, July 14, 2014
APPL NO 14/330177
ART UNIT 1634 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/58 (20130101)
A61K 31/58 (20130101)
A61K 31/4166 (20130101)
A61K 31/4166 (20130101)
A61K 2300/00 (20130101)
A61K 2300/00 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6886 (20130101) Original (OR) Class
C12Q 2600/106 (20130101)
C12Q 2600/156 (20130101)
C12Q 2600/158 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/57434 (20130101)
G01N 2333/904 (20130101)
G01N 2800/52 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09856539 Schaffer et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Eye Institute (NEI)
APPLICANT(S) The Regents of the University of California (Oakland, California)
ASSIGNEE(S) The Regents of the University of California (Oakland, California)
INVENTOR(S) David V. Schaffer (Danville, California);  Ryan R. Klimczak (San Francisco, California);  James T. Koerber (San Francisco, California);  John G. Flannery (Berkeley, California);  Deniz Dalkara Mourot (Berkeley, California);  Meike Visel (El Cerrito, California);  Leah C. T. Byrne (Berkeley, California)
ABSTRACT The present disclosure provides adeno-associated virus (AAV) virions with altered capsid protein, where the AAV virions exhibit greater infectivity of retinal cells, when administered via intravitreal injection, compared to wild-type AAV. The present disclosure further provides methods of delivering a gene product to a retinal cell in an individual, and methods of treating ocular disease.
FILED Tuesday, January 27, 2015
APPL NO 14/606543
ART UNIT 1633 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/0019 (20130101)
A61K 9/0048 (20130101)
A61K 38/1709 (20130101)
A61K 48/0008 (20130101)
A61K 48/0025 (20130101)
A61K 48/0075 (20130101)

Peptides
C07K 14/005 (20130101)
C07K 2319/33 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 7/00 (20130101)
C12N 15/86 (20130101)
C12N 15/113 (20130101)
C12N 15/115 (20130101)
C12N 2310/14 (20130101)
C12N 2310/16 (20130101)
C12N 2320/32 (20130101)
C12N 2750/14021 (20130101)
C12N 2750/14121 (20130101)
C12N 2750/14122 (20130101)
C12N 2750/14142 (20130101)
C12N 2750/14143 (20130101)
C12N 2750/14145 (20130101)
C12N 2750/14152 (20130101)
C12N 2810/40 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/70 (20130101)
C12Q 1/701 (20130101) Original (OR) Class
C12Q 2600/16 (20130101)
C12Q 2600/158 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/5008 (20130101)
G01N 33/5058 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09857354 Aneja et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) NOVAZOI THERANOSTICS, INC. (Plano, Texas)
ASSIGNEE(S) NOVAZOI THERANOSTICS, INC. (Plano, Texas)
INVENTOR(S) Ritu Aneja (Lilburn, Georgia);  Padmashree C. G. Rida (Plano, Texas)
ABSTRACT A protocol for assessing the prognosis for a patient diagnosed with a neoplasm or suspected of having a neoplasm is provided herein. The protocol involves the steps of determining a mitotic cells to proliferating cells ratio (M:P ratio) in a neoplastic tissue sample obtained from the patient and producing a prognosis for the neoplasm based on the M:P ratio.
FILED Friday, May 29, 2015
APPL NO 14/725862
ART UNIT 1657 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/5005 (20130101) Original (OR) Class
G01N 33/5011 (20130101)
G01N 33/57496 (20130101)
G01N 2800/52 (20130101)
G01N 2800/7028 (20130101)

Electric Digital Data Processing
G06F 19/10 (20130101)
G06F 19/345 (20130101)
G06F 19/3431 (20130101)
G06F 19/3487 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09857374 LaBaer et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Joshua LaBaer (Chandler, Arizona);  Karen Sue Anderson (Chestnut Hill, Massachusetts);  Garrick Wallstrom (Mesa, Arizona);  Sahar Sibani (La Mesa, California);  Niroshan Ramachandran (San Marcos, California)
ASSIGNEE(S) Arizona Board of Regents, A Body Corporate Acting For and On Behalf of Arizona State University (Scottsdale, Arizona);  President and Fellows of Harvard College (Cambridge, Massachusetts);  Dana Farber Cancer Institute, Inc. (Boston, Massachusetts)
INVENTOR(S) Joshua LaBaer (Chandler, Arizona);  Karen Sue Anderson (Chestnut Hill, Massachusetts);  Garrick Wallstrom (Mesa, Arizona);  Sahar Sibani (La Mesa, California);  Niroshan Ramachandran (San Marcos, California)
ABSTRACT The present invention provides reagents and methods for breast cancer detection.
FILED Monday, August 15, 2011
APPL NO 13/809695
ART UNIT 1647 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6886 (20130101)
C12Q 2600/158 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/57415 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09857380 Sakai et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) Lynn Y. Sakai (Portland, Oregon);  Lynn M. Marshall (Portland, Oregon);  Eric J. Carlson (Portland, Oregon);  Noe L. Charbonneau (Portland, Oregon);  Susan J. Hayflick (Portland, Oregon)
ASSIGNEE(S) SHRINERS HOSPITAL FOR CHILDREN (Tampa, Florida)
INVENTOR(S) Lynn Y. Sakai (Portland, Oregon);  Lynn M. Marshall (Portland, Oregon);  Eric J. Carlson (Portland, Oregon);  Noe L. Charbonneau (Portland, Oregon);  Susan J. Hayflick (Portland, Oregon)
ABSTRACT The present invention makes use of immunoassays, such as sandwich ELISAs, to profile the circulating concentration of elastic fiber and microfibril fragments in samples from individuals with diseases associated with elastic fiber and/or microfibril degradation. Examples of such diseases include, Marfan's syndrome, aortic aneurysm, and scleroderma. Profiling the concentration of such fragments can be used to diagnose disease and monitor disease progression.
FILED Tuesday, October 25, 2011
APPL NO 13/280644
ART UNIT 1642 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Animal Husbandry; Care of Birds, Fishes, Insects; Fishing; Rearing or Breeding Animals, Not Otherwise Provided For; New Breeds of Animals
A01K 67/0276 (20130101)
A01K 2217/075 (20130101)
A01K 2227/105 (20130101)
A01K 2267/03 (20130101)

Peptides
C07K 14/78 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/8509 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/6887 (20130101) Original (OR) Class
G01N 2333/78 (20130101)
G01N 2800/32 (20130101)
G01N 2800/329 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09857382 Sangaralingham et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) Mayo Foundation for Medical Education and Research (Rochester, Minnesota)
ASSIGNEE(S) Mayo Foundation for Medical Education and Research (Rochester, Minnesota)
INVENTOR(S) Sasantha J. Sangaralingham (Rochester, Minnesota);  John C. Burnett, Jr. (Rochester, Minnesota);  Alessandro Cataliotti (Rochester, Minnesota);  Denise M. Heublein (Altura, Minnesota)
ABSTRACT This document provides methods and materials involved in assessing renal structural alterations (e.g., renal fibrosis, glomerular basement thickening, mesangial matrix expansion, swollen podocytes, and foot processes effacement) as well as methods and materials involved in assessing outcomes. For example, methods and materials for using the level of urinary CNP (e.g., a urinary to plasma CNP ratio) to determine whether or not a mammal is developing renal structural alterations (e.g., renal fibrosis, glomerular basement thickening, mesangial matrix expansion, swollen podocytes, and foot processes effacement) as well as methods and materials for using the level of urinary CNP levels to identify patients having an increased likelihood of experiencing a poor outcome are provided.
FILED Wednesday, March 23, 2016
APPL NO 15/078835
ART UNIT 1647 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/2242 (20130101)
A61K 45/06 (20130101)

Peptides
C07K 14/58 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/6893 (20130101) Original (OR) Class
G01N 2333/58 (20130101)
G01N 2800/04 (20130101)
G01N 2800/32 (20130101)
G01N 2800/042 (20130101)
G01N 2800/52 (20130101)
G01N 2800/56 (20130101)
G01N 2800/324 (20130101)
G01N 2800/325 (20130101)
G01N 2800/347 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09857446 Zhang et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
APPLICANT(S) The Board of Trustees of the Leland Stanford Junior University (Palo Alto, California)
ASSIGNEE(S) The Board of Trustees of the Leland Stanford Junior University (Palo Alto, California)
INVENTOR(S) Tao Zhang (Stanford, California);  John M. Pauly (Stanford, California);  Yuxin Chen (Stanford, California);  Joseph Y. Cheng (Stanford, California);  Shreyas S. Vasanawala (Stanford, California)
ABSTRACT A method for providing at least one motion corrected magnetic resonance imaging (MRI) image of an object in an MRI system with an array of a plurality of receiving coils is provided. At least one motion navigator signal of the object is provided. Individual navigator data are collected from each of the plurality of receiving coils. Motion estimates are generated for each of the plurality of receiving coils from the collected individual navigator data. A subset of the plurality of coils is found that detects a dominant motion by clustering the generated motion estimates. Only motion estimates from coils in the found subset are used to create a determined motion estimate. At least one MRI image is reconstructed using the determined motion estimate.
FILED Wednesday, January 14, 2015
APPL NO 14/596959
ART UNIT 2852 — Printing/Measuring and Testing
CURRENT CPC
Measuring Electric Variables; Measuring Magnetic Variables
G01R 33/3415 (20130101)
G01R 33/5676 (20130101)
G01R 33/56316 (20130101)
G01R 33/56509 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09858665 Metzger et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Regents of the University of Minnesota (Minneapolis, Minnesota)
ASSIGNEE(S) Regents of the University of Minnesota (Minneapolis, Minnesota)
INVENTOR(S) Gregory J. Metzger (Lake Elmo, Minnesota);  Stephen C. Schmechel (Seattle, Washington);  Chaitanya Kalavagunta (Crofton, Maryland);  Joseph S. Koopmeiners (St. Paul, Minnesota);  Christopher A. Warlick (Lake Elmo, Minnesota)
ABSTRACT A user-independent, quantitative, multiparametric MRI model is developed and validated on co-registered correlative histopathology, yielding improved performance for cancer detection over single parameter estimators. A computing device may be configured to receive a first parametric map that maps imaged tissue of a patient using values of a first parameter, and a second parametric map that maps the imaged tissue using values of a second parameter, wherein the parametric maps are generated from medical imaging data for the imaged tissue. The computing device may be further configured to apply a multiparametric model to the maps to generate at least one Composite Biomarker Score for the tissue, the model being a function of the first parameter and the second parameter. The function may be determined based on co-registered histopathology data. The computing device may be further configured to generate an indication of whether the tissue includes predicted cancer, and output the indication.
FILED Friday, April 01, 2016
APPL NO 15/089273
ART UNIT 2667 — Image Analysis; Applications; Pattern Recognition; Color and compression; Enhancement and Transformation
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/055 (20130101)
A61B 5/4381 (20130101)
A61B 2576/02 (20130101)

Image Data Processing or Generation, in General
G06T 7/0012 (20130101) Original (OR) Class
G06T 2207/10088 (20130101)
G06T 2207/20081 (20130101)
G06T 2207/30024 (20130101)
G06T 2207/30081 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09858687 Oshinski et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Center for Research Resources (NCRR)
APPLICANT(S) EMORY UNIVERSITY (Atlanta, Georgia);  GEORGIA TECH RESEARCH CORPORATION (Atlanta, Georgia)
ASSIGNEE(S) Emory University (Atlanta, Georgia);  Georgia Tech Research Corporation (Atlanta, Georgia)
INVENTOR(S) John N. Oshinski (Decatur, Georgia);  Jonathan D. Suever (Atlanta, Georgia);  Michael S. Lloyd (Avondale Estates, Georgia);  Angel R. Leon (Atlanta, Georgia)
ABSTRACT Systems, methods and computer-readable storage mediums relate to generating an image that includes functional, anatomical, and physiological images. The generated image may be an integrated image based on the functional image on which the anatomical and physiological images are mapped. The generated image may indicate more than one location of optimal lead placement. The generated image may be useful in pre-planning cardiac intervention procedures.
FILED Wednesday, January 16, 2013
APPL NO 13/742648
ART UNIT 2668 — Image Analysis; Applications; Pattern Recognition; Color and compression; Enhancement and Transformation
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/04012 (20130101)
A61B 2090/374 (20160201)

Measuring Electric Variables; Measuring Magnetic Variables
G01R 33/56325 (20130101)

Image Data Processing or Generation, in General
G06T 3/0068 (20130101)
G06T 7/33 (20170101)
G06T 11/005 (20130101) Original (OR) Class
G06T 2207/10072 (20130101)
G06T 2207/10088 (20130101)
G06T 2207/10096 (20130101)
G06T 2207/20221 (20130101)
G06T 2207/30048 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09858915 Kuo et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute on Deafness and Other Communication Disorders (NIDCD)
APPLICANT(S) NORTHERN ILLINOIS RESEARCH FOUNDATION (Dekalb, Illinois)
ASSIGNEE(S) Northern Illinois Research Foundation (DeKalb, Illinois)
INVENTOR(S) Sen M. Kuo (Dekalb, Illinois);  Lichuan Liu (Batavia, Illinois)
ABSTRACT Systems, apparatuses and methods for integrating adaptive noise cancellation (ANC) with communication features in an enclosure, such as an incubator, bed, and the like. Utilizing one or more error and reference microphones, a controller for a noise cancellation portion reduces noise within a quiet area of the enclosure. Voice communications are provided to allow external voice signals to be transmitted to the enclosure with minimized interference with noise processing. Vocal communications from within the enclosure may be processed to determine certain characteristics/features of the vocal communications. Using these characteristics, certain emotive and/or physiological states may be identified.
FILED Wednesday, November 30, 2016
APPL NO 15/365496
ART UNIT 2688 — Dynamic Storage Systems; Mechanical parts of Disk Drives
CURRENT CPC
Household or Table Equipment
A47G 9/10 (20130101)
A47G 2009/006 (20130101)

Transport, Personal Conveyances, or Accommodation Specially Adapted for Patients or Disabled Persons; Operating Tables or Chairs; Chairs for Dentistry; Funeral Devices
A61G 11/00 (20130101)

Sound-producing Devices; Methods or Devices for Protecting Against, or for Damping, Noise or Other Acoustic Waves in General; Acoustics Not Otherwise Provided for
G10K 11/178 (20130101)
G10K 11/1786 (20130101) Original (OR) Class
G10K 2210/116 (20130101)
G10K 2210/1081 (20130101)
G10K 2210/3014 (20130101)

Loudspeakers, Microphones, Gramophone Pick-ups or Like Acoustic Electromechanical Transducers; Deaf-aid Sets; Public Address Systems
H04R 3/002 (20130101)
H04R 3/12 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Defense (DOD) 

US 09855055 Kosiorek et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
U.S. Army Medical Research and Materiel Command (USAMRMC)
APPLICANT(S) Christopher B. Kosiorek (La Vernia, Texas);  Dexter C. Drayton (San Antonio, Texas);  Esra Abir (New York, New York);  Neslihan Damar (Istanbul, Turkey);  Nilufer Polat (Brooklyn, New York);  Yavuz Avci (Sunnyside, New York)
ASSIGNEE(S) ALPHAPOINTE (Kansas City, Missouri);  THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (Washington, District of Columbia)
INVENTOR(S) Christopher B. Kosiorek (La Vernia, Texas);  Dexter C. Drayton (San Antonio, Texas);  Esra Abir (New York, New York);  Neslihan Damar (Istanbul, Turkey);  Nilufer Polat (Brooklyn, New York);  Yavuz Avci (Sunnyside, New York)
ABSTRACT A pre-fabricated tourniquet that is easy to apply, that ensures consistent and even circumferential pressure, that is light weight, that provides standard life saving operation, and that can be utilized in any setting or situation, and related methods are provided. Mechanically constricting tourniquet apparatus and related methods are provided that are comprised of a tourniquet body, a carriage, a torsion bar, a receiver and a slider. The tourniquet is long enough to encircle a human limb, for example, an arm or leg.
FILED Monday, September 29, 2014
APPL NO 14/500084
ART UNIT 3731 — Sheet Container Making, Package Making, Receptacles, Shoes, Apparel, and Tool Driving or Impacting
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 17/1322 (20130101)
A61B 17/1327 (20130101) Original (OR) Class

Technical Subjects Covered by Former US Classification
Y10T 29/49826 (20150115)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09855548 Savrun et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Research Laboratory (AFRL)
APPLICANT(S) Sienna Technologies, Inc. (Woodinville, Washington)
ASSIGNEE(S) Sienna Technologies, Inc. (Seattle, Washington)
INVENTOR(S) Ender Savrun (Seattle, Washington);  Stephanie J. Sawhill (Bothell, Washington)
ABSTRACT Ceramic catalyst carriers that are mechanically, thermally and chemically stable in a ionic salt monopropellant decomposition environment, high temperature catalysts for decomposition of liquid high-energy-density monopropellants and ceramic processing techniques for producing spherical catalyst carrier granules are disclosed. The ceramic processing technique is used to produce spherical catalyst carrier granules with controlled porosities and desired composition and allows for reproducible packing densities of catalyst granules in thruster chambers. The ceramic catalyst carrier has excellent thermal shock resistance, good compatibility with the active metal coating and metal coating deposition processes, melting point above >2300° C., chemical resistance to steam, nitrogen oxides and nitric acid, resistance to sintering to prevent void formation, and the absence of phase transition associated with volumetric changes at temperatures up to and beyond 1800° C.
FILED Thursday, June 19, 2014
APPL NO 14/309044
ART UNIT 1735 — Metallurgy, Metal Working, Inorganic Chemistry, Catalyst, Electrophotography, Photolithography
CURRENT CPC
Chemical or Physical Processes, e.g Catalysis or Colloid Chemistry; Their Relevant Apparatus
B01J 23/007 (20130101)
B01J 23/36 (20130101)
B01J 23/42 (20130101)
B01J 23/462 (20130101)
B01J 23/464 (20130101)
B01J 23/466 (20130101)
B01J 23/468 (20130101) Original (OR) Class
B01J 35/002 (20130101)
B01J 35/1019 (20130101)
B01J 37/0215 (20130101)

Lime, Magnesia; Slag; Cements; Compositions Thereof, e.g Mortars, Concrete or Like Building Materials; Artificial Stone; Ceramics; Refractories; Treatment of Natural Stone
C04B 35/01 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09855554 Ingber et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
APPLICANT(S) President and Fellows of Harvard College (Cambridge, Massachusetts)
ASSIGNEE(S) PRESIDENT AND FELLOWS OF HARVARD COLLEGE (Cambridge, Massachusetts)
INVENTOR(S) Donald E. Ingber (Boston, Massachusetts);  Daniel Levner (Cambridge, Massachusetts);  Guy Thompson, II (Lexington, Massachusetts);  Christopher David Hinojosa (Cambridge, Massachusetts)
ABSTRACT According to aspects of the present invention, a cartridge assembly for transporting fluid into or out of one or more fluidic devices includes a first layer and a second layer. The first layer includes a first surface. The first surface includes at least one partial channel disposed thereon. The second layer abuts the first surface, thereby forming a channel from the at least one partial channel. At least one of the first layer and the second layer is a resilient layer formed from a pliable material. At least one of the first layer and the second layer includes a via hole. The via hole is aligned with the channel to pass fluid thereto. The via hole is configured to pass fluid through the first layer or the second layer substantially perpendicularly to the channel. Embossments are also used to define aspects of a fluidic channel.
FILED Tuesday, July 22, 2014
APPL NO 14/906335
ART UNIT 1797 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry
CURRENT CPC
Chemical or Physical Laboratory Apparatus for General Use
B01L 3/56 (20130101)
B01L 3/502707 (20130101)
B01L 3/502715 (20130101) Original (OR) Class
B01L 2200/12 (20130101)
B01L 2200/027 (20130101)
B01L 2200/0684 (20130101)
B01L 2200/0689 (20130101)
B01L 2300/123 (20130101)
B01L 2300/0645 (20130101)
B01L 2300/0816 (20130101)
B01L 2300/0874 (20130101)
B01L 2300/0887 (20130101)
B01L 2400/0481 (20130101)
B01L 2400/0655 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09856018 King et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S) The Boeing Company (Chicago, Illinois)
ASSIGNEE(S) THE BOEING COMPANY (Chicago, Illinois)
INVENTOR(S) Carl King (Apache Junction, Arizona);  Glenn Thomas Pyle (Mesa, Arizona)
ABSTRACT Example doors for ducted fan inlet openings are disclosed herein. An example apparatus disclosed herein includes a door and a duct of a ducted fan unit extending through a body of an aircraft. The duct of the example apparatus defines a passageway between a first opening in a first side of the body and a second opening in a second side of the body opposite the first side. The example apparatus also includes an actuation system to move the door between a first position in which the door is disposed over the first opening and a second position in which the door is disposed over the first side of the body and outside of a diameter of the first opening. In the example apparatus, the door is orientated generally parallel to the first side of the body throughout movement of the door between the first position and the second position.
FILED Monday, January 11, 2016
APPL NO 14/992283
ART UNIT 3644 — Aeronautics, Agriculture, Fishing, Trapping, Vermin Destroying, Plant and Animal Husbandry, Weaponry, Nuclear Systems, and License and Review
CURRENT CPC
Aeroplanes; Helicopters
B64C 29/0025 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09856181 Sabatini et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
APPLICANT(S) Jesse J. Sabatini (Bel Air, Maryland);  Jared D. Moretti (Randolph, New Jersey)
ASSIGNEE(S) The United States of America as Represented by the Secretary of the Army (Washington, District of Columbia)
INVENTOR(S) Jesse J. Sabatini (Bel Air, Maryland);  Jared D. Moretti (Randolph, New Jersey)
ABSTRACT The present invention is a red-light-emitting composition based upon a potassium periodate oxidizer formulation, which is useful as the illuminant in the US military's M662 40 mm red star parachute projectile, and which composition is composed of readily commercially available ingredients—ingredients that are environmentally friendly. Further, the subject inventive potassium periodate formulation provides significant enhanced illumination and safety versus the current military M662 illuminant which is based upon potassium perchlorate oxidizer formulation.
FILED Thursday, March 19, 2015
APPL NO 14/662383
ART UNIT 1735 — Metallurgy, Metal Working, Inorganic Chemistry, Catalyst, Electrophotography, Photolithography
CURRENT CPC
Explosives or Thermic Compositions; Manufacture Thereof; Use of Single Substances as Explosives
C06B 33/14 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09856260 Fatatis et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
U.S. Army Medical Research and Materiel Command (USAMRMC)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute on Drug Abuse (NIDA)
APPLICANT(S) Drexel University (Philadelphia, Pennsylvania);  Alliance Discovery, Inc. (Doylestown, Pennsylvania)
ASSIGNEE(S) Drexel University (Philadelphia, Pennsylvania);  Alliance Discovery, Inc. (Doylestown, Pennsylvania)
INVENTOR(S) Alessandro Fatatis (Penn Valley, Pennsylvania);  Joseph M. Salvino (Chester Springs, Pennsylvania);  Olimpia Meucci (Penn Valley, Pennsylvania);  Whitney L. Gladney (Glenolden, Pennsylvania)
ABSTRACT The present invention includes compositions that are useful in preventing or treating metastasis in a subject diagnosed with cancer. The present invention also includes methods of preventing or treating metastasis in a subject diagnosed with cancer, wherein the method comprises administering to the subject in need thereof an effective amount of a pharmaceutical formulation comprising at least one pharmaceutically acceptable carrier and at least one CX3CR1 or fractalkine antagonist.
FILED Monday, June 06, 2016
APPL NO 15/174227
ART UNIT 1627 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/451 (20130101)
A61K 31/453 (20130101)
A61K 31/7088 (20130101)
A61K 39/3955 (20130101)

Heterocyclic Compounds
C07D 403/04 (20130101)
C07D 487/04 (20130101) Original (OR) Class

Peptides
C07K 16/28 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09856328 Grau et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
APPLICANT(S) The United States of America as Represented by the Secretary of the Army (Washington, District of Columbia)
ASSIGNEE(S) The United States of America as Represented by the Secretary of the Army (Washington, District of Columbia)
INVENTOR(S) Henry Grau (Wantage, New Jersey);  Alexander Fadeev (Yardley, Pennsylvania)
ABSTRACT Described herein are methods for chemical modification of nitrocellulose to generate lyophobic properties which are useful in propellant compositions. Such methods include the steps of: a) dissolving neat nitrocellulose in an organic solvent; b) adding a silyl based isocyanate and a catalyst to the solution; (d) stirring the solution in a moisture free environment; e) hydrolyzing the solution by exposing said solution to moisture; and (e) adding fluorinated oxysilane. The modified nitrocellulose retains its energetic properties while exhibiting high water and organic solvent phobicity, effectively functioning as a barrier to migration or diffusion of liquid components in propellant compositions.
FILED Thursday, June 02, 2016
APPL NO 15/170999
ART UNIT 1673 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Explosives or Thermic Compositions; Manufacture Thereof; Use of Single Substances as Explosives
C06B 25/18 (20130101)

Polysaccharides; Derivatives Thereof
C08B 5/02 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09856343 Palmese et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
APPLICANT(S) Drexel University (Philadelphia, Pennsylvania);  The United States of America as represented by the Secretary of the Army (Washington, District of Columbia)
ASSIGNEE(S) Drexel University (Philadelphia, Pennsylvania);  The United States of America as Represented by the Secretary of the Army (Washington, District of Columbia)
INVENTOR(S) Giuseppe R. Palmese (Hainesport, New Jersey);  John Joseph La Scala (Wilmington, Delaware);  Joshua Matthew Sadler (Middle River, Maryland);  Anh-Phuong Thy Lam (Newark, Delaware)
ABSTRACT Anhydrosugar-based monomers prepared from isosorbide, isomannide, and isoidide and resin systems containing these anhydrosugar-based monomers that are partially to fully bio-based, which may produce materials having properties that meet or exceed the properties of similar petroleum derived vinyl ester resins.
FILED Thursday, March 30, 2017
APPL NO 15/474101
ART UNIT 1763 — Organic Chemistry, Polymers, Compositions
CURRENT CPC
Heterocyclic Compounds
C07D 493/04 (20130101)

Macromolecular Compounds Obtained by Reactions Only Involving Carbon-to-carbon Unsaturated Bonds
C08F 122/20 (20130101)
C08F 124/00 (20130101)
C08F 220/32 (20130101)
C08F 222/20 (20130101) Original (OR) Class
C08F 224/00 (20130101)
C08F 2220/325 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09856499 Bennett et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
Army Research Office (CCDC ARO)
APPLICANT(S) William Marsh Rice University (Houston, Texas)
ASSIGNEE(S) William Marsh Rice University (Houston, Texas)
INVENTOR(S) George N. Bennett (Houston, Texas);  Xianpeng Cai (Houston, Texas)
ABSTRACT Method of cell culture, comprising adding a redox active compound with a redox potential of between −0.116 to −0.253 to a culture capable of forming hydrogen via a hydrogenase so that the redox potential is diverted from hydrogen to form a longer chain acids, e.g., butryic acid.
FILED Thursday, December 20, 2012
APPL NO 14/355402
ART UNIT 1653 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 1/20 (20130101)
C12N 1/38 (20130101)

Fermentation or Enzyme-using Processes to Synthesise a Desired Chemical Compound or Composition or to Separate Optical Isomers From a Racemic Mixture
C12P 7/40 (20130101)
C12P 7/52 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09856532 Hood et al.
FUNDED BY
Department of Defense (DOD)
APPLICANT(S) Institute for Systems Biology (Seattle, Washington)
ASSIGNEE(S) INSTITUTE FOR SYSTEMS BIOLOGY (Seattle, Washington)
INVENTOR(S) Leroy Hood (Seattle, Washington);  Kai Wang (Bellevue, Washington);  Inyoul Lee (Seattle, Washington);  Yong Zhou (Seattle, Washington);  Ji Hoon Cho (Seattle, Washington);  Dhimankrishna Ghosh (Seattle, Washington)
ABSTRACT Concentrations of certain miRNA, mRNA and/or protein markers in the biological fluids and/or tissues of a subject are used to determine the probability that the subject does or does not have Posttraumatic Stress Disorder (PTSD). The concentrations of these markers in fluids and/or tissues are different in subjects with PTSD as compared to subjects who do not suffer from this disorder.
FILED Thursday, March 14, 2013
APPL NO 13/830326
ART UNIT 1639 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6881 (20130101) Original (OR) Class
C12Q 1/6883 (20130101)
C12Q 2600/158 (20130101)
C12Q 2600/178 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09856566 Burns et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
APPLICANT(S) The United States of America as represented by the Secretary of the Air Force (Washington, District of Columbia)
ASSIGNEE(S) The United States of America as represented by the Secretary of the Air Force (Washington, District of Columbia)
INVENTOR(S) Andrew Michael Burns (Highland Village, Texas);  Matthew James Gutgsell (Jasper, Indiana);  Michael David Lee (Orlando, Florida);  Thomas Anthony Lepley (Gambrills, Maryland);  Zachary Paul Schrock (Prairie Grove, Arkansas);  Tony Harrison Zilli (Bellevue, Nebraska);  Kevin A Gibbons (Colorado Springs, Colorado)
ABSTRACT A monitored anode apparatus is provided. The apparatus includes a metal body having an exterior and a core, and a plurality of electrically conductive probes passing through the exterior and disposed at respective depths within the core. At least one of the plurality of conductive probes is disposed at a first depth, and at least one of the plurality of conductive probes is disposed at a second depth greater than the first depth. A bonding conductor is in electrical communication with the body and configured to create electrical continuity between the body and a protected structure. The metal body is configured as a galvanic anode, and at least one of the plurality of probes is configured to break electrical conductivity with the body upon galvanic consumption thereof.
FILED Tuesday, July 28, 2015
APPL NO 14/810504
ART UNIT 1759 — Coating, Etching, Cleaning, Single Crystal Growth
CURRENT CPC
Non-mechanical Removal of Metallic Material From Surface; Inhibiting Corrosion of Metallic Material or Incrustation in General; Multi-step Processes for Surface Treatment of Metallic Material Involving at Least One Process Provided for in Class C23 and at Least One Process Covered by Subclass C21D or C22F or Class C25
C23F 13/04 (20130101)
C23F 13/22 (20130101) Original (OR) Class
C23F 2213/10 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09856737 Propheter-Hinckley
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
APPLICANT(S) UNITED TECHNOLOGIES CORPORATION (Farmington, Connecticut)
ASSIGNEE(S) UNITED TECHNOLOGIES CORPORATION (Farmington, Connecticut)
INVENTOR(S) Tracy A. Propheter-Hinckley (Manchester, Connecticut)
ABSTRACT A blade damper for a gas turbine blade includes a blade damper body with a first damping surface and a second damping surface. The first damping surface is on a first side of the damper body and the second damping surface is on a second side of the damper body opposite the first damping surface for providing full functionality in both flipped and unflipped orientations.
FILED Thursday, March 05, 2015
APPL NO 14/639490
ART UNIT 3745 — Thermal & Combustion Technology, Motive & Fluid Power Systems
CURRENT CPC
Non-positive Displacement Machines or Engines, e.g Steam Turbines
F01D 5/16 (20130101) Original (OR) Class
F01D 5/22 (20130101)
F01D 11/006 (20130101)

Indexing Scheme for Aspects Relating to Non-positive-displacement Machines or Engines, Gas-turbines or Jet-propulsion Plants
F05D 2250/75 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09856956 Place et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
APPLICANT(S) UNITED TECHNOLOGIES CORPORATION (Hartford, Connecticut)
ASSIGNEE(S) United Technologies Corporation (Farmington, Connecticut)
INVENTOR(S) Emma J Place (New Hartford, Connecticut);  Donald W Peters (Colchester, Connecticut)
ABSTRACT The connector system (30) includes a pivoting member (38) pivotally attached to a guide anchor (36) that is moveable secured within a guide track (34). The guide anchor (36) is movably secured between first and second strength walls (58, 62). At least one guide shoulder (70) and the pivoting member (38) define throughbores (74, 76, 78) that receive a rod (92) of a rod-and-bracket connector (88) to pivotally secure the pivoting member (38), such as a convergent flap (26) of an exhaust nozzle assembly (22). The rod-and-bracket connector (88) utilizes an L-shaped arm (96) to eliminate need for a large thread and lock nut assembly (86) between the strength walls (58, 62) to thereby facilitate use of larger, stronger guide shoulders (70, 72) between the strength walls (58, 62) to maximize strength of the connector system (30) while minimizing its volumetric displacement.
FILED Tuesday, January 20, 2015
APPL NO 14/600518
ART UNIT 3658 — Material and Article Handling
CURRENT CPC
Jet-propulsion Plants
F02K 1/12 (20130101)
F02K 1/15 (20130101)

Gearing
F16H 21/06 (20130101)
F16H 21/44 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09857149 Rubtsov et al.
FUNDED BY
Department of Homeland Security (DHS)
Department of Defense (DOD)
APPLICANT(S) Vladimir Rubtsov (Los Angeles, California);  Gennady Sigal (Oakville, California)
ASSIGNEE(S) Optech Ventures, LLC (Torrance, California)
INVENTOR(S) Vladimir Rubtsov (Los Angeles, California);  Gennady Sigal (Oakville, California)
ABSTRACT Apparatus and method for using a light source having spatially separated light emitting areas emitting light at different wavelengths to incapacitate a subject by a pattern of temporal flashing and/or color flashing of the light source. Reflectors adapted for use with spatially separated light substrates provide for light concentration from lower powered optical sources.
FILED Thursday, March 13, 2014
APPL NO 14/209990
ART UNIT 2878 — Optics
CURRENT CPC
Lighting Devices or Systems Thereof, Being Portable or Specially Adapted for Transportation
F21L 4/027 (20130101)

Functional Features or Details of Lighting Devices or Systems Thereof; Structural Combinations of Lighting Devices With Other Articles, Not Otherwise Provided for
F21V 5/04 (20130101)
F21V 7/06 (20130101)
F21V 23/0407 (20130101)

Indexing Scheme Associated With Subclasses F21K, F21L, F21S and F21V, Relating to the Form or the Kind of the Light Sources or of the Colour of the Light Emitted
F21Y 2113/10 (20160801)
F21Y 2115/10 (20160801)

Armour; Armoured Turrets; Armoured or Armed Vehicles; Means of Attack or Defence, e.g Camouflage, in General
F41H 13/0087 (20130101) Original (OR) Class

Electric Heating; Electric Lighting Not Otherwise Provided for
H05B 33/0842 (20130101)
H05B 37/0281 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09857154 Minnicino, II
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
APPLICANT(S) U.S. Army Research Laboratory ATTN: RDRL-LOC-1 (Adelphi, Maryland)
ASSIGNEE(S) The United States of America as represented by the Secretary of the Army (Washington, District of Columbia)
INVENTOR(S) Michael A. Minnicino, II (Baltimore, Maryland)
ABSTRACT A munition having a warhead and an ogive coaxially rotatably mounted to the warhead. A controllable motor is mechanically coupled to the ogive to control the rotational position of the ogive relative to the warhead. The ogive includes an asymmetric surface while a windscreen is detachably connected to the ogive over the asymmetric surface so that, with the windscreen attached to the ogive, the outer surface of the ogive together with the windscreen are axisymmetric in shape. A detachment mechanism, when activated, detaches the windscreen from the ogive which permits steering of the munition by placement of the asymmetric surface relative to the warhead. The introduction of the asymmetric surface during flight produces an asymmetric pressure field resulting in a lateral force on the munition causing is to change direction.
FILED Wednesday, July 30, 2014
APPL NO 14/446377
ART UNIT 3641 — Aeronautics, Agriculture, Fishing, Trapping, Vermin Destroying, Plant and Animal Husbandry, Weaponry, Nuclear Systems, and License and Review
CURRENT CPC
Explosive Charges, e.g for Blasting, Fireworks, Ammunition
F42B 10/62 (20130101)
F42B 12/02 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09857156 McKeon et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
APPLICANT(S) Brian T McKeon (Portsmouth, Rhode Island);  John Sirmalis (Barrington, Rhode Island);  William P. Krol (Portsmouth, Rhode Island)
ASSIGNEE(S) The United States of America as represented by the Secretary of the Navy (Washington, District of Columbia)
INVENTOR(S) Brian T McKeon (Portsmouth, Rhode Island);  John Sirmalis (Barrington, Rhode Island);  William P. Krol (Portsmouth, Rhode Island)
ABSTRACT An extended range support module for an undersea vehicle includes an outer hull capable of accommodating the undersea vehicle therein. A navigation module is positioned on the outer hull and capable of being joined to the undersea vehicle. Controllable fins are provided on the outer hull and joined to allow control by the navigation module. A buoyancy control system is positioned within the outer hull and joined to the navigation module. An extended fuel tank is provided inside the outer hull between the outer hull and the undersea vehicle. The extended fuel tank is joined to provide fuel to the undersea vehicle. The navigation module can have GPS, inertial sensors, and sonar sensors to aid in navigation.
FILED Wednesday, October 07, 2015
APPL NO 14/877025
ART UNIT 3617 — Aeronautics, Agriculture, Fishing, Trapping, Vermin Destroying, Plant and Animal Husbandry, Weaponry, Nuclear Systems, and License and Review
CURRENT CPC
Offensive or Defensive Arrangements on Vessels; Mine-laying; Mine-sweeping; Submarines; Aircraft Carriers
B63G 8/18 (20130101)
B63G 2008/008 (20130101)

Explosive Charges, e.g for Blasting, Fireworks, Ammunition
F42B 19/04 (20130101) Original (OR) Class
F42B 19/06 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09857157 Scheid et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Naval Surface Warfare Center (NSWC)
APPLICANT(S) The United States of America as represented by the Secretary of the Navy (Washington, District of Columbia)
ASSIGNEE(S) The United States of America as represented by the Secretary of the Navy (Washington, District of Columbia)
INVENTOR(S) Eric Scheid (Bloomington, Indiana);  Brad Moan (Greenwood, Indiana)
ABSTRACT Exemplary apparatus, systems, and methods to provide an ability to quickly and securely hand emplace stand-off demolition charges to various surfaces or structures including surfaces including any flat surface. An aspect of the embodiment of the invention is a lightweight attachment bracket that will hold charges at distances up to (e.g., ten inches) away from a vertical target. The bracket is collapsible, therefore provides a user adjustable stand-off, which is necessary for some applications. Attachment to ferrous material can be instant through a set of rare earth metals imbedded in the base of the bracket. A skirt of high strength textile material provides attachment to other surfaces via integrated hooks and rings. Alternative embodiments of the invention could include an electromagnetic system provided to couple the bracket with a battery in order to provide a limited amount of power to operate the system.
FILED Tuesday, August 16, 2016
APPL NO 15/237674
ART UNIT 3641 — Aeronautics, Agriculture, Fishing, Trapping, Vermin Destroying, Plant and Animal Husbandry, Weaponry, Nuclear Systems, and License and Review
CURRENT CPC
Explosive Charges, e.g for Blasting, Fireworks, Ammunition
F42B 1/02 (20130101)

Blasting
F42D 1/00 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09857168 Gupta et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Office of Naval Research (ONR)
National Science Foundation (NSF)
Directorate for Computer and Information Science and Engineering (CISE)
Division of Information and Intelligent Systems (IIS)
APPLICANT(S) The Trustees of Columbia University in the City of New York (New York, New York)
ASSIGNEE(S) The Trustees of Columbia University in the City of New York (New York, New York)
INVENTOR(S) Mohit Gupta (New York, New York);  Shree K Nayar (New York, New York)
ABSTRACT Systems, methods, and media for performing shape measurement are provided. In some embodiments, systems for performing shape measurement are provided, the systems comprising: a projector that projects onto a scene a plurality of illumination patterns, wherein each of the illumination patterns has a given frequency, each of the illumination patterns is projected onto the scene during a separate period of time, three different illumination patterns are projected with a first given frequency, and only one or two different illumination patterns are projected with a second given frequency; a camera that detects an image of the scene during each of the plurality of periods of time; and a hardware processor that is configured to: determine the given frequencies of the plurality of illumination patterns; and measure a shape of an object in the scene.
FILED Thursday, February 12, 2015
APPL NO 14/621068
ART UNIT 2483 — Recording and Compression
CURRENT CPC
Measuring Length, Thickness or Similar Linear Dimensions; Measuring Angles; Measuring Areas; Measuring Irregularities of Surfaces or Contours
G01B 11/254 (20130101)
G01B 11/2536 (20130101) Original (OR) Class

Recognition of Data; Presentation of Data; Record Carriers; Handling Record Carriers
G06K 9/4661 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09857184 Kaehler et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
APPLICANT(S) APPLIED INVENTION, LLC (Burbank, California)
ASSIGNEE(S) Applied Invention, LLC (Burbank, California)
INVENTOR(S) Adrian Kaehler (Los Feliz, California);  Kjerstin Williams (Los Angeles, California);  Mark E. Duttweiler (Sherman Oaks, California)
ABSTRACT A plan through a space having a near field and a far field is determined. Using a sensor device, measurements of the far field are obtained and stored in an electronic memory. A processor uses the measurements to determine the viability of each far field plan among a plurality of candidate far field plans. The processor also determines a flexibility score for each of the candidate far field plans and selects a composite plan comprising the viable far field plan having a highest flexibility score among the viable candidate far field plans.
FILED Thursday, January 28, 2016
APPL NO 15/009779
ART UNIT 3662 — Computerized Vehicle Controls and Navigation, Radio Wave, Optical and Acoustic Wave Communication, Robotics, and Nuclear Systems
CURRENT CPC
Conjoint Control of Vehicle Sub-units of Different Type or Different Function; Control Systems Specially Adapted for Hybrid Vehicles; Road Vehicle Drive Control Systems for Purposes Not Related to the Control of a Particular Sub-unit
B60W 30/00 (20130101)

Measuring Distances, Levels or Bearings; Surveying; Navigation; Gyroscopic Instruments; Photogrammetry or Videogrammetry
G01C 21/34 (20130101)
G01C 21/3407 (20130101) Original (OR) Class

Systems for Controlling or Regulating Non-electric Variables
G05D 1/0212 (20130101)
G05D 2201/0213 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09857226 LeMaster et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
APPLICANT(S) The United States of America, as represented by the Secretary of the Air Force (Washington, District of Columbia)
ASSIGNEE(S) The United States of America as represented by the Secretary of the Air Force (Washington, District of Columbia)
INVENTOR(S) Daniel A. LeMaster (Dayton, Ohio);  Keigo Hirakawa (Dayton, Ohio)
ABSTRACT An integrated microgrid imaging polarimeter comprises a repeating pattern of wiregrid polarizers in a new 2×4 array that improves image resolution and quality by increasing the spatial bandwidth available for each Stokes image despite that the new repeating pattern is larger than prior art 2×2 arrays. An example embodiment has polarization orientations of the wiregrid polarizers in each 2×4 array, beginning from an arbitrary top left polarizer of each array and continuing clockwise, as: 45 degrees; zero degrees; 315 degrees; 90 degrees; zero degrees; 45 degrees; 90 degrees; and, 315 degrees. The disclosure includes an analysis showing development of the new 2×4 array and supporting its improved performance over prior art 2×2 arrays.
FILED Tuesday, February 10, 2015
APPL NO 14/619058
ART UNIT 2886 — Optics
CURRENT CPC
Measurement of Intensity, Velocity, Spectral Content, Polarisation, Phase or Pulse Characteristics of Infra-Red, Visible or Ultra-violet Light; Colorimetry; Radiation Pyrometry
G01J 4/04 (20130101) Original (OR) Class

Optical Elements, Systems, or Apparatus
G02B 5/3058 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09857293 Zabetakis et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
APPLICANT(S) The United States of America, as represented by the Secretary of the Navy (Washington, District of Columbia)
ASSIGNEE(S) The United States of America, as represented by the Secretary of the Navy (Washington, District of Columbia)
INVENTOR(S) Daniel Zabetakis (Brandywine, Maryland);  Scott A. Trammell (Springfield, Virginia);  Walter J. Dressick (Waldorf, Maryland);  David A. Stenger (Annapolis, Maryland);  Jasenka Verbarg (St. Louis, Missouri)
ABSTRACT Described herein is an approach using inexpensive, disposable chemical sensor probes that can be mounted on a small unmanned aerial vehicles (UAVs) and used to analyze a site (such as one known or suspected to contain explosive residue, spilled material or contaminated soil) without the need for a person to conduct ground operations at the site. The method involves contacting a soil or a surface with a filter paper wetted with a solvent, then subjecting the filter paper to voltammetry and/or spectroscopy, thus detecting a possible variation indicative of one or more analytes, wherein the solvent is the deep eutectic solvent consisting of a mixture of ethylene glycol and choline chloride.
FILED Friday, November 18, 2016
APPL NO 15/356021
ART UNIT 1756 — Optics
CURRENT CPC
Aeroplanes; Helicopters
B64C 39/024 (20130101)
B64C 2201/12 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 21/35 (20130101) Original (OR) Class
G01N 21/65 (20130101)
G01N 27/48 (20130101)
G01N 33/227 (20130101)
G01N 2021/3595 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09857294 Zabetakis et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
APPLICANT(S) The United States of America, as represented by the Secretary of the Navy (Washington, District of Columbia)
ASSIGNEE(S) The United States of America, as represented by the Secretary of the Navy (Washington, District of Columbia)
INVENTOR(S) Daniel Zabetakis (Brandywine, Maryland);  Scott A. Trammell (Springfield, Virginia);  Walter J. Dressick (Waldorf, Maryland);  David A. Stenger (Annapolis, Maryland);  Jasenka Verbarg (St. Louis, Missouri)
ABSTRACT Described herein is an approach using inexpensive, disposable chemical sensor probes that can be mounted on a small unmanned aerial vehicles (UAVs) and used to analyze a site (such as one known or suspected to contain explosive residue, spilled material or contaminated soil) without the need for a person to conduct ground operations at the site. The method involves contacting a soil or a surface with a filter paper wetted with a solvent, then subjecting the filter paper to spectroscopy, thus detecting a possible variation indicative of one or more analytes, wherein the solvent is a deep eutectic solvents consisting of a mixture of ethylene glycol and choline chloride.
FILED Friday, November 18, 2016
APPL NO 15/356089
ART UNIT 1756 — Optics
CURRENT CPC
Aeroplanes; Helicopters
B64C 39/024 (20130101)
B64C 2201/12 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 21/35 (20130101) Original (OR) Class
G01N 21/65 (20130101)
G01N 27/48 (20130101)
G01N 33/227 (20130101)
G01N 2021/3595 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09857295 Poutous et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Office of Naval Research (ONR)
APPLICANT(S) Menelaos K. Poutous (Charlotte, North Carolina);  Ishwar D. Aggarwal (Charlotte, North Carolina);  Kevin J. Major (Charlotte, North Carolina);  Jas S. Sanghera (Charlotte, North Carolina);  Ken Ewing (Charlotte, North Carolina)
ASSIGNEE(S) The University Of North Carolina At Charlotte (Charlotte, North Carolina)
INVENTOR(S) Menelaos K. Poutous (Charlotte, North Carolina);  Ishwar D. Aggarwal (Charlotte, North Carolina);  Kevin J. Major (Charlotte, North Carolina);  Jas S. Sanghera (Charlotte, North Carolina);  Ken Ewing (Charlotte, North Carolina)
ABSTRACT A comparative discrimination spectral detection (CDSD) system for the identification of chemicals with overlapping spectral signatures, including: a radiation source for delivering radiation to a sample; a radiation collector for collecting radiation from the sample; a plurality of beam splitters for splitting the radiation collected from the sample into a plurality of radiation beams; a plurality of low-resolution optical filters for filtering the plurality of radiation beams; a plurality of radiation detectors for detecting the plurality filtered radiation beams; and a processor for: receiving a set of reference spectra related to a set of target chemicals and generating a set of base vectors for the set of target chemicals from the set of reference spectra, wherein the set of base vectors define a geometrical shape in a configuration space; receiving a set of filtered test spectra from the plurality of radiation detectors and generating a set of test vectors in the configuration space from the set of filtered test spectra; assessing a geometrical relationship of the set of test vectors and the geometrical shape defined by the set of base vectors in the configuration space; and based on the assessed geometrical relationship, establishing a probability that a given test spectrum or spectra matches a given reference spectrum or spectra.
FILED Friday, December 11, 2015
APPL NO 14/966807
ART UNIT 2884 — Optics
CURRENT CPC
Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 21/35 (20130101)
G01N 21/3504 (20130101) Original (OR) Class
G01N 2201/1293 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09857356 Parker et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
APPLICANT(S) President and Fellows of Harvard College (Cambridge, Massachusetts)
ASSIGNEE(S) President and Fellows of Havard College (Cambridge, Massachusetts)
INVENTOR(S) Kevin Kit Parker (Cambridge, Massachusetts);  Josue Adrian Goss (Cambridge, Massachusetts);  Anna Grosberg (Irvine, California);  Patrick W. Alford (Minneapolis, Minnesota);  Adam W. Feinberg (Pittsburgh, Pennsylvania);  Ashutosh Agarwal (Somerville, Massachusetts);  Megan Laura McCain (Culver City, California);  Johan Ulrik Lind (Boston, Massachusetts)
ABSTRACT The present invention provides high throughput assays for identifying compounds that modulate a contractile function, as well as devices suitable for these assays.
FILED Monday, December 10, 2012
APPL NO 14/362287
ART UNIT 1655 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/5008 (20130101) Original (OR) Class
G01N 33/5088 (20130101)
G01N 2500/04 (20130101)
G01N 2500/10 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09857455 Foreman
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
APPLICANT(S) Terry L. Foreman (Colonial Beach, Virginia)
ASSIGNEE(S) The United States of America as represented by the Secretary of the Navy (Washington, District of Columbia)
INVENTOR(S) Terry L. Foreman (Colonial Beach, Virginia)
ABSTRACT A computer-implemented method is provided for filtering clutter from a radar signal received by an antenna. The method includes determining a transient clutter voltage at first and second times separated by a time interval, determining a clutter correlation for the time interval, and dividing a received signal correlation by the clutter correlation. In alternate embodiments, the clutter correlation can be combined with a noise correlation and the sum divided by the signal correlation.
FILED Monday, July 20, 2015
APPL NO 14/804279
ART UNIT 3648 — Aeronautics, Agriculture, Fishing, Trapping, Vermin Destroying, Plant and Animal Husbandry, Weaponry, Nuclear Systems, and License and Review
CURRENT CPC
Radio Direction-finding; Radio Navigation; Determining Distance or Velocity by Use of Radio Waves; Locating or Presence-detecting by Use of the Reflection or Reradiation of Radio Waves; Analogous Arrangements Using Other Waves
G01S 7/414 (20130101)
G01S 7/2925 (20130101) Original (OR) Class
G01S 13/95 (20130101)
G01S 13/956 (20130101)
G01S 2013/0245 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09857531 Budd et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
APPLICANT(S) International Business Machines Corporation (Armonk, New York)
ASSIGNEE(S) International Business Machines Corporation (Armonk, New York)
INVENTOR(S) Russell A. Budd (North Salem, New York);  Daniel M. Kuchta (Patterson, New York);  Benjamin Giles Lee (New York, New York);  Laurent Schares (Sleepy Hollow, New York);  Clint Lee Schow (Ossining, New York)
ABSTRACT A system comprises a first optical component comprising at least one waveguide and at least one self-alignment feature; and a second optical component comprising at least another waveguide and at least another self-alignment feature; wherein the self-alignment feature of the second optical component engage to assist in optically-coupling the waveguide of the first optical component and the waveguide of the second optical component when the first optical component has a manufacturing tolerance in a given geometric dimension and is mounted in the second optical component.
FILED Thursday, November 03, 2016
APPL NO 15/342566
ART UNIT 2874 — Optics
CURRENT CPC
Optical Elements, Systems, or Apparatus
G02B 6/12 (20130101) Original (OR) Class
G02B 6/125 (20130101)
G02B 6/423 (20130101)
G02B 6/3652 (20130101)
G02B 2006/12119 (20130101)
G02B 2006/12147 (20130101)
G02B 2006/12166 (20130101)
G02B 2006/12173 (20130101)
G02B 2006/12176 (20130101)

Technical Subjects Covered by Former US Classification
Y10T 156/10 (20150115)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09857868 Plagemann et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Office of Naval Research (ONR)
APPLICANT(S) Christian Plagemann (Menlo Park, California);  Hendrik Dahlkamp (Palo Alto, California);  Hariraam Varun Ganapathi (Palo Alto, California);  Sebastian Thrun (Los Altos Hills, California)
ASSIGNEE(S) The Board of Trustees of the Leland Stanford Junior University (Palo Alto, California)
INVENTOR(S) Christian Plagemann (Menlo Park, California);  Hendrik Dahlkamp (Palo Alto, California);  Hariraam Varun Ganapathi (Palo Alto, California);  Sebastian Thrun (Los Altos Hills, California)
ABSTRACT With the advent of touch-free interfaces such as described in the present disclosure, it is no longer necessary for computer interfaces to be in predefined locations (e.g., desktops) or configuration (e.g., rectangular keyboard). The present invention makes use of touch-free interfaces to encourage users to interface with a computer in an ergonomically sound manner. Among other things, the present invention implements a system for localizing human body parts such as hands, arms, shoulders, or even the fully body, with a processing device such as a computer along with a computer display to provide visual feedback on the display that encourages a user to maintain an ergonomically preferred position with ergonomically preferred motions. For example, the present invention encourages a user to maintain his motions within an ergonomically preferred range without have to reach out excessively or repetitively.
FILED Saturday, March 19, 2011
APPL NO 13/052050
ART UNIT 2623 — Selective Visual Display Systems
CURRENT CPC
Electric Digital Data Processing
G06F 3/011 (20130101) Original (OR) Class
G06F 3/017 (20130101)
G06F 3/0304 (20130101)
G06F 3/04815 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09858053 Lethin et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Research Laboratory (AFRL)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S) Reservoir Labs, Inc. (New York, New York)
ASSIGNEE(S) Reservoir Labs, Inc. (New York, New York)
INVENTOR(S) Richard A. Lethin (New York, New York);  Allen K. Leung (New York, New York);  Benoit J. Meister (New York, New York);  David E. Wohlford (Portland, Oregon)
ABSTRACT Methods, apparatus and computer software product for optimization of data transfer between two memories includes determining access to master data stored in one memory and/or to local data stored in another memory such that either or both of the size of total data transferred and the number of data transfers required to transfer the total data can be minimized. The master and/or local accesses are based on, at least in part, respective structures of the master and local data.
FILED Friday, February 14, 2014
APPL NO 14/181201
ART UNIT 2184 — Computer Architecture and I/O
CURRENT CPC
Electric Digital Data Processing
G06F 8/443 (20130101) Original (OR) Class
G06F 12/023 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09858159 Kawachiya et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Office of Scientific Research (AFOSR)
Air Force Research Laboratory (AFRL)
APPLICANT(S) International Business Machines Corporation (Armonk, New York)
ASSIGNEE(S) International Business Machines Corporation (Armonk, New York)
INVENTOR(S) Kiyokuni Kawachiya (Yokohama, Japan);  Vijay A. Saraswat (Mahopac, New York)
ABSTRACT The present information processing apparatus executes fault-tolerant distributed computing through a network and the information processing apparatus comprises: a finish initiator that creates a finish state on a home node; an activity creator that instructs to create at least one activity on a remote node; an activity launcher that allows to store in a resilient store a value indicating that at least one live activity is present on the remote node; an activity closer that decreases the number in the local memory when the living activity is completed and resets the value in the resilient store to indicate that no live activity is present on the remote node; and a finish closer that closes the finish state when the value stored in the resilient store indicates an absence of remote nodes having at least one live activity.
FILED Friday, February 20, 2015
APPL NO 14/627312
ART UNIT 2114 — Computer Error Control, Reliability, & Control Systems
CURRENT CPC
Electric Digital Data Processing
G06F 11/00 (20130101)
G06F 11/1471 (20130101) Original (OR) Class
G06F 2201/85 (20130101)
G06F 2201/805 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09858220 Culurciello et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Office of Naval Research (ONR)
APPLICANT(S) Purdue Research Foundation (West Lafayette, Indiana)
ASSIGNEE(S) Purdue Research Foundation (West Lafayette, Indiana)
INVENTOR(S) Eugenio Culurciello (Lafayette, Indiana);  Berin Eduard Martini (Lafayette, Indiana);  Vinayak Anand Gokhale (West Lafayette, Indiana);  Jonghoon Jin (West Lafayette, Indiana);  Aysegul Dundar (Lafayette, Indiana)
ABSTRACT A coprocessor (PL) is disclosed. The PL includes a memory router, at least one collection block that is configured to transfer data to/from the memory router, each collection block includes a collection router that is configured to i) transfer data to/from the memory router, ii) transfer data to/from at least one collection router of a neighboring collection block, and iii) transfer data to/from blocks within the collection block, and at least one programmable operator that is configured to i) transfer data to/from the collection router, and ii) perform a programmable operation on data received from the collection router.
FILED Tuesday, March 17, 2015
APPL NO 14/660589
ART UNIT 2185 — Computer Architecture and I/O
CURRENT CPC
Electric Digital Data Processing
G06F 9/46 (20130101)
G06F 9/4411 (20130101)
G06F 12/023 (20130101)
G06F 13/28 (20130101) Original (OR) Class
G06F 2212/261 (20130101)

Computer Systems Based on Specific Computational Models
G06N 3/063 (20130101)

Climate Change Mitigation Technologies Related to Buildings, e.g Housing, House Appliances or Related End-user Applications
Y02B 60/1228 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09858324 Joy et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
APPLICANT(S) Northrop Grumman Systems Corporation (Falls Church, Virginia)
ASSIGNEE(S) Northrop Grumman Systems Corporation (Los Angeles, California)
INVENTOR(S) William Joy (Melbourne, Florida);  Armen Djougarian (Flushing, New York)
ABSTRACT A method of extracting unclassified data from a collection of data including both classified data and unclassified data, includes: providing a plain text format file including a plurality of attributes; using the attributes to identify unclassified data within a collection of data that includes a combination of unclassified and classified data; and extracting the identified unclassified data from the collection of data. An apparatus that implements the method is also provided.
FILED Thursday, June 12, 2014
APPL NO 14/302735
ART UNIT 2161 — Data Bases & File Management
CURRENT CPC
Electric Digital Data Processing
G06F 17/30572 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09858457 Bowden et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
APPLICANT(S) The United States of America, as Represented by the Secretary of the Army (Washington, District of Columbia);  Michelle Lynn Hossenlopp (Belton, Texas)
ASSIGNEE(S) The United States of America as represented by the Secretary of the Army (Washington, District of Columbia)
INVENTOR(S) Robert Allen Bowden (Far Hills, New Jersey);  Michelle Lynn Hossenlopp (Belton, Texas)
ABSTRACT The system in at least one embodiment provides a tamper evident specimen sample lock that in a further embodiment includes an embedded storage medium. They system and method in at least one embodiment allows for efficiently and securely creating, maintaining, identifying, tracking, and controlling inventories (either prospective or retrospective) of biological and chemical sample containers and their contents, while eliminating potential loss and degradation associated with handling the samples. The system in at least one embodiment provides a sample container tray or cryogenic box having one or more integrated RFID readers within an associated smart lid that sense RFIDs associated with the individual samples thereby eliminating the need to remove, visually inspect, and/or handle the samples.
FILED Monday, May 09, 2016
APPL NO 15/149453
ART UNIT 2686 — Data Bases & File Management
CURRENT CPC
Chemical or Physical Laboratory Apparatus for General Use
B01L 3/545 (20130101)
B01L 2200/141 (20130101)
B01L 2300/022 (20130101)

Containers for Storage or Transport of Articles or Materials, e.g Bags, Barrels, Bottles, Boxes, Cans, Cartons, Crates, Drums, Jars, Tanks, Hoppers, Forwarding Containers; Accessories, Closures, or Fittings Therefor; Packaging Elements; Packages
B65D 85/00 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 1/42 (20130101)
G01N 35/00732 (20130101)
G01N 2001/007 (20130101)
G01N 2035/00782 (20130101)

Recognition of Data; Presentation of Data; Record Carriers; Handling Record Carriers
G06K 7/10366 (20130101) Original (OR) Class

Signalling or Calling Systems; Order Telegraphs; Alarm Systems
G08B 13/2462 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09858527 Farley et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
APPLICANT(S) Stephen M. Farley (Sterling, Virginia);  Jerry Rosson Smith, Jr. (Springfield, Virginia)
ASSIGNEE(S) The United States of America as represented by the Secretary of the Navy (Washington, District of Columbia)
INVENTOR(S) Stephen M. Farley (Sterling, Virginia);  Jerry Rosson Smith, Jr. (Springfield, Virginia)
ABSTRACT Exemplary practice of this invention implements a computer to model human decision-making within a comprehensive human-perception construct dichotomized as probabilistically perceptual and preferentially perceptual. Potential actions are identified. Each identified potential action is evaluated in consideration of (i) probabilities of success as perceived by the decision-maker, and (ii) preferences of the decision-maker relating to consistency, credibility, confidence, bias, and urgency. Decision-making is modeled on a continual basis whereby evaluation of at least one potential action is performed anew in each successive time-step. Evaluations of potential actions yield “goodness” values, which are compared to determine best potential actions. Threshold “goodness” parameters are established to filter out some potential actions and leave other potential actions for goodness comparison. The best potential action of a particular time-step is compared to the best potential action of the preceding time-step in order to decide whether to maintain or change the existing course of action.
FILED Thursday, February 27, 2014
APPL NO 14/192093
ART UNIT 2129 — AI & Simulation/Modeling
CURRENT CPC
Computer Systems Based on Specific Computational Models
G06N 5/04 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09858529 Adams et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
Department of the Navy (DON)
APPLICANT(S) President and Fellows of Harvard College (Cambridge, Massachusetts);  Governing Council of the Univ. of Toronto (Toronto, Canada)
ASSIGNEE(S) President and Fellows of Harvard College (Cambridge, Massachusetts);  The Governing Council of the Univ. of Toronto (Toronto, Canada)
INVENTOR(S) Ryan P. Adams (Somerville, Massachusetts);  Roland Jasper Snoek (Cambridge, Massachusetts);  Kevin Swersky (Toronto, Canada)
ABSTRACT Techniques for use in connection with performing optimization using a plurality of objective functions associated with a respective plurality of tasks. The techniques include using at least one computer hardware processor to perform: identifying, based at least in part on a joint probabilistic model of the plurality of objective functions, a first point at which to evaluate an objective function in the plurality of objective functions; selecting, based at least in part on the joint probabilistic model, a first objective function in the plurality of objective functions to evaluate at the identified first point; evaluating the first objective function at the identified first point; and updating the joint probabilistic model based on results of the evaluation to obtain an updated joint probabilistic model.
FILED Friday, May 30, 2014
APPL NO 14/291255
ART UNIT 2129 — AI & Simulation/Modeling
CURRENT CPC
Electric Digital Data Processing
G06F 17/11 (20130101)

Computer Systems Based on Specific Computational Models
G06N 5/048 (20130101) Original (OR) Class
G06N 7/005 (20130101)
G06N 99/005 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09858531 Monroe et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Office of the Director of National Intelligence (ODNI)
Intelligence Advanced Research Projects Activity (IARPA)
APPLICANT(S) UNIVERSITY OF MARYLAND (College Park, Maryland);  DUKE UNIVERSITY (Durham, North Carolina);  UNIVERSITY OF BRITISH COLUMBIA (Vancouver, Canada)
ASSIGNEE(S) University of Maryland (College Park, Maryland);  Duke University (Durham, North Carolina);  University of British Columbia (Vancouver, British Columbia, Canada)
INVENTOR(S) Christopher Monroe (Ellicott City, Maryland);  Jungsang Kim (Chapel Hill, North Carolina);  Robert Raussendorf (Vancouver, Canada)
ABSTRACT A modular quantum computer architecture is developed with a hierarchy of interactions that can scale to very large numbers of qubits. Local entangling quantum gates between qubit memories within a single modular register are accomplished using natural interactions between the qubits, and entanglement between separate modular registers is completed via a probabilistic photonic interface between qubits in different registers, even over large distances. This architecture is suitable for the implementation of complex quantum circuits utilizing the flexible connectivity provided by a reconfigurable photonic interconnect network. The subject architecture is made fault-tolerant which is a prerequisite for scalability. An optimal quantum control of multimode couplings between qubits is accomplished via individual addressing the qubits with segmented optical pulses to suppress crosstalk in each register, thus enabling high-fidelity gates that can be scaled to larger qubit registers for quantum computation and simulation.
FILED Friday, August 01, 2014
APPL NO 14/449477
ART UNIT 2122 — AI & Simulation/Modeling
CURRENT CPC
Devices or Arrangements, the Optical Operation of Which Is Modified by Changing the Optical Properties of the Medium of the Devices or Arrangements for the Control of the Intensity, Colour, Phase, Polarisation or Direction of Light, e.g Switching, Gating, Modulating or Demodulating; Techniques or Procedures for the Operation Thereof; Frequency-changing; Non-linear Optics; Optical Logic Elements; Optical Analogue/digital Converters
G02F 1/113 (20130101)

Electric Digital Data Processing
G06F 15/76 (20130101)
G06F 2015/768 (20130101)

Computer Systems Based on Specific Computational Models
G06N 99/002 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09858656 Young
FUNDED BY
Department of Defense (DOD)
National Geospatial Intelligence Agency (NGA)
APPLICANT(S) Raytheon Company (Waltham, Massachusetts)
ASSIGNEE(S) Raytheon Company (Waltham, Massachusetts)
INVENTOR(S) Darrel L. Young (Falls Church, Virginia)
ABSTRACT According to embodiment, an interpretability and quality estimation method includes generating an interpretability or quality estimate for an image or frame using one or more feature characteristics of a reference image when a reference image associated with an image is available or partially available, and generating an interpretability or quality estimate for the image or frame using one or more feature characteristics of the image when a reference image associated with the image is not available.
FILED Wednesday, March 13, 2013
APPL NO 13/801549
ART UNIT 2665 — Image Analysis; Applications; Pattern Recognition; Color and compression; Enhancement and Transformation
CURRENT CPC
Image Data Processing or Generation, in General
G06T 7/0002 (20130101) Original (OR) Class
G06T 2207/30168 (20130101)

Pictorial Communication, e.g Television
H04N 17/004 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09859079 Jarrahi et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
Army Research Office (CCDC ARO)
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Civil, Mechanical and Manufacturing Innovation (CMMI)
APPLICANT(S) The Regents of the University of Michigan (Ann Arbor, Michigan)
ASSIGNEE(S) The Regents of the University of Michigan (Ann Arbor, Michigan)
INVENTOR(S) Mona Jarrahi (Los Angeles, California);  Mehmet Unlu (Ankara, Turkey);  Christopher W. Berry (Albuquerque, New Mexico);  Shenglin Li (Aliso Viejo, California)
ABSTRACT A reconfigurable device for terahertz (THz) or infrared (IR) ranges that includes a base substrate, a lower array attached to the base substrate, and an upper array attached to the base substrate and at least partially suspended over the lower array. Activation of the reconfigurable device causes the upper array to mechanically flex towards the lower array so that electrical contact is made therebetween. Methods of fabricating and operating the reconfigurable device are also provided.
FILED Wednesday, August 06, 2014
APPL NO 14/910523
ART UNIT 2842 — Electrical Circuits and Systems
CURRENT CPC
Optical Elements, Systems, or Apparatus
G02B 6/29361 (20130101)
G02B 6/29395 (20130101)

Electric Switches; Relays; Selectors; Emergency Protective Devices
H01H 49/00 (20130101)
H01H 50/005 (20130101)
H01H 51/27 (20130101) Original (OR) Class
H01H 51/32 (20130101)
H01H 57/00 (20130101)
H01H 59/0009 (20130101)
H01H 2057/006 (20130101)
H01H 2201/024 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09859116 Niu et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Communications-Electronics Research, Development and Engineering Center (CERDEC)
Night Vision and Electronic Sensors Directorate (NVESD)
APPLICANT(S) SAMSUNG ELECTRONICS CO., LTD (Suwon-si, South Korea)
ASSIGNEE(S) SAMSUNG ELECTRONICS CO., LTD. (Gyeonggi-Do, South Korea)
INVENTOR(S) Yuhua Niu (Waltham, Massachusetts);  Peter T. Kazlas (Sudbury, Massachusetts)
ABSTRACT A method for preparing a sol-gel film is disclosed. The method comprises providing a sol-gel composition comprising one or more sol-gel film precursors and a crystallization aid, and processing the sol-gel composition by solution processing to form the sol-gel film. In certain embodiments, the sol-gel film comprises one or more metal oxides. A preferred crystallization aid includes triphenylphosphine oxide. A composition for making a sol-gel film, a sol-gel film, a device including a sol-gel film and a method for making such device are also disclosed.
FILED Wednesday, June 04, 2014
APPL NO 14/296163
ART UNIT 2816 — Semiconductors/Memory
CURRENT CPC
Coating Metallic Material; Coating Material With Metallic Material; Surface Treatment of Metallic Material by Diffusion into the Surface, by Chemical Conversion or Substitution; Coating by Vacuum Evaporation, by Sputtering, by Ion Implantation or by Chemical Vapour Deposition, in General
C23C 18/1216 (20130101)
C23C 18/1233 (20130101)
C23C 18/1241 (20130101)
C23C 18/1245 (20130101)
C23C 18/1254 (20130101)
C23C 18/1275 (20130101)
C23C 18/1283 (20130101)

Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 21/02565 (20130101)
H01L 21/02628 (20130101) Original (OR) Class
H01L 29/15 (20130101)
H01L 29/24 (20130101)
H01L 51/5072 (20130101)
H01L 2251/303 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09859227 Cabral, Jr. et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Office of Naval Research (ONR)
APPLICANT(S) International Business Machines Corporation (Armonk, New York)
ASSIGNEE(S) International Business Machines Corporation (Armonk, New York)
INVENTOR(S) Cyril Cabral, Jr. (Yorktown Heights, New York);  Kenneth P. Rodbell (Sandy Hook, Connecticut)
ABSTRACT An integrated circuit structure and formation thereof. The integrated circuit structure includes a substrate and a front-end-of-the-line (FEOL) portion. The FEOL portion rests on top of and in contact with the substrate. The integrated circuit structure includes a memory level portion. The memory level portion rests on top of and in contact with the FEOL portion. The integrated circuit structure includes a back-end-of-the-line (BEOL) portion. The BEOL portion rests on top of and in contact with the memory level portion. The integrated circuit structure includes a multiple layer that includes one or more pairs of reactive materials. The multiple layer is one or more of: i) on top of the BEOL portion; ii) within the BEOL portion; iii) within the memory level portion; iv) within the FEOL portion; v) embedded in the substrate; and vi) on bottom of a thinned substrate.
FILED Thursday, June 30, 2016
APPL NO 15/198709
ART UNIT 2895 — Semiconductors/Memory
CURRENT CPC
Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 21/76892 (20130101)
H01L 23/573 (20130101) Original (OR) Class
H01L 27/2463 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09859379 Bol et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S) International Business Machines Corporation (Armonk, New York)
ASSIGNEE(S) International Business Machines Corporation (Armonk, New York)
INVENTOR(S) Ageeth A. Bol (Yorktown Heights, New York);  Steven E. Steen (Peekskill, New York);  James Vichiconti (Peekskill, New York)
ABSTRACT A method to transfer a layer of graphene from one substrate to another substrate is provided. The method includes providing a first layered structure including, from bottom to top, a copper foil, a layer of graphene, an adhesive layer and a carrier substrate. The copper foil is removed exposing a surface of the layer of graphene. Next, an oxide bonding enhancement dielectric layer is formed on the exposed surface of the layer of graphene. A second layered structure including a receiver substrate and a dielectric oxide layer is provided. Next, an exposed surface of the dielectric oxide layer is bonded to an exposed surface of the oxide bonding enhancement dielectric layer. The carrier substrate and the adhesive layer are removed exposing the layer of graphene.
FILED Thursday, August 04, 2016
APPL NO 15/228117
ART UNIT 2811 — Semiconductors/Memory
CURRENT CPC
Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 21/0262 (20130101)
H01L 21/02425 (20130101)
H01L 21/02527 (20130101)
H01L 21/6835 (20130101)
H01L 21/76251 (20130101)
H01L 23/66 (20130101)
H01L 29/0649 (20130101)
H01L 29/778 (20130101)
H01L 29/1606 (20130101) Original (OR) Class
H01L 29/66045 (20130101)
H01L 29/66742 (20130101)
H01L 29/78603 (20130101)
H01L 29/78684 (20130101)
H01L 2221/6835 (20130101)
H01L 2221/68368 (20130101)
H01L 2221/68381 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09859448 Scarpulla
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
The Aerospace Corporation (AEROSPACE)
Federally Funded Research and Development Center (FFRDC)
Operated by The Aerospace Corporation (AEROSPACE) at El Segundo, CA
APPLICANT(S) The Aerospace Corporation (El Segundo, California)
ASSIGNEE(S) The Aerospace Corporation (El Segundo, California)
INVENTOR(S) John R. Scarpulla (Rancho Palos Verdes, California)
ABSTRACT Under one aspect, a power Schottky diode includes a cathode; a semiconductor disposed over the cathode, the semiconductor including at least a first region and a second region, the second region defining a guard ring; an anode disposed over the first region and at least a portion of the guard ring, the anode including a metal, a junction between the anode and the first region defining a Schottky barrier; and an oxide disposed over the guard ring. Additionally, the power Schottky diode can include a resistive material disposed over at least a portion of the guard ring and at least a portion of the oxide. The resistive material can inhibit a flow of holes from the guard ring to the anode following a heavy ion strike to the guard ring. The anode further can be disposed over at least a portion of, or the entirety of, the resistive material.
FILED Friday, May 06, 2016
APPL NO 15/149020
ART UNIT 2898 — Semiconductors/Memory
CURRENT CPC
Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 21/0217 (20130101)
H01L 21/0262 (20130101)
H01L 21/266 (20130101)
H01L 21/0273 (20130101)
H01L 21/02057 (20130101)
H01L 21/02532 (20130101)
H01L 21/02595 (20130101)
H01L 21/28537 (20130101)
H01L 21/31116 (20130101)
H01L 23/291 (20130101)
H01L 23/3171 (20130101)
H01L 27/0248 (20130101)
H01L 28/20 (20130101)
H01L 29/36 (20130101)
H01L 29/47 (20130101)
H01L 29/0623 (20130101)
H01L 29/872 (20130101) Original (OR) Class
H01L 29/66143 (20130101)

Pulse Technique
H03K 17/08 (20130101)
H03K 2017/0803 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09859599 Guyette et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
APPLICANT(S) The United States of America, as represented by the Secretary of the Navy (Washington, District of Columbia)
ASSIGNEE(S) The United States of America, as represented by the Secretary of the Navy (Washington, District of Columbia)
INVENTOR(S) Andrew C. Guyette (Alexandria, Virginia);  Eric J. Naglich (Alexandria, Virginia)
ABSTRACT Systems and methods are provided for creating higher order microwave bandstop filters with total through-line length of significantly less than one-quarter wavelength at the filter center frequency. The mixed electric and magnetic field coupling bandstop filter topologies provided by embodiments of the present disclosure can be used to reduce the size, weight, and throughline insertion loss of microwave bandstop filters. In an embodiment, if the relative field strengths are intelligently designed for each coupling structure, effective phase offsets can be produced between resonators along the through line. These phase offsets can be used to absorb some or all of the length of the λ/4 inverters between resonators.
FILED Thursday, March 17, 2016
APPL NO 15/073292
ART UNIT 2842 — Electrical Circuits and Systems
CURRENT CPC
Waveguides; Resonators, Lines, or Other Devices of the Waveguide Type
H01P 1/203 (20130101) Original (OR) Class
H01P 1/2039 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09859678 Middleton et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
APPLICANT(S) HARRIS CORPORATION (Melbourne, Florida)
ASSIGNEE(S) HARRIS CORPORATION (Melbourne, Florida)
INVENTOR(S) Charles Middleton (Rockledge, Florida);  Richard DeSalvo (Satellite Beach, Florida);  Scott L. Meredith (Vero Beach, Florida);  Peter S. Scheuter (Melbourne, Florida)
ABSTRACT A communications device may include a remote device having a first E/O modulator to modulate an optical carrier signal with an input signal having a first frequency, an optical waveguide coupled to the remote device, and a local device coupled to the optical waveguide. The local device may include an optical source to generate the optical carrier signal, a second E/O modulator to modulate the optical carrier signal with a reference signal to generate a modulated reference signal, an OIL source coupled to the second E/O modulator and to amplify the modulated reference signal, and an O/E converter coupled to the OIL source and to generate an output signal including a replica of the input signal at a second frequency based upon the reference signal.
FILED Tuesday, September 23, 2014
APPL NO 14/494051
ART UNIT 2636 — Optical Communications
CURRENT CPC
Devices Using the Process of Light Amplification by Stimulated Emission of Radiation [LASER] to Amplify or Generate Light; Devices Using Stimulated Emission of Electromagnetic Radiation in Wave Ranges Other Than Optical
H01S 5/0085 (20130101) Original (OR) Class

Transmission
H04B 10/25758 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09859704 Guo et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S) International Business Machines Corporation (Armonk, New York)
ASSIGNEE(S) International Business Machines Corporation (Armonk, New York)
INVENTOR(S) Chen Guo (San Jose, California);  Yutaka Nakamura (Kyoto, Japan);  Jun Sawada (Austin, Texas)
ABSTRACT An embodiment includes a tie-off circuit includes multiple field effect transistors (FETs), and a node isolation circuit that is connected to a first output node and a second output node of the tie-off circuit. The node isolation circuit consists of a first FET with a third output node and a second FET with a fourth output node. The second output node includes a logical LO node and is coupled to a gate of the first FET and generates a TIE HI output.
FILED Friday, January 27, 2017
APPL NO 15/417656
ART UNIT 2836 — Electrical Circuits and Systems
CURRENT CPC
Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 27/0266 (20130101)

Emergency Protective Circuit Arrangements
H02H 9/046 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09859849 Stuenkel et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S) BAE SYSTEMS INFORMATION AND ELECTRONIC SYSTEMS INTEGRATION INC. (Nashua, New Hampshire)
ASSIGNEE(S) BAE Systems Information and Electronic Systems Integration Inc. (Nashua, New Hampshire)
INVENTOR(S) Mark E. Stuenkel (Hooksett, New Hampshire);  Kevin W. Sliech (Nashua, New Hampshire)
ABSTRACT A feedback amplifier having an improved feedback network including two cross coupled switches that isolate the amplifier from extraneous undesired electrical signals present in a system or network when the amplifier is turned off (i.e., in an off-state). The cross coupled switches interconnect two feedback paths of a feedback network to enable out-of-phase differential signals to be summed and effectively canceled. Further, the feedback amplifier provides on-stage advantages to enable different amplifier characteristics and parameter to be selectively engaged by turning on or turning off certain feedback networks.
FILED Thursday, July 21, 2016
APPL NO 15/216156
ART UNIT 2842 — Electrical Circuits and Systems
CURRENT CPC
Amplifiers
H03F 1/3211 (20130101) Original (OR) Class
H03F 3/72 (20130101)
H03F 3/45475 (20130101)
H03F 3/45977 (20130101)
H03F 2203/45534 (20130101)
H03F 2203/45562 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09860258 Collins et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
APPLICANT(S) The United States of America as represented by the Secretary of the Air Force (Washington, District of Columbia)
ASSIGNEE(S) The United States of America as represented by the Secretary of the Air Force (Washington, District of Columbia)
INVENTOR(S) James C Collins (Mico, Texas);  Chet M Wall (San Antonio, Texas);  Robert J Kaufman, III (San Antonio, Texas)
ABSTRACT An Enhanced Ethernet Network Interface Card (EENIC) interfaces with a host and a network. The EENIC includes an internal network interface controller (NIC), a field programmable array (FPGA) in electrical communication with the internal network interface controller, and a peripheral component interconnect express (PCIe) controller, in independent electrical communication with the field programmable array or the internal network interface controller. The FPGA is configured to intercept data from either the host, or from the network, or from a combination thereof. Additionally, the configured interception is undetected by the host, or by the network, or a combination thereof.
FILED Wednesday, July 01, 2015
APPL NO 14/788835
ART UNIT 2497 — Cryptography and Security
CURRENT CPC
Transmission of Digital Information, e.g Telegraphic Communication
H04L 63/08 (20130101)
H04L 63/0209 (20130101)
H04L 63/0876 (20130101)
H04L 63/1408 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09860443 Ford et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
APPLICANT(S) The Regents of the University of California (Oakland, California)
ASSIGNEE(S) The Regents of the University of California (Oakland, California)
INVENTOR(S) Joseph E. Ford (Solana Beach, California);  Ilya Agurok (San Diego, California);  Igor Stamenov (La Jolla, California)
ABSTRACT Methods, systems, and devices are disclosed for capturing and forming large high quality images using monocentric optical imaging. In one aspect, an optical imaging system includes an optical imaging module that collects light to form an image on an imaging surface, one or more imaging sensors each including an array of optical detectors located away from the imaging surface to receive light representing the image initially formed on the imaging surface and to convert the received light into detector signals, and optical waveguides coupled between the imaging surface and the one or more imaging sensors to receive light from the imaging surface and configured to selectively deliver a desired portion of the received light to the one or more imaging sensors while suppressing undesired stray light from reaching the one or more imaging sensors so that the optical waveguides effectuate an optical aperture stop with a limited angle range for receiving light by the one or more imaging sensors.
FILED Tuesday, August 20, 2013
APPL NO 14/423097
ART UNIT 2663 — Image Analysis; Applications; Pattern Recognition; Color and compression; Enhancement and Transformation
CURRENT CPC
Optical Elements, Systems, or Apparatus
G02B 6/255 (20130101)
G02B 9/02 (20130101)
G02B 13/06 (20130101)

Apparatus or Arrangements for Taking Photographs or for Projecting or Viewing Them; Apparatus or Arrangements Employing Analogous Techniques Using Waves Other Than Optical Waves; Accessories Therefor
G03B 37/00 (20130101)

Pictorial Communication, e.g Television
H04N 5/2254 (20130101)
H04N 5/23238 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09860694 Nation et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Naval Surface Warfare Center (NSWC)
APPLICANT(S) The United States of America as represented by the Secretary of the Navy (Washington, District of Columbia)
ASSIGNEE(S) The United States of America as represented by the Secretary of the Navy (Washington, District of Columbia)
INVENTOR(S) Jeremy Nation (Bloomington, Indiana);  Michael F. Hardy (Bloomfield, Indiana);  Keith Buck (Bloomfield, Indiana);  Mathew Hardman (Mitchell, Indiana)
ABSTRACT A computing platform, comprising at least one computing device including a plurality of device applications; a command server disposed at a first location and configured to provide data communication to the at least one computing device by way of a radio access point and to receive data communication from the at least one computing device; a first radio device communicably coupled to the at least one computing device and the command server, the first radio device being coupled to the radio access point to enable data communication between the at least one computing device and the command server. At least one device application of the at least one computing device is configured to transmit a plurality of data including location data and at least one of image data, text data, and voice data, the location data corresponding to a location of one or more personnel positioned at a second location that is spaced apart from the first location.
FILED Wednesday, March 08, 2017
APPL NO 15/453319
ART UNIT 2642 — Telecommunications: Analog Radio Telephone; Satellite and Power Control; Transceivers, Measuring and Testing; Bluetooth; Receivers and Transmitters; Equipment Details
CURRENT CPC
Wireless Communication Networks
H04W 4/02 (20130101) Original (OR) Class
H04W 4/008 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09860992 Chao et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
APPLICANT(S) The United States of America as Represented by the Secretary of the Army (Washington, District of Columbia)
ASSIGNEE(S) The United States of America as Represented by the Secretary of the Army (Washington, District of Columbia)
INVENTOR(S) Nien-Hua Chao (Parsippany, New Jersey);  John A. Dispenza (Long Valley, New Jersey);  Mario DeAngelis (Ringoes, New Jersey)
ABSTRACT A polymer layering process that encapsulates and protects electronics components with complex and imprecise geometries. The protective layering process provides a combination of a flexible mold and/or a rigid mold that apply close-forming, encapsulating the polymer layers to the electronic components and precision assemblies. Polymer layer protective jackets are shaped to as-populated circuit boards and assemblies, providing tightly fit barriers with fine resolution accommodating imprecise geometries. The protective jackets can be formed in rigid, semi-rigid, or highly flexible polymer films, to protect the circuitry from the elements, CTE mismatches, shock and vibration loads and extreme g-forces.
FILED Wednesday, December 09, 2015
APPL NO 14/963920
ART UNIT 1743 — Tires, Adhesive Bonding, Glass/Paper making, Plastics Shaping & Molding
CURRENT CPC
Printed Circuits; Casings or Constructional Details of Electric Apparatus; Manufacture of Assemblages of Electrical Components
H05K 3/0014 (20130101) Original (OR) Class
H05K 3/0047 (20130101)
H05K 3/4644 (20130101)
H05K 2203/1316 (20130101)
H05K 2203/1322 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Energy (DOE) 

US 09855217 Brinker et al.
FUNDED BY
Department of Energy (DOE)
National Nuclear Security Administration (NNSA)
Sandia National Laboratories (SNL)
Federally Funded Research and Development Center (FFRDC)
Operated by National Technology and Engineering Solutions of Sandia, LLC (NTESS) at Albuquerque, NM
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
APPLICANT(S) STC.UNM (Albuquerque, New Mexico);  National Technology and Engineering Solutions of Sandia, LLC (Albuquerque, New Mexico)
ASSIGNEE(S) STC. UNM (Albuquerque, New Mexico);  National Technology and Engineering Solutions of Sandia, LLC (Albuquerque, New Mexico)
INVENTOR(S) C. Jeffrey Brinker (Albuquerque, New Mexico);  Yu-Shen Lin (Albuquerque, New Mexico)
ABSTRACT In one aspect, the invention provides novel monodisperse, colloidally-stable, toroidal mesoporous silica nanoparticles (TMSNPs) which are synthesized from ellipsoid-shaped mesoporous silica nanoparticles (MSNPs) which are prepared using an ammonia basecatalyzed method under a low surfactant conditions. Significantly, the TMSNPs can be loaded simultaneously with a small molecule active agent, a siRNA, a mRNA, a plasmid and other cargo and can be used in the diagnosis and/or treatment of a variety of disorders, including a cancer, a bacterial infection and/or a viral infection, among others. Related protocells, pharmaceutical compositions and therapeutic and diagnostic methods are also provided.
FILED Thursday, September 18, 2014
APPL NO 15/023110
ART UNIT 1616 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/14 (20130101)
A61K 9/1271 (20130101) Original (OR) Class
A61K 9/5115 (20130101)
A61K 9/5123 (20130101)
A61K 31/7088 (20130101)
A61K 38/16 (20130101)
A61K 38/43 (20130101)
A61K 39/395 (20130101)

Specific Uses or Applications of Nanostructures; Measurement or Analysis of Nanostructures; Manufacture or Treatment of Nanostructures
B82Y 5/00 (20130101)
B82Y 15/00 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/88 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09855329 Korber et al.
FUNDED BY
Department of Energy (DOE)
Los Alamos National Security, LLC (LANS)
National Nuclear Security Administration (NNSA)
Los Alamos National Laboratory (LANL)
Federally Funded Research and Development Center (FFRDC)
Operated by Triad National Security, LLC (TRIAD) at Los Alamos, NM
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) Los Alamos National Security, LLC (Los Alamos, New Mexico);  Duke University (Durham, North Carolina);  Dana-Farber Cancer Institute, Inc. (, None)
ASSIGNEE(S) Los Alamos National Security, LLC (Los Alamos, New Mexico);  Dana-Farber Cancer Institute (Brookline, Massachusetts);  Duke University (Durham, North Carolina)
INVENTOR(S) Bette T. M. Korber (Los Alamos, New Mexico);  S. Gnanakaran (Los Alamos, New Mexico);  Simon Perkins (Boulder, Colorado);  Joseph Sodroski (Boston, Massachusetts);  Barton Haynes (Durham, North Carolina)
ABSTRACT Disclosed herein are mosaic HIV envelope (Env) polypeptides that can elicit an immune response to HIV (such as cytotoxic T cell (CTL), helper T cell, and/or humoral responses). Also disclosed are sets of the disclosed mosaic Env polypeptides, which include two or more (for example, three) of the polypeptides. Also disclosed herein are methods for treating or inhibiting HIV in a subject including administering one or more of the disclosed immunogenic polypeptides or compositions to a subject infected with HIV or at risk of HIV infection. In some embodiments, the methods include inducing an immune response to HIV in a subject comprising administering to the subject at least one (such as two, three, or more) of the immunogenic polypeptides or at least one (such as two, three, or more) nucleic acids encoding at least one of the immunogenic polypeptides disclosed herein.
FILED Tuesday, September 30, 2014
APPL NO 15/025806
ART UNIT 1648 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 39/12 (20130101)
A61K 39/21 (20130101) Original (OR) Class
A61K 45/06 (20130101)
A61K 2039/57 (20130101)

Peptides
C07K 14/005 (20130101)
C07K 14/162 (20130101)
C07K 16/1063 (20130101)
C07K 2317/34 (20130101)
C07K 2317/76 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 7/00 (20130101)
C12N 2740/16034 (20130101)
C12N 2740/16122 (20130101)
C12N 2740/16134 (20130101)
C12N 2740/16171 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09855549 Gao et al.
FUNDED BY
Department of Energy (DOE)
Office of Energy Efficiency and Renewable Energy (EERE)
APPLICANT(S) University of Connecticut (Farmington, Connecticut)
ASSIGNEE(S) UNIVERSITY OF CONNECTICUT (Farmington, Connecticut)
INVENTOR(S) Pu-Xian Gao (Coventry, Connecticut);  Yanbing Guo (Vernon Rockville, Connecticut);  Zheng Ren (Willimantic, Connecticut)
ABSTRACT A metal oxide nanorod array structure according to embodiments disclosed herein includes a monolithic substrate having a surface and multiple channels, an interface layer bonded to the surface of the substrate, and a metal oxide nanorod array coupled to the substrate surface via the interface layer. The metal oxide can include ceria, zinc oxide, tin oxide, alumina, zirconia, cobalt oxide, and gallium oxide. The substrate can include a glass substrate, a plastic substrate, a silicon substrate, a ceramic monolith, and a stainless steel monolith. The ceramic can include cordierite, alumina, tin oxide, and titania. The nanorod array structure can include a perovskite shell, such as a lanthanum-based transition metal oxide, or a metal oxide shell, such as ceria, zinc oxide, tin oxide, alumina, zirconia, cobalt oxide, and gallium oxide, or a coating of metal particles, such as platinum, gold, palladium, rhodium, and ruthenium, over each metal oxide nanorod. Structures can be bonded to the surface of a substrate and resist erosion if exposed to high velocity flow rates.
FILED Friday, September 28, 2012
APPL NO 14/347850
ART UNIT 1736 — Metallurgy, Metal Working, Inorganic Chemistry, Catalyst, Electrophotography, Photolithography
CURRENT CPC
Separation
B01D 53/944 (20130101)
B01D 2255/10 (20130101)
B01D 2255/1021 (20130101)

Chemical or Physical Processes, e.g Catalysis or Colloid Chemistry; Their Relevant Apparatus
B01J 21/063 (20130101)
B01J 23/002 (20130101)
B01J 23/34 (20130101)
B01J 23/42 (20130101)
B01J 23/44 (20130101)
B01J 23/60 (20130101)
B01J 23/63 (20130101)
B01J 23/66 (20130101)
B01J 23/83 (20130101) Original (OR) Class
B01J 23/462 (20130101)
B01J 23/464 (20130101)
B01J 23/8913 (20130101)
B01J 35/002 (20130101)
B01J 35/04 (20130101)
B01J 35/006 (20130101)
B01J 35/0013 (20130101)
B01J 35/1009 (20130101)
B01J 37/031 (20130101)
B01J 37/038 (20130101)
B01J 37/0244 (20130101)

Technical Subjects Covered by Former US Classification
Y10T 428/24612 (20150115)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09855625 El-Dasher et al.
FUNDED BY
Department of Energy (DOE)
National Nuclear Security Administration (NNSA)
Lawrence Livermore National Laboratory (LLNL)
Federally Funded Research and Development Center (FFRDC)
Operated by Lawrence Livermore National Security LLC (LLNS) at Livermore, CA
APPLICANT(S) Lawrence Livermore National Security, LLC (Livermore, California)
ASSIGNEE(S) Lawrence Livermore National Security, LLC (Livermore, California)
INVENTOR(S) Bassem S. El-Dasher (Livermore, California);  Andrew Bayramian (Manteca, California);  James A. Demuth (Mountain View, California);  Joseph C. Farmer (Tracy, California);  Sharon G. Torres (Livermore, California)
ABSTRACT A system is disclosed for performing an Additive Manufacturing (AM) fabrication process on a powdered material forming a substrate. The system may make use of a diode array for generating an optical signal sufficient to melt a powdered material of the substrate. A mask may be used for preventing a first predetermined portion of the optical signal from reaching the substrate, while allowing a second predetermined portion to reach the substrate. At least one processor may be used for controlling an output of the diode array.
FILED Tuesday, January 05, 2016
APPL NO 14/988190
ART UNIT 1743 — Tires, Adhesive Bonding, Glass/Paper making, Plastics Shaping & Molding
CURRENT CPC
Working Metallic Powder; Manufacture of Articles From Metallic Powder; Making Metallic Powder
B22F 3/1055 (20130101)
B22F 2003/1056 (20130101)
B22F 2003/1057 (20130101)

Soldering or Unsoldering; Welding; Cladding or Plating by Soldering or Welding; Cutting by Applying Heat Locally, e.g Flame Cutting; Working by Laser Beam
B23K 26/042 (20151001)
B23K 26/066 (20151001)
B23K 26/144 (20151001)
B23K 26/342 (20151001) Original (OR) Class
B23K 26/0622 (20151001)
B23K 26/0643 (20130101)

Shaping or Joining of Plastics; Shaping of Material in a Plastic State, Not Otherwise Provided For; After-treatment of the Shaped Products, e.g Repairing
B29C 67/0077 (20130101)

Additive Manufacturing, i.e Manufacturing of Three-dimensional [3-D] Objects by Additive Deposition, Additive Agglomeration or Additive Layering, e.g by 3-d Printing, Stereolithography or Selective Laser Sintering
B33Y 30/00 (20141201)
B33Y 50/02 (20141201)
B33Y 80/00 (20141201)

Alloys
C22C 32/0026 (20130101)

Climate Change Mitigation Technologies in the Production or Processing of Goods
Y02P 10/295 (20151101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09856281 Nuckolls et al.
FUNDED BY
Department of Energy (DOE)
Office of Science (DOE-SC)
Basic Energy Sciences (BES)
Energy Frontier Research Centers (EFRC)
APPLICANT(S) The Trustees of Columbia University in the City of New York (New York, New York)
ASSIGNEE(S) The Trustees of Columbia University in the City of New York (New York, New York)
INVENTOR(S) Colin Nuckolls (New York, New York);  Michael Louis Steigerwald (Martinsville, New Jersey);  Xavier Roy (Brooklyn, New York);  Philip Kim (New York, New York);  Chulho Lee (New York, New York);  Seok Ju Kang (New York, New York)
ABSTRACT A solid-state material comprising a solid-state compound is provided. The solid-state compound has the formula: [Cluster1][Cluster2]n, where Cluster1 can be a metal chalcogenide molecular cluster, Cluster2 a carbon cluster, and n the number of Cluster2 clusters in the solid-state compound. A method of forming a solid-state material is also provided.
FILED Tuesday, September 02, 2014
APPL NO 14/474972
ART UNIT 1761 — Organic Chemistry, Polymers, Compositions
CURRENT CPC
Specific Uses or Applications of Nanostructures; Measurement or Analysis of Nanostructures; Manufacture or Treatment of Nanostructures
B82Y 10/00 (20130101)

Non-metallic Elements; Compounds Thereof;
C01B 19/007 (20130101)

Indexing Scheme Relating to Structural and Physical Aspects of Solid Inorganic Compounds
C01P 2002/72 (20130101)
C01P 2002/76 (20130101)
C01P 2002/77 (20130101)
C01P 2002/78 (20130101)
C01P 2002/82 (20130101)
C01P 2002/84 (20130101)
C01P 2004/02 (20130101)
C01P 2004/03 (20130101)
C01P 2006/32 (20130101)
C01P 2006/42 (20130101)

Acyclic, Carbocyclic or Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium or Tellurium
C07F 11/00 (20130101)
C07F 15/04 (20130101)
C07F 15/06 (20130101) Original (OR) Class

Cables; Conductors; Insulators; Selection of Materials for Their Conductive, Insulating or Dielectric Properties
H01B 1/121 (20130101)

Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 51/0046 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09856383 Sleiman et al.
FUNDED BY
Department of Energy (DOE)
Office of Science (DOE-SC)
Lawrence Berkeley National Laboratory (LBNL)
Federally Funded Research and Development Center (FFRDC)
Operated by University of California (UC BERKELEY) at Berkeley, CA
APPLICANT(S) The Regents of the University of California (Oakland, California)
ASSIGNEE(S) The Regents of the University of California (Oakland, California)
INVENTOR(S) Mohamad Sleiman (Berkeley, California);  Thomas Kirchstetter (Oakland, California);  Hugo Destaillats (Scottsdale, Arizona);  Ronnen Levinson (Berkeley, California);  Paul Berdahl (Walnut Creek, California);  Hashem Akbari (Lafayette, California)
ABSTRACT This disclosure provides systems, methods, and apparatus related to simulated soiling and weathering of materials. In one aspect, a soiling mixture may include an aqueous suspension of various amounts of salt, soot, dust, and humic acid. In another aspect, a method may include weathering a sample of material in a first exposure of the sample to ultraviolet light, water vapor, and elevated temperatures, depositing a soiling mixture on the sample, and weathering the sample in a second exposure of the sample to ultraviolet light, water vapor, and elevated temperatures.
FILED Thursday, March 14, 2013
APPL NO 13/827772
ART UNIT 1717 — Coating, Etching, Cleaning, Single Crystal Growth
CURRENT CPC
Processes for Applying Fluent Materials to Surfaces, in General
B05D 3/062 (20130101)
B05D 3/065 (20130101)

Coating Compositions, e.g Paints, Varnishes or Lacquers; Filling Pastes; Chemical Paint or Ink Removers; Inks; Correcting Fluids; Woodstains; Pastes or Solids for Colouring or Printing; Use of Materials Therefor
C09D 7/1216 (20130101) Original (OR) Class
C09D 7/1233 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 17/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09856449 Lovley et al.
FUNDED BY
Department of Energy (DOE)
Advanced Research Projects Agency - Energy (ARPA-E)
Office of Science (DOE-SC)
APPLICANT(S) UNIVERSITY OF MASSACHUSETTS (Boston, Massachusetts)
ASSIGNEE(S) UNIVERSITY OF MASSACHUSETTS (Boston, Massachusetts)
INVENTOR(S) Derek R. Lovley (Amherst, Massachusetts);  Kelly P. Nevin (Amherst, Massachusetts)
ABSTRACT The invention provides systems and methods for generating organic compounds using carbon dioxide as a source of carbon and electrical current as an energy source. In one embodiment, a reaction cell is provided having a cathode electrode and an anode electrode that are connected to a source of electrical power, and which are separated by a permeable membrane. A biological film is provided on the cathode. The biological film comprises a bacterium that can accept electrons and that can convert carbon dioxide to a carbon-bearing compound and water in a cathode half-reaction. At the anode, water is decomposed to free molecular oxygen and solvated protons in an anode half-reaction. The half-reactions are driven by the application of electrical current from an external source. Compounds that have been produced include acetate, butanol, 2-oxobutyrate, propanol, ethanol, and formate.
FILED Monday, September 21, 2015
APPL NO 14/860211
ART UNIT 1651 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Apparatus for Enzymology or Microbiology;
C12M 21/12 (20130101)
C12M 35/02 (20130101) Original (OR) Class
C12M 41/00 (20130101)

Fermentation or Enzyme-using Processes to Synthesise a Desired Chemical Compound or Composition or to Separate Optical Isomers From a Racemic Mixture
C12P 7/16 (20130101)
C12P 7/40 (20130101)
C12P 7/54 (20130101)

Electrolytic or Electrophoretic Processes for the Production of Compounds or Non-metals; Apparatus Therefor
C25B 3/00 (20130101)
C25B 3/04 (20130101)

Processes or Means, e.g Batteries, for the Direct Conversion of Chemical Energy into Electrical Energy
H01M 8/16 (20130101)

Reduction of Greenhouse Gas [GHG] Emissions, Related to Energy Generation, Transmission or Distribution
Y02E 50/10 (20130101)
Y02E 60/527 (20130101)

Climate Change Mitigation Technologies in the Production or Processing of Goods
Y02P 20/133 (20151101)
Y02P 20/135 (20151101)
Y02P 70/56 (20151101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09856461 Fortman et al.
FUNDED BY
Department of Energy (DOE)
Office of Science (DOE-SC)
Lawrence Berkeley National Laboratory (LBNL)
Federally Funded Research and Development Center (FFRDC)
Operated by University of California (UC BERKELEY) at Berkeley, CA
National Science Foundation (NSF)
APPLICANT(S) The Regents of the University of California (Oakland, California)
ASSIGNEE(S) The Regents of the University of California (Oakland, California)
INVENTOR(S) Jeffrey L. Fortman (San Francisco, California);  Leonard Katz (Oakland, California);  Eric J. Steen (Berkeley, California);  Jay D Keasling (Berkeley, California)
ABSTRACT The present invention provides for a polyketide synthase (PKS) capable of synthesizing an α-olefin, such as 1-hexene or butadiene. The present invention also provides for a host cell comprising the PKS and when cultured produces the α-olefin.
FILED Monday, September 14, 2015
APPL NO 14/853821
ART UNIT 1656 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 9/1029 (20130101) Original (OR) Class
C12N 15/52 (20130101)

Fermentation or Enzyme-using Processes to Synthesise a Desired Chemical Compound or Composition or to Separate Optical Isomers From a Racemic Mixture
C12P 5/005 (20130101)
C12P 5/007 (20130101)
C12P 5/026 (20130101)

Enzymes
C12Y 203/01 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09856563 Martinson et al.
FUNDED BY
Department of Energy (DOE)
Office of Science (DOE-SC)
Argonne National Laboratory (ANL)
Federally Funded Research and Development Center (FFRDC)
Operated by UChicago Argonne, LLC (UCHICAGO) at Argonne, IL
APPLICANT(S) Alex B. F. Martinson (Woodridge, Illinois);  Joseph A. Libera (Clarendon Hill, Illinois);  Jeffrey W. Elam (Elmhurst, Illinois);  Shannon C. Riha (Park Ridge, Illinois)
ASSIGNEE(S) UCHICAGO ARGONNE, LLC (Chicago, Illinois)
INVENTOR(S) Alex B. F. Martinson (Woodridge, Illinois);  Joseph A. Libera (Clarendon Hill, Illinois);  Jeffrey W. Elam (Elmhurst, Illinois);  Shannon C. Riha (Park Ridge, Illinois)
ABSTRACT The invention is directed to QCM measurements in monitoring ALD processes. Previously, significant barriers remain in the ALD processes and accurate execution. To turn this exclusively dedicated in situ technique into a routine characterization method, an integral QCM fixture was developed. This new design is easily implemented on a variety of ALD tools, allows rapid sample exchange, prevents backside deposition, and minimizes both the footprint and flow disturbance. Unlike previous QCM designs, the fast thermal equilibration enables tasks such as temperature-dependent studies and ex situ sample exchange, further highlighting the feasibility of this QCM design for day-to-day use. Finally, the in situ mapping of thin film growth rates across the ALD reactor was demonstrated in a popular commercial tool operating in both continuous and quasi-static ALD modes.
FILED Wednesday, August 22, 2012
APPL NO 13/591498
ART UNIT 1718 — Coating, Etching, Cleaning, Single Crystal Growth
CURRENT CPC
Coating Metallic Material; Coating Material With Metallic Material; Surface Treatment of Metallic Material by Diffusion into the Surface, by Chemical Conversion or Substitution; Coating by Vacuum Evaporation, by Sputtering, by Ion Implantation or by Chemical Vapour Deposition, in General
C23C 16/52 (20130101)
C23C 16/45525 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09856754 Pasch
FUNDED BY
Department of Energy (DOE)
National Nuclear Security Administration (NNSA)
Sandia National Laboratories (SNL)
Federally Funded Research and Development Center (FFRDC)
Operated by National Technology and Engineering Solutions of Sandia, LLC (NTESS) at Albuquerque, NM
APPLICANT(S) Sandia Corporation (Albuquerque, New Mexico)
ASSIGNEE(S) National Technology and Engineering Solutions of Sandia, LLC (Albuquerque, New Mexico)
INVENTOR(S) James J. Pasch (Albuquerque, New Mexico)
ABSTRACT The present disclosure is directed to a cascaded recompression closed Brayton cycle (CRCBC) system and method of operation thereof, where the CRCBC system includes a compressor for compressing the system fluid, a separator for generating fluid feed streams for each of the system's turbines, and separate segments of a heater that heat the fluid feed streams to different feed temperatures for the system's turbines. Fluid exiting each turbine is used to preheat the fluid to the turbine. In an embodiment, the amount of heat extracted is determined by operational costs.
FILED Monday, April 17, 2017
APPL NO 15/489338
ART UNIT 3748 — Thermal & Combustion Technology, Motive & Fluid Power Systems
CURRENT CPC
Steam Engine Plants; Steam Accumulators; Engine Plants Not Otherwise Provided For; Engines Using Special Working Fluids or Cycles
F01K 7/16 (20130101) Original (OR) Class
F01K 11/00 (20130101)
F01K 13/02 (20130101)
F01K 19/04 (20130101)
F01K 23/04 (20130101)
F01K 25/103 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09856791 Müller et al.
FUNDED BY
Department of Energy (DOE)
Advanced Research Projects Agency - Energy (ARPA-E)
APPLICANT(S) Board of Trustees of Michigan State University (East Lansing, Michigan)
ASSIGNEE(S) Board of Trustees of Michigan State University (East Lansing, Michigan)
INVENTOR(S) Norbert Müller (Haslett, Michigan);  Janusz Piechna (Warsaw, Poland);  Guangwei Sun (East Lansing, Michigan);  Pablo-Francisco Parraga (East Lansing, Michigan)
ABSTRACT A wave disc engine apparatus is provided. A further aspect employs a constricted nozzle in a wave rotor channel. A further aspect provides a sharp bend between an inlet and an outlet in a fluid pathway of a wave rotor, with the bend being spaced away from a peripheral edge of the wave rotor. A radial wave rotor for generating electricity in an automotive vehicle is disclosed in yet another aspect.
FILED Monday, August 19, 2013
APPL NO 13/969900
ART UNIT 3741 — Thermal & Combustion Technology, Motive & Fluid Power Systems
CURRENT CPC
Non-positive Displacement Machines or Engines, e.g Steam Turbines
F01D 1/32 (20130101)

Gas-turbine Plants; Air Intakes for Jet-propulsion Plants; Controlling Fuel Supply in Air-breathing Jet-propulsion Plants
F02C 3/14 (20130101) Original (OR) Class
F02C 3/165 (20130101)
F02C 5/04 (20130101)
F02C 5/10 (20130101)

Jet-propulsion Plants
F02K 7/04 (20130101)

Indexing Scheme for Aspects Relating to Non-positive-displacement Machines or Engines, Gas-turbines or Jet-propulsion Plants
F05D 2240/302 (20130101)
F05D 2250/82 (20130101)

Climate Change Mitigation Technologies Related to Transportation
Y02T 50/673 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09857235 Hamann et al.
FUNDED BY
Department of Energy (DOE)
APPLICANT(S) International Business Machines Corporation (Armonk, New York)
ASSIGNEE(S) International Business Machines Corporation (Armonk, New York)
INVENTOR(S) Hendrik F. Hamann (Yorktown Heights, New York);  Hongfei Li (Briarcliff Manor, New York);  Srinivas Yarlanki (White Plains, New York)
ABSTRACT Techniques for real-time modeling temperature distributions based on streaming sensor data are provided. In one aspect, a method for creating a three-dimensional temperature distribution model for a room having a floor and a ceiling is provided. The method includes the following steps. A ceiling temperature distribution in the room is determined. A floor temperature distribution in the room is determined. An interpolation between the ceiling temperature distribution and the floor temperature distribution is used to obtain the three-dimensional temperature distribution model for the room.
FILED Friday, March 08, 2013
APPL NO 13/791140
ART UNIT 2863 — Printing/Measuring and Testing
CURRENT CPC
Measuring Temperature; Measuring Quantity of Heat; Thermally-sensitive Elements Not Otherwise Provided for
G01K 1/02 (20130101)
G01K 7/42 (20130101) Original (OR) Class
G01K 2213/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09857239 Woo et al.
FUNDED BY
Department of Energy (DOE)
National Nuclear Security Administration (NNSA)
Lawrence Livermore National Laboratory (LLNL)
Federally Funded Research and Development Center (FFRDC)
Operated by Lawrence Livermore National Security LLC (LLNS) at Livermore, CA
APPLICANT(S) EmiSense Technologies, LLC (Ladera Ranch, California);  Lawrence Livermore National Security, LLC (Livermore, California)
ASSIGNEE(S) Lawrence Livermore National Security, LLC (Livermore, California);  EmiSense Technologies, LLC (Ladera Ranch, California)
INVENTOR(S) Leta Yar-Li Woo (Oakland, California);  Robert Scott Glass (Livermore, California);  Joseph Jay Fitzpatrick (Glendale, California);  Gangqiang Wang (Salt Lake City, Utah);  Brett Tamatea Henderson (Salt Lake City, Utah);  Anthoniraj Lourdhusamy (West Jordan, Utah);  James John Steppan (Park City, Utah);  Klaus Karl Allmendinger (San Juan Capistrano, California)
ABSTRACT A method for temperature analysis of a gas stream. The method includes identifying a temperature parameter of an affected waveform signal. The method also includes calculating a change in the temperature parameter by comparing the affected waveform signal with an original waveform signal. The method also includes generating a value from the calculated change which corresponds to the temperature of the gas stream.
FILED Tuesday, February 28, 2017
APPL NO 15/444427
ART UNIT 1798 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry
CURRENT CPC
Measuring Temperature; Measuring Quantity of Heat; Thermally-sensitive Elements Not Otherwise Provided for
G01K 13/02 (20130101) Original (OR) Class
G01K 2013/024 (20130101)
G01K 2205/04 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 27/4065 (20130101)
G01N 27/4071 (20130101)
G01N 27/4074 (20130101)
G01N 27/4075 (20130101)
G01N 33/0037 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09857267 Nelson, Jr. et al.
FUNDED BY
Department of Energy (DOE)
Office of Science (DOE-SC)
APPLICANT(S) Aerodyne Research, Inc. (Billerica, Massachusetts)
ASSIGNEE(S) Aerodyne Research, Inc. (Billerica, Massachusetts)
INVENTOR(S) David D. Nelson, Jr. (N. Chelmsford, Massachusetts);  Scott C. Herndon (Littleton, Massachusetts)
ABSTRACT In one embodiment, a CO2 leak detection instrument detects leaks from a site (e.g., a CO2 sequestration facility) using rapid concentration measurements of CO2, O2 and optionally water concentration that are achieved, for example, using laser spectroscopy (e.g. direct absorption laser spectroscopy). Water vapor in the sample gas may not be removed, or only partially removed. The sample gas may be collected using a multiplexed inlet assembly from a plurality of locations. CO2 and O2 concentrations may be corrected based on the water concentration. A resulting dataset of the CO2 and O2 concentrations is analyzed over time intervals to detect any changes in CO2 concentration that are not anti-correlated with O2 concentration, and to identify a potential CO2 leak in response thereto. The analysis may include determining eddy covariance flux measurements of sub-surface potential carbon.
FILED Monday, November 14, 2016
APPL NO 15/350925
ART UNIT 2886 — Optics
CURRENT CPC
Testing Static or Dynamic Balance of Machines or Structures; Testing of Structures or Apparatus, Not Otherwise Provided for
G01M 3/38 (20130101) Original (OR) Class

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 21/05 (20130101)
G01N 21/27 (20130101)
G01N 33/004 (20130101)
G01N 33/0036 (20130101)
G01N 2201/12 (20130101)
G01N 2201/06113 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09857325 Woo et al.
FUNDED BY
Department of Energy (DOE)
National Nuclear Security Administration (NNSA)
Lawrence Livermore National Laboratory (LLNL)
Federally Funded Research and Development Center (FFRDC)
Operated by Lawrence Livermore National Security LLC (LLNS) at Livermore, CA
APPLICANT(S) EmiSense Technologies, LLC (Ladera Ranch, California);  Lawrence Livermore National Security, LLC (Livermore, California)
ASSIGNEE(S) Lawrence Livermore National Security, LLC (Livermore, California);  EmiSense Technologies, LLC (Ladera Ranch, California)
INVENTOR(S) Leta Yar-Li Woo (Oakland, California);  Robert Scott Glass (Livermore, California);  Joseph Jay Fitzpatrick (Glendale, California);  Gangqiang Wang (Salt Lake City, Utah);  Brett Tamatea Henderson (Salt Lake City, Utah);  Anthoniraj Lourdhusamy (West Jordan, Utah);  James John Steppan (Park City, Utah);  Klaus Karl Allmendinger (San Juan Capistrano, California)
ABSTRACT A device for signal processing. The device includes a signal generator, a signal detector, and a processor. The signal generator generates an original waveform. The signal detector detects an affected waveform. The processor is coupled to the signal detector. The processor receives the affected waveform from the signal detector. The processor also compares at least one portion of the affected waveform with the original waveform. The processor also determines a difference between the affected waveform and the original waveform. The processor also determines a value corresponding to a unique portion of the determined difference between the original and affected waveforms. The processor also outputs the determined value.
FILED Tuesday, February 28, 2017
APPL NO 15/444416
ART UNIT 1798 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry
CURRENT CPC
Measuring Temperature; Measuring Quantity of Heat; Thermally-sensitive Elements Not Otherwise Provided for
G01K 13/02 (20130101)
G01K 2013/024 (20130101)
G01K 2205/04 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 27/4065 (20130101) Original (OR) Class
G01N 27/4071 (20130101)
G01N 27/4074 (20130101)
G01N 27/4075 (20130101)
G01N 33/0037 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09857326 Woo et al.
FUNDED BY
Department of Energy (DOE)
National Nuclear Security Administration (NNSA)
Lawrence Livermore National Laboratory (LLNL)
Federally Funded Research and Development Center (FFRDC)
Operated by Lawrence Livermore National Security LLC (LLNS) at Livermore, CA
APPLICANT(S) EmiSense Technologies, LLC (Ladera Ranch, California);  Lawrence Livermore National Security, LLC (Livermore, California)
ASSIGNEE(S) Lawrence Livermore National Security, LLC (Livermore, California);  EmiSense Technologies, LLC (Ladera Ranch, California)
INVENTOR(S) Leta Yar-Li Woo (Oakland, California);  Robert Scott Glass (Livermore, California);  Joseph Jay Fitzpatrick (Glendale, California);  Gangqiang Wang (Salt Lake City, Utah);  Brett Tamatea Henderson (Salt Lake City, Utah);  Anthoniraj Lourdhusamy (West Jordan, Utah);  James John Steppan (Park City, Utah);  Klaus Karl Allmendinger (San Juan Capistrano, California)
ABSTRACT A method for analysis of a gas stream. The method includes identifying an affected region of an affected waveform signal corresponding to at least one characteristic of the gas stream. The method also includes calculating a voltage-current time differential between the affected region of the affected waveform signal and a corresponding region of an original waveform signal. The affected region and the corresponding region of the waveform signals have a sensitivity specific to the at least one characteristic of the gas stream. The method also includes generating a value for the at least one characteristic of the gas stream based on the calculated voltage-current time differential.
FILED Tuesday, February 28, 2017
APPL NO 15/444420
ART UNIT 1798 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry
CURRENT CPC
Measuring Temperature; Measuring Quantity of Heat; Thermally-sensitive Elements Not Otherwise Provided for
G01K 13/02 (20130101)
G01K 2013/024 (20130101)
G01K 2205/04 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 27/4065 (20130101) Original (OR) Class
G01N 27/4071 (20130101)
G01N 27/4074 (20130101)
G01N 27/4075 (20130101)
G01N 33/0037 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09857370 Harper et al.
FUNDED BY
Department of Energy (DOE)
National Nuclear Security Administration (NNSA)
Sandia National Laboratories (SNL)
Federally Funded Research and Development Center (FFRDC)
Operated by National Technology and Engineering Solutions of Sandia, LLC (NTESS) at Albuquerque, NM
APPLICANT(S) National Technology and Engineering Solutions of Sandia, LLC (Albuquerque, New Mexico)
ASSIGNEE(S) National Technology and Engineering Solutions of Sandia, LLC (Albuquerque, New Mexico)
INVENTOR(S) Jason C. Harper (Rio Rancho, New Mexico);  Thayne L. Edwards (Albuquerque, New Mexico);  Bryan Carson (Tijeras, New Mexico);  Melissa Finley (Albuquerque, New Mexico);  William Arndt (Albuquerque, New Mexico)
ABSTRACT The present invention, in part, relates to methods and apparatuses for on-chip amplification and/or detection of various targets, including biological targets and any amplifiable targets. In some examples, the microculture apparatus includes a single-use, normally-closed fluidic valve that is initially maintained in the closed position by a valve element bonded to an adhesive coating. The valve is opened using a magnetic force. The valve element includes a magnetic material or metal. Such apparatuses and methods are useful for in-field or real-time detection of targets, especially in limited resource settings.
FILED Thursday, January 16, 2014
APPL NO 14/157378
ART UNIT 1677 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Chemical or Physical Laboratory Apparatus for General Use
B01L 3/502738 (20130101)
B01L 2300/0663 (20130101)
B01L 2300/0816 (20130101)
B01L 2300/0887 (20130101)
B01L 2400/0406 (20130101)
B01L 2400/0633 (20130101)

Valves; Taps; Cocks; Actuating-floats; Devices for Venting or Aerating
F16K 31/086 (20130101)
F16K 99/003 (20130101)
F16K 99/0046 (20130101)
F16K 2099/0084 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/56911 (20130101) Original (OR) Class

Technical Subjects Covered by Former US Classification
Y10T 137/87917 (20150401)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09857480 Warburton et al.
FUNDED BY
Department of Energy (DOE)
Office of Science (DOE-SC)
APPLICANT(S) XIA LLC (Hayward, California)
ASSIGNEE(S) XIA LLC (Hayward, California)
INVENTOR(S) William K. Warburton (Oakland, California);  Wolfgang G. Hennig (Fremont, California)
ABSTRACT A method and apparatus for measuring the concentrations of radioxenon isotopes in a gaseous sample wherein the sample cell is surrounded by N sub-detectors that are sensitive to both electrons and to photons from radioxenon decays. Signal processing electronics are provided that can detect events within the sub-detectors, measure their energies, determine whether they arise from electrons or photons, and detect coincidences between events within the same or different sub-detectors. The energies of detected two or three event coincidences are recorded as points in associated two or three-dimensional histograms. Counts within regions of interest in the histograms are then used to compute estimates of the radioxenon isotope concentrations. The method achieves lower backgrounds and lower minimum detectable concentrations by using smaller detector crystals, eliminating interference between double and triple coincidence decay branches, and segregating double coincidences within the same sub-detector from those occurring between different sub-detectors.
FILED Friday, April 08, 2016
APPL NO 15/094793
ART UNIT 2884 — Optics
CURRENT CPC
Measurement of Nuclear or X-radiation
G01T 1/178 (20130101) Original (OR) Class
G01T 1/208 (20130101)
G01T 1/2018 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09857660 DeVore et al.
FUNDED BY
Department of Energy (DOE)
National Nuclear Security Administration (NNSA)
Lawrence Livermore National Laboratory (LLNL)
Federally Funded Research and Development Center (FFRDC)
Operated by Lawrence Livermore National Security LLC (LLNS) at Livermore, CA
APPLICANT(S) LAWRENCE LIVERMORE NATIONAL SECURITY, LLC (Livermore, California)
ASSIGNEE(S) Lawrence Livermore National Security, LLC (Livermore, California)
INVENTOR(S) Peter Thomas Setsuda DeVore (Pleasant Hill, California);  Jason T. Chou (Walnut Creek, California)
ABSTRACT An Optical Information Transfer Enhancer System includes a first system for producing an information bearing first optical wave that is impressed with a first information having a first information strength wherein the first optical wave has a first shape. A second system produces a second optical wave. An information strength enhancer module receives the first and said second optical waves and impresses the first optical wave upon the second optical wave via cross-phase modulation (XPM) to produce an information-strength-enhanced second optical wave having a second information strength that is greater than the first information strength of the first optical wave. Following a center-wavelength changer by an Optical Information Transfer Enhancer System improves its performance.
FILED Friday, May 13, 2016
APPL NO 15/153991
ART UNIT 2874 — Optics
CURRENT CPC
Optical Elements, Systems, or Apparatus
G02B 27/10 (20130101)
G02B 27/283 (20130101)

Devices or Arrangements, the Optical Operation of Which Is Modified by Changing the Optical Properties of the Medium of the Devices or Arrangements for the Control of the Intensity, Colour, Phase, Polarisation or Direction of Light, e.g Switching, Gating, Modulating or Demodulating; Techniques or Procedures for the Operation Thereof; Frequency-changing; Non-linear Optics; Optical Logic Elements; Optical Analogue/digital Converters
G02F 1/3511 (20130101) Original (OR) Class

Transmission
H04B 10/11 (20130101)
H04B 10/503 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09857825 Johnson et al.
FUNDED BY
Department of Energy (DOE)
Office of Electricity (DOE-OE)
APPLICANT(S) Washington State University (Pullman, Washington)
ASSIGNEE(S) Washington State University (Pullman, Washington)
INVENTOR(S) Brett Emery Trabun Johnson (Pullman, Washington);  Thoshitha Thanushka Gamage (Pullman, Washington);  David Edward Bakken (Pullman, Washington)
ABSTRACT This disclosure describes, in part, a system management component and failure detection component for use in a power grid data network to identify anomalies within the network and systematically adjust the quality of service of data published by publishers and subscribed to by subscribers within the network. In one implementation, subscribers may identify a desired data rate, a minimum acceptable data rate, desired latency, minimum acceptable latency and a priority for each subscription. The failure detection component may identify an anomaly within the network and a source of the anomaly. Based on the identified anomaly, data rates and or data paths may be adjusted in real-time to ensure that the power grid data network does not become overloaded and/or fail.
FILED Monday, October 28, 2013
APPL NO 14/065225
ART UNIT 2454 — Computer Networks
CURRENT CPC
Systems for Regulating Electric or Magnetic Variables
G05F 5/00 (20130101) Original (OR) Class

Data Processing Systems or Methods, Specially Adapted for Administrative, Commercial, Financial, Managerial, Supervisory or Forecasting Purposes; Systems or Methods Specially Adapted for Administrative, Commercial, Financial, Managerial, Supervisory or Forecasting Purposes, Not Otherwise Provided for
G06Q 50/06 (20130101)

Transmission of Digital Information, e.g Telegraphic Communication
H04L 41/0631 (20130101)
H04L 41/5019 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09858144 DeBenedictis
FUNDED BY
Department of Energy (DOE)
National Nuclear Security Administration (NNSA)
Sandia National Laboratories (SNL)
Federally Funded Research and Development Center (FFRDC)
Operated by National Technology and Engineering Solutions of Sandia, LLC (NTESS) at Albuquerque, NM
APPLICANT(S) National Technology and Engineering Solutions of Sandia, LLC (Albuquerque, New Mexico)
ASSIGNEE(S) National Technology and Engineering Solutions of Sandia, LLC (Albuquerque, New Mexico)
INVENTOR(S) Erik DeBenedictis (Albuquerque, New Mexico)
ABSTRACT A method and apparatus for performing reliable general-purpose computing. Each sub-core of a plurality of sub-cores of a processor core processes a same instruction at a same time. A code analyzer receives a plurality of residues that represents a code word corresponding to the same instruction and an indication of whether the code word is a memory address code or a data code from the plurality of sub-cores. The code analyzer determines whether the plurality of residues are consistent or inconsistent. The code analyzer and the plurality of sub-cores perform a set of operations based on whether the code word is a memory address code or a data code and a determination of whether the plurality of residues are consistent or inconsistent.
FILED Thursday, August 20, 2015
APPL NO 14/831711
ART UNIT 2112 — Computer Error Control, Reliability, & Control Systems
CURRENT CPC
Electric Digital Data Processing
G06F 11/1068 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09858502 Moody et al.
FUNDED BY
Department of Energy (DOE)
Los Alamos National Security, LLC (LANS)
National Nuclear Security Administration (NNSA)
Los Alamos National Laboratory (LANL)
Federally Funded Research and Development Center (FFRDC)
Operated by Triad National Security, LLC (TRIAD) at Los Alamos, NM
APPLICANT(S) Los Alamos National Security, LLC (Los Alamos, New Mexico)
ASSIGNEE(S) Los Alamos National Security, LLC (Los Alamos, New Mexico)
INVENTOR(S) Daniela Moody (Los Alamos, New Mexico);  Brendt Wohlberg (Los Alamos, New Mexico)
ABSTRACT An approach for land cover classification, seasonal and yearly change detection and monitoring, and identification of changes in man-made features may use a clustering of sparse approximations (CoSA) on sparse representations in learned dictionaries. The learned dictionaries may be derived using efficient convolutional sparse coding to build multispectral or hyperspectral, multiresolution dictionaries that are adapted to regional satellite image data. Sparse image representations of images over the learned dictionaries may be used to perform unsupervised k-means clustering into land cover categories. The clustering process behaves as a classifier in detecting real variability. This approach may combine spectral and spatial textural characteristics to detect geologic, vegetative, hydrologic, and man-made features, as well as changes in these features over time.
FILED Thursday, April 21, 2016
APPL NO 15/134437
ART UNIT 2668 — Image Analysis; Applications; Pattern Recognition; Color and compression; Enhancement and Transformation
CURRENT CPC
Recognition of Data; Presentation of Data; Record Carriers; Handling Record Carriers
G06K 9/0063 (20130101)
G06K 9/6267 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09859046 Shen
FUNDED BY
Department of Energy (DOE)
Office of Science (DOE-SC)
Fermi National Accelerator Laboratory (FNAL)
Federally Funded Research and Development Center (FFRDC)
Operated by Fermi Research Alliance, LLC (FRA) at Batavia, IL
APPLICANT(S) Fermi Research Alliance, LLC (Batavia, Illinois)
ASSIGNEE(S) Fermi Research Alliance, LLC (Batavia, Illinois)
INVENTOR(S) Tengming Shen (Naperville, Illinois)
ABSTRACT A method, system, and apparatus for fabricating a high-strength Superconducting cable comprises pre-oxidizing at least one high-strength alloy wire, coating at least one Superconducting wire with a protective layer, and winding the high-strength alloy wire and the Superconducting wire to form a high-strength Superconducting cable.
FILED Tuesday, September 13, 2016
APPL NO 15/263935
ART UNIT 1735 — Metallurgy, Metal Working, Inorganic Chemistry, Catalyst, Electrophotography, Photolithography
CURRENT CPC
Processes for Applying Fluent Materials to Surfaces, in General
B05D 3/0254 (20130101)

Modifying the Physical Structure of Ferrous Metals; General Devices for Heat Treatment of Ferrous or Non-ferrous Metals or Alloys; Making Metal Malleable, e.g by Decarburisation or Tempering
C21D 9/525 (20130101)

Changing the Physical Structure of Non-ferrous Metals and Non-ferrous Alloys
C22F 1/10 (20130101)

Magnets; Inductances; Transformers; Selection of Materials for Their Magnetic Properties
H01F 1/143 (20130101)
H01F 1/147 (20130101)
H01F 6/06 (20130101) Original (OR) Class
H01F 41/048 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09859515 Hammond et al.
FUNDED BY
Department of Energy (DOE)
Office of Energy Efficiency and Renewable Energy (EERE)
National Renewable Energy Laboratory (NREL)
Federally Funded Research and Development Center (FFRDC)
Operated by Alliance for Sustainable Energy, LLC (ASE) at Golden, CO
APPLICANT(S) Alliance for Sustainable Energy, LLC (Golden, Colorado);  SolarWindow Technologies, Inc. (Columbia, Maryland)
ASSIGNEE(S) Alliance for Sustainable Energy, LLC (Golden, Colorado);  SolarWindow Technologies, Inc. (Columbia, Maryland)
INVENTOR(S) Scott Ryan Hammond (Denver, Colorado);  Dana C. Olson (Boulder, Colorado);  Marinus Franciscus Antonius Maria van Hest (Lakewood, Colorado)
ABSTRACT Methods for producing thin film charge selective transport layers are provided. In one embodiment, a method for forming a thin film charge selective transport layer comprises: providing a precursor solution comprising a metal containing reactive precursor material dissolved into a complexing solvent; depositing the precursor solution onto a surface of a substrate to form a film; and forming a charge selective transport layer on the substrate by annealing the film.
FILED Friday, March 07, 2014
APPL NO 14/200315
ART UNIT 2893 — Semiconductors/Memory
CURRENT CPC
Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 51/0026 (20130101)
H01L 51/0036 (20130101)
H01L 51/0047 (20130101)
H01L 51/4253 (20130101) Original (OR) Class
H01L 2251/303 (20130101)

Reduction of Greenhouse Gas [GHG] Emissions, Related to Energy Generation, Transmission or Distribution
Y02E 10/549 (20130101)

Climate Change Mitigation Technologies in the Production or Processing of Goods
Y02P 70/521 (20151101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09859531 Young et al.
FUNDED BY
Department of Energy (DOE)
Advanced Research Projects Agency - Energy (ARPA-E)
APPLICANT(S) Ovonic Battery Company, Inc. (Rochester Hills, Michigan)
ASSIGNEE(S) Ovonic Battery Company, Inc. (Rochester Hills, Michigan)
INVENTOR(S) Kwo-hsiung Young (Troy, Michigan);  Jean Nei (Southgate, Michigan);  Tiejun Meng (Novi, Michigan)
ABSTRACT Provided are sealed pouch-cell batteries that are alkaline batteries or non-aqueous proton-conducing batteries. A pouch cell includes a flexible housing such as is used for pouch cell construction where the housing is in the form of a pouch, a cathode comprising a cathode active material suitable for use in an alkaline battery, an anode comprising an anode active material suitable for use in an alkaline battery, an electrolyte that is optionally an alkaline or proton-conducting electrolyte, and wherein the pouch does not include or require a safety vent or other gas absorbing or releasing system as the anode active material and the cathode active material do not increase the internal atmospheric pressure any more than 2 psig during cycling. The batteries provided function contrary to the art recognized belief that such battery systems were impossible due to unacceptable gas production during cycling.
FILED Friday, February 06, 2015
APPL NO 14/615796
ART UNIT 1758 — Semiconductors/Memory
CURRENT CPC
Processes or Means, e.g Batteries, for the Direct Conversion of Chemical Energy into Electrical Energy
H01M 2/0207 (20130101) Original (OR) Class
H01M 2/0275 (20130101)
H01M 4/32 (20130101)
H01M 4/242 (20130101)
H01M 10/30 (20130101)
H01M 10/48 (20130101)
H01M 10/345 (20130101)
H01M 10/425 (20130101)
H01M 10/4257 (20130101)
H01M 2010/4271 (20130101)
H01M 2300/0014 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09859583 Delnick et al.
FUNDED BY
Department of Energy (DOE)
National Nuclear Security Administration (NNSA)
Sandia National Laboratories (SNL)
Federally Funded Research and Development Center (FFRDC)
Operated by National Technology and Engineering Solutions of Sandia, LLC (NTESS) at Albuquerque, NM
APPLICANT(S) National Technology and Engineering Solutions of Sandia, LLC (Albuquerque, New Mexico);  UT-Battelle, LLC (Oak Ridge, Tennessee)
ASSIGNEE(S) National Technology and Engineering Solutions of Sandia, LLC (Albuquerque, New Mexico);  UT-Battelle, LLC (Oak Ridge, Tennessee)
INVENTOR(S) Frank M. Delnick (Maryville, Tennessee);  David Ingersoll (Albuquerque, New Mexico);  Chengdu Liang (Knoxville, Tennessee)
ABSTRACT The fundamental charge storage mechanisms in a number of currently studied high energy redox couples are based on intercalation, conversion, or displacement reactions. With exception to certain metal-air chemistries, most often the active redox materials are stored physically in the electrochemical cell stack thereby lowering the practical gravimetric and volumetric energy density as a tradeoff to achieve reasonable power density. In a general embodiment, a mediated redox flow battery includes a series of secondary organic molecules that form highly reduced anionic radicals as reaction mediator pairs for the reduction and oxidation of primary high capacity redox species ex situ from the electrochemical cell stack. Arenes are reduced to stable anionic radicals that in turn reduce a primary anode to the charged state. The primary anode is then discharged using a second lower potential (more positive) arene. Compatible separators and solvents are also disclosed herein.
FILED Wednesday, October 15, 2014
APPL NO 14/515423
ART UNIT 1724 — Fuel Cells, Battery, Flammable Gas, Solar Cells, Liquid Crystal Compositions
CURRENT CPC
Processes or Means, e.g Batteries, for the Direct Conversion of Chemical Energy into Electrical Energy
H01M 4/8652 (20130101)
H01M 4/9041 (20130101)
H01M 8/188 (20130101) Original (OR) Class
H01M 8/0221 (20130101)

Reduction of Greenhouse Gas [GHG] Emissions, Related to Energy Generation, Transmission or Distribution
Y02E 60/528 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

National Science Foundation (NSF) 

US 09854987 Chang et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Electrical, Communications and Cyber Systems (ECCS)
APPLICANT(S) Sun-Il Chang (Ann Arbor, Michigan);  Euisik Yoon (Superior Township, Michigan)
ASSIGNEE(S) The Regents of the University of Michigan (Ann Arbor, Michigan)
INVENTOR(S) Sun-Il Chang (Ann Arbor, Michigan);  Euisik Yoon (Superior Township, Michigan)
ABSTRACT A neural interface for measuring or stimulating brain neural activity, either as a standalone unit or as a part of a larger system of similar neural interfaces. The neural interface includes a bolt-shaped housing having a tool-engaging head and threaded shank with internal circuitry and at least one electrode. In use, the housing is threaded into a cranial bore such that the electrode contacts the outer surface of the meninges. The neural interface circuitry includes an SAR ADC that provides at least rail-to-rail operation to convert received signals from the electrode(s) into digital data that can be modulated and wirelessly transmitted by intra-skin or other suitable communication.
FILED Wednesday, October 20, 2010
APPL NO 13/503196
ART UNIT 3739 — SELECT * FROM codes_techcenter;
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/0028 (20130101)
A61B 5/0478 (20130101) Original (OR) Class
A61B 5/7232 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09855103 Tsekos et al.
FUNDED BY
National Science Foundation (NSF)
APPLICANT(S) University of Houston System (Houston, Texas)
ASSIGNEE(S) UNIVERSITY OF HOUSTON SYSTEM (Houston, Texas)
INVENTOR(S) Nikolaos v. Tsekos (Houston, Texas);  Nikhil V. Navkar (Corona, California)
ABSTRACT Provided herein are systems, modules and methods of using the same for in-situ real time imaging guidance of a robot during a surgical procedure. The systems comprise a plurality of modules that intraoperatively link an imaging modality, particularly a magnetic resonance imaging modality, a medical robot and an operator thereof via a plurality of interfaces. The modules are configured to operate in at least one computer having a memory, a processor and a network connection to enable instructions to generally control the imaging modality, track the robot, track a tissue of interest in an area of procedure, process data acquire from imaging modality and the robot and visualize the area and robot. Also provided are non-transitory computer-readable data storage medium storing computer-executable instructions comprising the modules and a computer program produce tangibly embodied in the storage medium.
FILED Tuesday, August 27, 2013
APPL NO 14/011574
ART UNIT 3777 — Sheet Container Making, Package Making, Receptacles, Shoes, Apparel, and Tool Driving or Impacting
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 19/50 (20130101) Original (OR) Class
A61B 34/10 (20160201)
A61B 34/30 (20160201)
A61B 34/76 (20160201)
A61B 2017/00243 (20130101)
A61B 2034/2051 (20160201)
A61B 2090/306 (20160201)
A61B 2090/374 (20160201)
A61B 2090/378 (20160201)
A61B 2090/3614 (20160201)
A61B 2090/3958 (20160201)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09855363 Stokes et al.
FUNDED BY
National Science Foundation (NSF)
APPLICANT(S) Edward Brittain Stokes (Charlotte, North Carolina);  Jennifer Godwin Pagan (Charlotte, North Carolina);  Thomas Andrew Schmedake (Charlotte, North Carolina)
ASSIGNEE(S) AquiSense Technologies LLC (Erlanger, Kentucky);  The University of North Carolina at Charlotte (Charlotte, North Carolina)
INVENTOR(S) Edward Brittain Stokes (Charlotte, North Carolina);  Jennifer Godwin Pagan (Charlotte, North Carolina);  Thomas Andrew Schmedake (Charlotte, North Carolina)
ABSTRACT A system for disinfecting a fluid, including: a flow cell including one or more inlet ports and one or more outlet ports, wherein the flow cell is configured to communicate a fluid containing a biological contaminant from the one or more inlet ports to the one or more outlet portions through an interior portion thereof; and one or more point radiation sources disposed about the flow cell, wherein the one or more point radiation sources are operable for delivering radiation to the biological contaminant; wherein an interior surface of the flow cell is operable for reflecting the radiation delivered to the biological contaminant by the one or more point radiation sources; and wherein the interior surface of the flow cell is operable for reflecting the radiation delivered to the biological contaminant by the one or more point radiation sources such that a radiation intensity is uniform throughout the interior portion of the flow cell. In one exemplary embodiment, the flow cell is an integrating sphere. Optionally, the system also includes a photocatalyzing material disposed on at least a portion of the interior surface of the flow cell.
FILED Friday, June 17, 2011
APPL NO 13/163055
ART UNIT 1779 — Chemical Apparatus, Separation and Purification, Liquid and Gas Contact Apparatus
CURRENT CPC
Methods or Apparatus for Sterilising Materials or Objects in General; Disinfection, Sterilisation, or Deodorisation of Air; Chemical Aspects of Bandages, Dressings, Absorbent Pads, or Surgical Articles; Materials for Bandages, Dressings, Absorbent Pads, or Surgical Articles
A61L 9/205 (20130101) Original (OR) Class
A61L 2209/11 (20130101)

Treatment of Water, Waste Water, Sewage, or Sludge
C02F 1/325 (20130101)
C02F 2201/328 (20130101)
C02F 2201/3222 (20130101)
C02F 2201/3225 (20130101)
C02F 2201/3227 (20130101)
C02F 2303/04 (20130101)
C02F 2305/10 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 21/33 (20130101)
G01N 2201/065 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09855538 Suslick et al.
FUNDED BY
National Science Foundation (NSF)
APPLICANT(S) The Board of Trustees of the University of Illinois (Urbana, Illinois)
ASSIGNEE(S) The Board of Trustees of the University of Illinois (Urbana, Illinois)
INVENTOR(S) Kenneth S. Suslick (Champaign, Illinois);  Bradley W. Zeiger (Portland, Oregon);  Hyo Na Kim (Champaign, Illinois)
ABSTRACT An ultrasonic apparatus for producing particles of a pharmaceutical agent or other material comprises a flow-through ultrasonic horn comprising an inlet, an outlet, and an interior channel that connects the inlet to the outlet for flow of a fluid therethrough. The ultrasonic horn is connectable to a transducer, and a crystallization tube is adjacent to the ultrasonic horn. The crystallization tube comprises an inlet port and outlet port for flow of an antisolvent therethrough, and it further includes a side access port. The outlet of the ultrasonic horn is inserted into the side access port so as to be in fluid communication with the crystallization tube.
FILED Tuesday, March 04, 2014
APPL NO 14/772255
ART UNIT 1743 — Tires, Adhesive Bonding, Glass/Paper making, Plastics Shaping & Molding
CURRENT CPC
Containers Specially Adapted for Medical or Pharmaceutical Purposes; Devices or Methods Specially Adapted for Bringing Pharmaceutical Products into Particular Physical or Administering Forms; Devices for Administering Food or Medicines Orally; Baby Comforters; Devices for Receiving Spittle
A61J 3/02 (20130101)

Chemical or Physical Processes, e.g Catalysis or Colloid Chemistry; Their Relevant Apparatus
B01J 2/18 (20130101) Original (OR) Class

Spraying Apparatus; Atomising Apparatus; Nozzles
B05B 7/0012 (20130101)
B05B 17/063 (20130101)
B05B 17/0676 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09855545 Dichtel et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Chemistry (CHE)
APPLICANT(S) Cornell University (Ithaca, New York)
ASSIGNEE(S) Cornell University (Ithaca, New York)
INVENTOR(S) William R. Dichtel (Wilmette, Illinois);  Alaaeddin Alsbaiee (King of Prussia, Pennsylvania);  Brian J. Smith (Ithaca, New York);  Juan Hinestroza (Ithaca, New York);  Diego Alzate-Sanchez (Ithaca, New York);  Leilei Xiao (Ithaca, New York);  Yuhan Ling (Ithaca, New York);  Damian Helbling (Ithaca, New York)
ABSTRACT A nucleophilic substitution reaction to crosslink cyclodextrin (CD) polymer with rigid aromatic groups, providing a high surface area, mesoporous CD-containing polymers (P-CDPs). The P-CDPs can be used for removing organic contaminants from water. By encapsulating pollutants to form well-defined host-guest complexes with complementary selectivities to activated carbon (AC) sorbents. The P-CDPs can rapidly sequester pharmaceuticals, pesticides, and other organic micropollutants, achieving equilibrium binding capacity in seconds with adsorption rate constants 15-200 times greater than ACs and nonporous CD sorbents. The CD polymer can be regenerated several times, through a room temperature washing procedure, with no loss in performance.
FILED Friday, March 03, 2017
APPL NO 15/449206
ART UNIT 1673 — Tires, Adhesive Bonding, Glass/Paper making, Plastics Shaping & Molding
CURRENT CPC
Separation
B01D 15/40 (20130101)
B01D 53/025 (20130101)
B01D 2253/31 (20130101)
B01D 2253/202 (20130101)
B01D 2253/306 (20130101)
B01D 2253/308 (20130101)
B01D 2257/708 (20130101)

Chemical or Physical Processes, e.g Catalysis or Colloid Chemistry; Their Relevant Apparatus
B01J 20/24 (20130101) Original (OR) Class
B01J 20/289 (20130101)
B01J 20/28033 (20130101)

Treatment of Water, Waste Water, Sewage, or Sludge
C02F 1/285 (20130101)
C02F 2101/305 (20130101)
C02F 2103/06 (20130101)

Polysaccharides; Derivatives Thereof
C08B 37/0012 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 30/14 (20130101)
G01N 30/30 (20130101)
G01N 33/02 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09856272 Echegoyen et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
National Science Foundation (NSF)
APPLICANT(S) Luis A. Echegoyen (El Paso, Texas);  Danisha M. Rivera-Nazario (El Paso, Texas);  Edison A. Castro Portillo (El Paso, Texas);  Zachary Martinez (El Paso, Texas);  Manuel Llano (El Paso, Texas)
ASSIGNEE(S) THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (Austin, Texas)
INVENTOR(S) Luis A. Echegoyen (El Paso, Texas);  Danisha M. Rivera-Nazario (El Paso, Texas);  Edison A. Castro Portillo (El Paso, Texas);  Zachary Martinez (El Paso, Texas);  Manuel Llano (El Paso, Texas)
ABSTRACT Certain embodiments useful as HIV-inhibitor agents are directed to fullerene derivatives tetrahydro-1H—C60-fulleropyrrolo[1,2-c][1,3]thiazine salts (Formula I) or tetrahydro-1H—C70-fulleropyrrolo[1,2-c][1,3]thiazine salts (Formula II), while further embodiments are directed to α, β, γ, and/or δ isomer of tetrahydro-1H—C70-fulleropyrrolo[1,2-c][1,3]thiazine salt.
FILED Friday, November 04, 2016
APPL NO 15/343631
ART UNIT 1624 — Organic Chemistry
CURRENT CPC
Heterocyclic Compounds
C07D 513/04 (20130101) Original (OR) Class
C07D 519/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09856332 Rege et al.
FUNDED BY
National Science Foundation (NSF)
APPLICANT(S) Kaushal Rege (Chandler, Arizona);  Taraka Sai Pavan Grandhi (Tempe, Arizona);  Andrew Dobos (Tempe, Arizona)
ASSIGNEE(S) Arizona Board of Regents on Behalf of Arizona State University (Scottsdale, Arizona)
INVENTOR(S) Kaushal Rege (Chandler, Arizona);  Taraka Sai Pavan Grandhi (Tempe, Arizona);  Andrew Dobos (Tempe, Arizona)
ABSTRACT Biomedical devices and methods are disclosed for the development of 3D polymeric scaffolds for cell culture, high throughput screens for biomolecule purification, and generation of bone mimetic materials. The devices may feature multiple geometries, and scaffold generation capabilities include multiple gel types utilizing organic and aqueous phase pregel. Additionally, macroporous and non-macroporous morphologies are possible.
FILED Tuesday, March 22, 2016
APPL NO 15/077743
ART UNIT 1657 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Macromolecular Compounds Obtained by Reactions Only Involving Carbon-to-carbon Unsaturated Bonds
C08F 10/00 (20130101) Original (OR) Class

Apparatus for Enzymology or Microbiology;
C12M 25/14 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 5/0068 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09856348 Harth et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Chemistry (CHE)
APPLICANT(S) Vanderbilt University (Nashville, Tennessee)
ASSIGNEE(S) Vanderbilt University (Nashville, Tennessee)
INVENTOR(S) Eva M. Harth (Nashville, Tennessee);  David J. Calkins (Nashville, Tennessee);  Alice E. Van Der Ende (Antioch, Tennessee)
ABSTRACT In one aspect, the invention relates to polymers, crosslinked polymers, functionalized polymers, nanoparticles, and functionalized nanoparticles and methods of making and using same. In one aspect, the invention relates to degradable polymers and degradable nanoparticles. In one aspect, the invention relates to methods of preparing degradable nanoparticles and, more specifically, methods of controlling particle size during the preparation of degradable nanoparticles. In one aspect, the degradable nanoparticles are useful for complexing, delivering, and releasing payloads, including pharmaceutically active payloads. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
FILED Monday, February 22, 2016
APPL NO 15/049781
ART UNIT 1766 — Organic Chemistry, Polymers, Compositions
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/0048 (20130101)
A61K 9/5153 (20130101)
A61K 47/482 (20130101)
A61K 47/48176 (20130101)
A61K 47/48192 (20130101)
A61K 47/48207 (20130101)
A61K 47/48907 (20130101)
A61K 49/0041 (20130101)
A61K 49/0056 (20130101)
A61K 49/0093 (20130101)

Macromolecular Compounds Obtained Otherwise Than by Reactions Only Involving Unsaturated Carbon-to-carbon Bonds
C08G 63/08 (20130101)
C08G 63/78 (20130101)
C08G 63/912 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09856448 Melosh et al.
FUNDED BY
National Science Foundation (NSF)
APPLICANT(S) The Board of Trustees of the Leland Stanford Junior University (Palo Alto, California)
ASSIGNEE(S) The Board of Trustees of the Leland Stanford Junior Univesity (Palo Alto, California)
INVENTOR(S) Nicholas Alexander Melosh (Menlo Park, California);  Piyush Verma (Mountain View, California);  Benjamin David Almquist (Somerville, Massachusetts)
ABSTRACT Nanoscale probes for forming stable, non-destructive seals with cell membranes. The probes, systems including these probes, and methods of fabricating and using the probes described herein may be used to sense from, stimulate, modify, or otherwise effect individual cells or groups of cells. In particular, described herein are nanoscale cellular probes that may be used to fuse with, and in some variations span, the lipid membrane of a cell to provide stable and long lasting contact to the cell. Thus, the probes described herein may be used as part of a system, method or device that would benefit from stable, non-destructive access to and across a cell membrane. In some variations the nanoscale probe devices or systems described herein may be used as part of a drug screening procedure.
FILED Friday, August 15, 2014
APPL NO 14/461303
ART UNIT 1759 — Coating, Etching, Cleaning, Single Crystal Growth
CURRENT CPC
Apparatus for Enzymology or Microbiology;
C12M 35/00 (20130101) Original (OR) Class

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/48728 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09856460 Dueber et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Engineering Education and Centers (EEC)
APPLICANT(S) The Regents of the University of California (Oakland, California)
ASSIGNEE(S) The Regents of the University of California (Oakland, California)
INVENTOR(S) John E. Dueber (Oakland, California);  Jay D. Keasling (Berkeley, California);  Gabriel C. Wu (Daly City, California);  Ghulam Reza K. Malmirchegini (Livermore, California)
ABSTRACT The present invention provides methods of producing a product or product precursor of a biosynthetic pathway in a genetically modified host cell. The present invention also provides genetically modified host cells comprising nucleic acids encoding a scaffold polypeptide and nucleic acids comprising nucleotide sequences encoding two or more enzymes in a biosynthetic pathway. The present invention further provides nucleic acids comprising nucleotide sequences encoding scaffold polypeptides, for use in a subject method.
FILED Wednesday, June 25, 2014
APPL NO 14/315102
ART UNIT 1652 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Peptides
C07K 2/00 (20130101)
C07K 2319/00 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 9/00 (20130101) Original (OR) Class
C12N 15/52 (20130101)
C12N 15/62 (20130101)
C12N 15/63 (20130101)
C12N 15/1044 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09856461 Fortman et al.
FUNDED BY
Department of Energy (DOE)
Office of Science (DOE-SC)
Lawrence Berkeley National Laboratory (LBNL)
Federally Funded Research and Development Center (FFRDC)
Operated by University of California (UC BERKELEY) at Berkeley, CA
National Science Foundation (NSF)
APPLICANT(S) The Regents of the University of California (Oakland, California)
ASSIGNEE(S) The Regents of the University of California (Oakland, California)
INVENTOR(S) Jeffrey L. Fortman (San Francisco, California);  Leonard Katz (Oakland, California);  Eric J. Steen (Berkeley, California);  Jay D Keasling (Berkeley, California)
ABSTRACT The present invention provides for a polyketide synthase (PKS) capable of synthesizing an α-olefin, such as 1-hexene or butadiene. The present invention also provides for a host cell comprising the PKS and when cultured produces the α-olefin.
FILED Monday, September 14, 2015
APPL NO 14/853821
ART UNIT 1656 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 9/1029 (20130101) Original (OR) Class
C12N 15/52 (20130101)

Fermentation or Enzyme-using Processes to Synthesise a Desired Chemical Compound or Composition or to Separate Optical Isomers From a Racemic Mixture
C12P 5/005 (20130101)
C12P 5/007 (20130101)
C12P 5/026 (20130101)

Enzymes
C12Y 203/01 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09856567 Choi et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Chemistry (CHE)
APPLICANT(S) Wisconsin Alumni Research Foundation (Madison, Wisconsin)
ASSIGNEE(S) Wisconsin Alumni Research Foundation (Madison, Wisconsin)
INVENTOR(S) Kyoung-Shin Choi (Fitchburg, Wisconsin);  Tae Woo Kim (Madison, Wisconsin)
ABSTRACT Photoelectrochemical materials and photoelectrodes comprising the materials are provided. The photoelectrochemical materials comprise a porous, high-surface-area BiVO4 that is composed of particles smaller than the hole diffusion length of BiVO4.
FILED Monday, June 16, 2014
APPL NO 14/305064
ART UNIT 1736 — Metallurgy, Metal Working, Inorganic Chemistry, Catalyst, Electrophotography, Photolithography
CURRENT CPC
Compounds Containing Metals Not Covered by Subclasses C01D or C01F
C01G 31/00 (20130101)

Indexing Scheme Relating to Structural and Physical Aspects of Solid Inorganic Compounds
C01P 2004/03 (20130101)
C01P 2004/51 (20130101)
C01P 2004/62 (20130101)
C01P 2004/80 (20130101)
C01P 2006/12 (20130101)
C01P 2006/14 (20130101)
C01P 2006/16 (20130101)
C01P 2006/17 (20130101)
C01P 2006/40 (20130101)

Electrolytic or Electrophoretic Processes for the Production of Compounds or Non-metals; Apparatus Therefor
C25B 1/003 (20130101)
C25B 1/04 (20130101)
C25B 11/04 (20130101)
C25B 11/035 (20130101) Original (OR) Class

Reduction of Greenhouse Gas [GHG] Emissions, Related to Energy Generation, Transmission or Distribution
Y02E 60/366 (20130101)

Climate Change Mitigation Technologies in the Production or Processing of Goods
Y02P 20/135 (20151101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09856581 Gonen Williams et al.
FUNDED BY
Department of Commerce (DOC)
National Science Foundation (NSF)
APPLICANT(S) PIXELLIGENT TECHNOLOGIES, LLC (Baltimore, Maryland)
ASSIGNEE(S) PIXELLIGENT TECHNOLOGIES, LLC (Baltimore, Maryland)
INVENTOR(S) Zehra Serpil Gonen Williams (Lanham, Maryland);  Yijun Wang (Greenbelt, Maryland);  Robert J. Wiacek (Silver Spring, Maryland);  Xia Bai (Olney, Maryland);  Linfeng Gou (Greenbelt, Maryland);  Selina I. Thomas (Hyattsville, Maryland);  Wei Xu (Greenbelt, Maryland);  Jun Xu (Gaithersburg, Maryland);  Rakesh Patel (Lawrenceville, New Jersey)
ABSTRACT Preparation of semiconductor nanocrystals and their dispersions in solvents and other media is described. The nanocrystals described herein have small (1-10 nm) particle size with minimal aggregation and can be synthesized with high yield. The capping agents on the as-synthesized nanocrystals as well as nanocrystals which have undergone cap exchange reactions result in the formation of stable suspensions in polar and nonpolar solvents which may then result in the formation of high quality nanocomposite films.
FILED Monday, March 21, 2016
APPL NO 15/075536
ART UNIT 1762 — Organic Chemistry, Polymers, Compositions
CURRENT CPC
Specific Uses or Applications of Nanostructures; Measurement or Analysis of Nanostructures; Manufacture or Treatment of Nanostructures
B82Y 30/00 (20130101)
B82Y 40/00 (20130101)

Acyclic, Carbocyclic or Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium or Tellurium
C07F 7/28 (20130101)
C07F 7/1836 (20130101)

Single-crystal-growth; Unidirectional Solidification of Eutectic Material or Unidirectional Demixing of Eutectoid Material; Refining by Zone-melting of Material; Production of a Homogeneous Polycrystalline Material With Defined Structure; Single Crystals or Homogeneous Polycrystalline Material With Defined Structure; After-treatment of Single Crystals or a Homogeneous Polycrystalline Material With Defined Structure; Apparatus Therefor
C30B 7/10 (20130101)
C30B 7/14 (20130101)
C30B 29/16 (20130101) Original (OR) Class
C30B 29/32 (20130101)

Cables; Conductors; Insulators; Selection of Materials for Their Conductive, Insulating or Dielectric Properties
H01B 1/14 (20130101)
H01B 1/20 (20130101)
H01B 1/22 (20130101)

Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 21/02565 (20130101)
H01L 21/02601 (20130101)
H01L 21/02628 (20130101)
H01L 51/005 (20130101)
H01L 51/0094 (20130101)

Technical Subjects Covered by Former USPC Cross-reference Art Collections [XRACs] and Digests
Y10S 977/774 (20130101)
Y10S 977/896 (20130101)
Y10S 977/932 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09857168 Gupta et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Office of Naval Research (ONR)
National Science Foundation (NSF)
Directorate for Computer and Information Science and Engineering (CISE)
Division of Information and Intelligent Systems (IIS)
APPLICANT(S) The Trustees of Columbia University in the City of New York (New York, New York)
ASSIGNEE(S) The Trustees of Columbia University in the City of New York (New York, New York)
INVENTOR(S) Mohit Gupta (New York, New York);  Shree K Nayar (New York, New York)
ABSTRACT Systems, methods, and media for performing shape measurement are provided. In some embodiments, systems for performing shape measurement are provided, the systems comprising: a projector that projects onto a scene a plurality of illumination patterns, wherein each of the illumination patterns has a given frequency, each of the illumination patterns is projected onto the scene during a separate period of time, three different illumination patterns are projected with a first given frequency, and only one or two different illumination patterns are projected with a second given frequency; a camera that detects an image of the scene during each of the plurality of periods of time; and a hardware processor that is configured to: determine the given frequencies of the plurality of illumination patterns; and measure a shape of an object in the scene.
FILED Thursday, February 12, 2015
APPL NO 14/621068
ART UNIT 2483 — Recording and Compression
CURRENT CPC
Measuring Length, Thickness or Similar Linear Dimensions; Measuring Angles; Measuring Areas; Measuring Irregularities of Surfaces or Contours
G01B 11/254 (20130101)
G01B 11/2536 (20130101) Original (OR) Class

Recognition of Data; Presentation of Data; Record Carriers; Handling Record Carriers
G06K 9/4661 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09857246 Bowden et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Civil, Mechanical and Manufacturing Innovation (CMMI)
APPLICANT(S) SENSABLE TECHNOLOGIES, LLC (Lindon, Utah)
ASSIGNEE(S) SENSABLE TECHNOLOGIES, LLC (Lindon, Utah)
INVENTOR(S) Anton E. Bowden (Lindon, Utah);  David T. Fullwood (Provo, Utah);  Daniel A. Baradoy (Provo, Utah)
ABSTRACT In one general aspect, an apparatus can include a sensing membrane including a plurality of conductive fillers included in a matrix. The apparatus can include a plurality of electrical leads coupled to an outer portion of the sensing membrane where the conductive fillers have a volumetric percentage of less than 25% of the volume of the sensing membrane.
FILED Wednesday, September 16, 2015
APPL NO 14/856235
ART UNIT 2855 — Printing/Measuring and Testing
CURRENT CPC
Measuring Force, Stress, Torque, Work, Mechanical Power, Mechanical Efficiency, or Fluid Pressure
G01L 1/18 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09857315 Patterson et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Physics (PHY)
APPLICANT(S) President and Fellows of Harvard College (Cambridge, Massachusetts)
ASSIGNEE(S) PRESIDENT AND FELLOWS OF HARVARD COLLEGE (Cambridge, Massachusetts)
INVENTOR(S) David S. Patterson (Somerville, Massachusetts);  John M. Doyle (Belmont, Massachusetts)
ABSTRACT A spectrometer includes: (1) a housing defining a volume into which an analyte gas is introduced, the analyte gas including a chiral component; (2) a microwave generator coupled to the housing and configured to apply a microwave pulse to the analyte gas, the microwave pulse being polarized along a first direction; (3) an electric field generator coupled to the housing and configured to apply a switched electric field to the analyte gas, the electric field being oriented along a second direction different from the first direction; (4) a phase-sensitive microwave detector coupled to the housing and configured to detect an induced microwave emitted by the analyte gas, the induced microwave being polarized along a third direction different from the first direction and the second direction; and (5) an analyzer coupled to the phase-sensitive microwave detector and configured to detect an enantiomer of the chiral component based on a phase of the induced microwave.
FILED Thursday, March 14, 2013
APPL NO 14/415211
ART UNIT 2866 — Printing/Measuring and Testing
CURRENT CPC
Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 22/00 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09857371 Brujic et al.
FUNDED BY
National Science Foundation (NSF)
APPLICANT(S) New York University (New York, New York)
ASSIGNEE(S) NEW YORK UNIVERSITY (New York, New York)
INVENTOR(S) Jasna Brujic (New York, New York);  Lea-Laetitia Pontani (New York, New York)
ABSTRACT A biomimetic system is provided for use in modeling cell-cell adhesion mechanisms comprising functionalized emulsion droplets. Further, a cell culture medium and a drug delivery system using said biomimetic system are provided.
FILED Tuesday, May 07, 2013
APPL NO 13/889083
ART UNIT 1612 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/107 (20130101)
A61K 47/24 (20130101)
A61K 47/62 (20170801)
A61K 47/557 (20170801)
A61K 47/6907 (20170801)
A61K 47/6911 (20170801)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/56966 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09859079 Jarrahi et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
Army Research Office (CCDC ARO)
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Civil, Mechanical and Manufacturing Innovation (CMMI)
APPLICANT(S) The Regents of the University of Michigan (Ann Arbor, Michigan)
ASSIGNEE(S) The Regents of the University of Michigan (Ann Arbor, Michigan)
INVENTOR(S) Mona Jarrahi (Los Angeles, California);  Mehmet Unlu (Ankara, Turkey);  Christopher W. Berry (Albuquerque, New Mexico);  Shenglin Li (Aliso Viejo, California)
ABSTRACT A reconfigurable device for terahertz (THz) or infrared (IR) ranges that includes a base substrate, a lower array attached to the base substrate, and an upper array attached to the base substrate and at least partially suspended over the lower array. Activation of the reconfigurable device causes the upper array to mechanically flex towards the lower array so that electrical contact is made therebetween. Methods of fabricating and operating the reconfigurable device are also provided.
FILED Wednesday, August 06, 2014
APPL NO 14/910523
ART UNIT 2842 — Electrical Circuits and Systems
CURRENT CPC
Optical Elements, Systems, or Apparatus
G02B 6/29361 (20130101)
G02B 6/29395 (20130101)

Electric Switches; Relays; Selectors; Emergency Protective Devices
H01H 49/00 (20130101)
H01H 50/005 (20130101)
H01H 51/27 (20130101) Original (OR) Class
H01H 51/32 (20130101)
H01H 57/00 (20130101)
H01H 59/0009 (20130101)
H01H 2057/006 (20130101)
H01H 2201/024 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Veterans Affairs (DVA) 

US 09855178 Rogers
FUNDED BY
Department of Veterans Affairs (DVA)
APPLICANT(S) Kurk Anthony Rogers (San Diego, California)
ASSIGNEE(S) The United States of America as Represented by the Department of Veterans Affairs (Washington, District of Columbia)
INVENTOR(S) Kurk Anthony Rogers (San Diego, California)
ABSTRACT Described are surgical drapes and system with universal application to heavy equipment useful in operating room environments. Surgical drape systems of the invention are particularly capable of covering patient support machinery such as hoists, lifts, and slings, whether the equipment is mobile or stationary, or configured as a floor-based or as an overhead support/lifting system. The drapes of the current invention provide for protecting the equipment from exposure to surgical biohazard waste e.g.; blood or body fluids, as well as providing the ability to use equipment that is otherwise not presently allowed to enter into an operating room because of the impossibility to render such equipment sterile. The drapes further allow for the holding, lifting and positioning of the patient whole body or limbs while maintaining sterility during prepping and surgical procedures. Also included are support slings for use with the drapes.
FILED Thursday, April 16, 2015
APPL NO 14/688099
ART UNIT 3772 — Medical & Surgical Instruments, Treatment Devices, Surgery and Surgical Supplies
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 19/081 (20130101)
A61B 19/088 (20130101)

Transport, Personal Conveyances, or Accommodation Specially Adapted for Patients or Disabled Persons; Operating Tables or Chairs; Chairs for Dentistry; Funeral Devices
A61G 7/1017 (20130101)
A61G 7/1046 (20130101)
A61G 7/1051 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09855312 Schally et al.
FUNDED BY
Department of Veterans Affairs (DVA)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) UNIVERSITY OF MIAMI (Miami, Florida);  THE UNITED STATES OF AMERICA, REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS (Washington, District of Columbia)
ASSIGNEE(S) UNIVERSITY OF MIAMI (Miami, Florida);  THE UNITED STATES OF AMERICA, REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS (Washington, District of Columbia)
INVENTOR(S) Andrew V. Schally (Miami Beach, Florida);  Joshua M. Hare (Miami Beach, Florida);  Norman L. Block (Hollywood, Florida);  Samirah A. Gomes (Miami Beach, Florida);  Rosemeire M. Kanashiro-Takeuchi (Miami, Florida)
ABSTRACT Disclosed herein are compositions of GHRH agonists and peptides, and methods to treat disorders, such as ischemia and reperfusion injury. In one embodiment, a method of treating a reperfusion injury in a subject in need may involve administering a therapeutically effective amount of at least one GHRH agonist peptide to the subject. In additional embodiment, a method of promoting vasculogenesis in a mammal may involve administering a therapeutically effective amount of at least one GHRH agonist peptide to the subject. In a further embodiment, a method of promoting differentiation of mesenchymal stem cells into endothelial cells may involve contacting mesenchymal stem cells with at least one GHRH agonist peptide.
FILED Monday, December 23, 2013
APPL NO 14/138391
ART UNIT 1675 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/16 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09855368 Murray et al.
FUNDED BY
Department of Veterans Affairs (DVA)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
APPLICANT(S) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (Oakland, California)
ASSIGNEE(S) The Regents of the University of California (Oakland, California);  Department of Veterans Affairs (Washington, District of Columbia)
INVENTOR(S) Samuel S. Murray (Saugus, California);  Elsa J. Murray (Saugus, California);  Jeffrey C. Wang (Sherman Oaks, California);  Keyvan Behnam (Simi Valley, California)
ABSTRACT A cyclized peptide designated BMP Binding Peptide (BBP) is a synthetic peptide that avidly binds rhBMP-2, as do endogenous forms of BBP, and sequence conservation between species results in a variety of useful BBP compositions. BBP increases the over-all osteogenic activity of rhBMP-2, increases the rate at which rhBMP-2 induces bone formation, and BBP induces calcification alone. Compositions and substrates including BBP, and methods of using BBP are useful in therapeutic, diagnostic and clinical applications requiring calcification and osteogenesis.
FILED Friday, March 06, 2015
APPL NO 14/640451
ART UNIT 1647 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 35/28 (20130101)
A61K 38/12 (20130101)
A61K 38/1841 (20130101)
A61K 38/1841 (20130101)
A61K 38/1875 (20130101)
A61K 38/1875 (20130101)
A61K 2300/00 (20130101)
A61K 2300/00 (20130101)

Methods or Apparatus for Sterilising Materials or Objects in General; Disinfection, Sterilisation, or Deodorisation of Air; Chemical Aspects of Bandages, Dressings, Absorbent Pads, or Surgical Articles; Materials for Bandages, Dressings, Absorbent Pads, or Surgical Articles
A61L 27/54 (20130101)
A61L 27/227 (20130101) Original (OR) Class
A61L 27/3821 (20130101)
A61L 27/3834 (20130101)
A61L 2400/18 (20130101)
A61L 2430/02 (20130101)

Peptides
C07K 7/08 (20130101)
C07K 14/51 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 5/0668 (20130101)
C12N 2501/15 (20130101)
C12N 2501/155 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09856204 Adams et al.
FUNDED BY
Department of Veterans Affairs (DVA)
APPLICANT(S) Christopher M. Adams (Iowa City, Iowa);  Steven D. Kunkel (Iowa City, Iowa);  Manish Suneja (Coralville, Iowa);  Michael Welsh (Riverside, Iowa)
ASSIGNEE(S) UNIVERSITY OF IOWA RESEARCH FOUNDATION (Iowa City, Iowa);  THE UNITED STATES OF AMERICA AS REPRESENTED BY VETERANS AFFAIRS (Washington, District of Columbia)
INVENTOR(S) Christopher M. Adams (Iowa City, Iowa);  Steven D. Kunkel (Iowa City, Iowa);  Manish Suneja (Coralville, Iowa);  Michael Welsh (Riverside, Iowa)
ABSTRACT In one aspect, the invention relates methods for inhibiting or preventing muscle atrophy or increasing muscle mass by providing to a subject in need thereof an effective amount of ursolic acid, a derivative thereof, or an analog of the ursane scaffold. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
FILED Thursday, May 19, 2011
APPL NO 13/698645
ART UNIT 1621 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/19 (20130101)
A61K 31/191 (20130101)
A61K 31/198 (20130101)
A61K 31/215 (20130101)

Acyclic or Carbocyclic Compounds
C07C 61/29 (20130101) Original (OR) Class
C07C 69/12 (20130101)
C07C 69/757 (20130101)
C07C 235/82 (20130101)

Heterocyclic Compounds
C07D 265/30 (20130101)

Steroids
C07J 53/002 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Agriculture (USDA) 

US 09855323 Talaat
FUNDED BY
Department of Agriculture (USDA)
National Institute of Food and Agriculture (NIFA)
APPLICANT(S) Wisconsin Alumni Research Foundation (Madison, Wisconsin)
ASSIGNEE(S) Wisconsin Alumni Research Foundation (Madison, Wisconsin)
INVENTOR(S) Adel Mohammed Talaat (Madison, Wisconsin)
ABSTRACT A composition and method for immunizing a mammal infected with Mycobacterium are disclosed. The genes gcpE, pstA, kdpC, papA2, impA, umaA1, fabG2_2, aceAB, mbtH2, IpqP, map0834c, cspB, lipN, and map1634 of M. paratuberculosis and the products that they encode are vaccine targets for Johne's and Crohn's disease. Eighteen M. paratuberculosis-specific genomic islands (MAPs) were identified. Three inverted large genomic fragments in M. paratuberculosis (INV) were also identified. These genomic identifiers represent novel virulence determinants that can be used as targets for vaccines and for developments of drugs against Johne's disease. The methods can be used to deliver an immunizing compound to a mammal, to provide an immune response against Johne's or Crohn's disease in the mammal.
FILED Wednesday, August 10, 2016
APPL NO 15/233539
ART UNIT 1645 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 39/00 (20130101)
A61K 39/04 (20130101) Original (OR) Class
A61K 2039/53 (20130101)
A61K 2039/552 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09856531 Khatib
FUNDED BY
Department of Agriculture (USDA)
Agricultural Research Service (ARS)
Cooperative State Research, Education, and Extension Service (CSREES)
APPLICANT(S) WISCONSIN ALUMNI RESEARCH FOUNDATION (Madison, Wisconsin)
ASSIGNEE(S) WISCONSIN ALUMNI RESEARCH FOUNDATION (Madison, Wisconsin)
INVENTOR(S) Hasan Khatib (Fitchburg, Wisconsin)
ABSTRACT An isolated nucleic acid molecule comprising a polymorphic site selected from the group consisting of positions 164, 269, 284, 407 and 989 of SEQ ID NO: 1, an array or a kit comprising the same. Also provided are a method for detecting single nucleotide polymorphism (SNP) in bovine proteinase inhibitor (PI) gene, a method for haplotyping a bovine cell, a method for progeny testing of cattle based on said haplotyping, a method for selectively breeding of cattle based on haplotyping a parent animal. The present invention further provides a method for testing a dairy cattle for its milk production trait, comprising haplotyping its cells, wherein a cattle having haplotypes 1, 3, 4 or 5 indicates that the cattle has desirable milk production trait. Haplotype 1 indicates that the cattle has the most desirable milk production trait.
FILED Friday, January 08, 2016
APPL NO 14/990810
ART UNIT 1634 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Veterinary Instruments, Implements, Tools, or Methods
A61D 19/02 (20130101)
A61D 19/04 (20130101)

Sugars; Derivatives Thereof; Nucleosides; Nucleotides; Nucleic Acids
C07H 21/04 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6876 (20130101) Original (OR) Class
C12Q 1/6888 (20130101)
C12Q 2600/124 (20130101)
C12Q 2600/156 (20130101)
C12Q 2600/172 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US PP28831 Brand et al.
FUNDED BY
Department of Agriculture (USDA)
APPLICANT(S) University of Connecticut (Farmington, Connecticut)
ASSIGNEE(S) University of Connecticut Technology Commercialization Services (, None)
INVENTOR(S) Mark Henry Brand (Willington, Connecticut);  Bryan Allan Connolly (Mansfield Center, Connecticut)
ABSTRACT A new and distinct Aronia cultivar named ‘UCONNAM166’ is disclosed, characterized by a distinctly upright plant form, reaching a mature height between 4 to 5 feet. Vigorous but controlled plant growth. Multicolored Fall foliage. Plants are adaptable to a variety of landscape uses, including hedging or mass planting. Triploid plants produce very few, or no fruits. The new variety is a Aronia, normally produced as an outdoor landscape plant.
FILED Wednesday, February 10, 2016
APPL NO 14/998768
ART UNIT 1661 — Plants
CURRENT CPC
Plants
PLT/156
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Commerce (DOC) 

US 09856471 Jacobson et al.
FUNDED BY
Department of Commerce (DOC)
National Institute of Standards and Technology (NIST)
APPLICANT(S) Gen9, Inc. (Cambridge, Massachusetts)
ASSIGNEE(S) Gen9, Inc. (Cambridge, Massachusetts)
INVENTOR(S) Joseph Jacobson (Newton, Massachusetts);  George Church (Brookline, Massachusetts);  Larry Li-Yang Chu (Cambridge, Massachusetts)
ABSTRACT Disclosed are methods for synthesizing and/or assembling at least one polynucleotide product having a predefined sequence from a plurality of different oligonucleotides. In exemplary embodiments, the methods involve synthesis and/or amplification of different oligonucleotides immobilized on a solid support, release of synthesized/amplified oligonucleotides in solution to form droplets, recognition and removal of error-containing oligonucleotides, moving or combining two droplets to allow hybridization and/or ligation between two different oligonucleotides, and further chain extension reaction following hybridization and/or ligation to hierarchically generate desired length of polynucleotide products.
FILED Friday, June 27, 2014
APPL NO 14/317082
ART UNIT 1634 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Chemical or Physical Processes, e.g Catalysis or Colloid Chemistry; Their Relevant Apparatus
B01J 2219/0052 (20130101)
B01J 2219/0059 (20130101)
B01J 2219/00378 (20130101)
B01J 2219/00389 (20130101)
B01J 2219/00529 (20130101)
B01J 2219/00585 (20130101)
B01J 2219/00596 (20130101)
B01J 2219/00599 (20130101)
B01J 2219/00608 (20130101)
B01J 2219/00659 (20130101)
B01J 2219/00693 (20130101)
B01J 2219/00722 (20130101)

Chemical or Physical Laboratory Apparatus for General Use
B01L 3/0268 (20130101)
B01L 3/502792 (20130101)
B01L 2400/0436 (20130101)
B01L 2400/0439 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/10 (20130101)
C12N 15/66 (20130101)
C12N 15/1093 (20130101) Original (OR) Class

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6837 (20130101)
C12Q 1/6837 (20130101)
C12Q 1/6844 (20130101)
C12Q 1/6844 (20130101)
C12Q 2521/514 (20130101)
C12Q 2521/514 (20130101)
C12Q 2525/131 (20130101)
C12Q 2525/131 (20130101)
C12Q 2565/501 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09856581 Gonen Williams et al.
FUNDED BY
Department of Commerce (DOC)
National Science Foundation (NSF)
APPLICANT(S) PIXELLIGENT TECHNOLOGIES, LLC (Baltimore, Maryland)
ASSIGNEE(S) PIXELLIGENT TECHNOLOGIES, LLC (Baltimore, Maryland)
INVENTOR(S) Zehra Serpil Gonen Williams (Lanham, Maryland);  Yijun Wang (Greenbelt, Maryland);  Robert J. Wiacek (Silver Spring, Maryland);  Xia Bai (Olney, Maryland);  Linfeng Gou (Greenbelt, Maryland);  Selina I. Thomas (Hyattsville, Maryland);  Wei Xu (Greenbelt, Maryland);  Jun Xu (Gaithersburg, Maryland);  Rakesh Patel (Lawrenceville, New Jersey)
ABSTRACT Preparation of semiconductor nanocrystals and their dispersions in solvents and other media is described. The nanocrystals described herein have small (1-10 nm) particle size with minimal aggregation and can be synthesized with high yield. The capping agents on the as-synthesized nanocrystals as well as nanocrystals which have undergone cap exchange reactions result in the formation of stable suspensions in polar and nonpolar solvents which may then result in the formation of high quality nanocomposite films.
FILED Monday, March 21, 2016
APPL NO 15/075536
ART UNIT 1762 — Organic Chemistry, Polymers, Compositions
CURRENT CPC
Specific Uses or Applications of Nanostructures; Measurement or Analysis of Nanostructures; Manufacture or Treatment of Nanostructures
B82Y 30/00 (20130101)
B82Y 40/00 (20130101)

Acyclic, Carbocyclic or Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium or Tellurium
C07F 7/28 (20130101)
C07F 7/1836 (20130101)

Single-crystal-growth; Unidirectional Solidification of Eutectic Material or Unidirectional Demixing of Eutectoid Material; Refining by Zone-melting of Material; Production of a Homogeneous Polycrystalline Material With Defined Structure; Single Crystals or Homogeneous Polycrystalline Material With Defined Structure; After-treatment of Single Crystals or a Homogeneous Polycrystalline Material With Defined Structure; Apparatus Therefor
C30B 7/10 (20130101)
C30B 7/14 (20130101)
C30B 29/16 (20130101) Original (OR) Class
C30B 29/32 (20130101)

Cables; Conductors; Insulators; Selection of Materials for Their Conductive, Insulating or Dielectric Properties
H01B 1/14 (20130101)
H01B 1/20 (20130101)
H01B 1/22 (20130101)

Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 21/02565 (20130101)
H01L 21/02601 (20130101)
H01L 21/02628 (20130101)
H01L 51/005 (20130101)
H01L 51/0094 (20130101)

Technical Subjects Covered by Former USPC Cross-reference Art Collections [XRACs] and Digests
Y10S 977/774 (20130101)
Y10S 977/896 (20130101)
Y10S 977/932 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Homeland Security (DHS) 

US 09857149 Rubtsov et al.
FUNDED BY
Department of Homeland Security (DHS)
Department of Defense (DOD)
APPLICANT(S) Vladimir Rubtsov (Los Angeles, California);  Gennady Sigal (Oakville, California)
ASSIGNEE(S) Optech Ventures, LLC (Torrance, California)
INVENTOR(S) Vladimir Rubtsov (Los Angeles, California);  Gennady Sigal (Oakville, California)
ABSTRACT Apparatus and method for using a light source having spatially separated light emitting areas emitting light at different wavelengths to incapacitate a subject by a pattern of temporal flashing and/or color flashing of the light source. Reflectors adapted for use with spatially separated light substrates provide for light concentration from lower powered optical sources.
FILED Thursday, March 13, 2014
APPL NO 14/209990
ART UNIT 2878 — Optics
CURRENT CPC
Lighting Devices or Systems Thereof, Being Portable or Specially Adapted for Transportation
F21L 4/027 (20130101)

Functional Features or Details of Lighting Devices or Systems Thereof; Structural Combinations of Lighting Devices With Other Articles, Not Otherwise Provided for
F21V 5/04 (20130101)
F21V 7/06 (20130101)
F21V 23/0407 (20130101)

Indexing Scheme Associated With Subclasses F21K, F21L, F21S and F21V, Relating to the Form or the Kind of the Light Sources or of the Colour of the Light Emitted
F21Y 2113/10 (20160801)
F21Y 2115/10 (20160801)

Armour; Armoured Turrets; Armoured or Armed Vehicles; Means of Attack or Defence, e.g Camouflage, in General
F41H 13/0087 (20130101) Original (OR) Class

Electric Heating; Electric Lighting Not Otherwise Provided for
H05B 33/0842 (20130101)
H05B 37/0281 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09858829 Brooks et al.
FUNDED BY
Department of Homeland Security (DHS)
APPLICANT(S) The United States of America, as represented by the Secretary of Homeland Security (Washington, District of Columbia)
ASSIGNEE(S) The United States of America, as represented by the Secretary of Homeland Security (Washington, District of Columbia)
INVENTOR(S) Ernest Brooks (Glynco, Georgia);  Lee Dubose (Glynco, Georgia)
ABSTRACT Aspects of disclosure provide a system for reducing traction of a vehicle. The system includes a mobile controller, and a remote controller. The mobile controller is configured to control release of a liquid. The mobile controller corresponds to a vehicle and configured to direct the release of the liquid to specified wheels of the vehicle. The remote controller is in wireless communication with the mobile controller. The remote controller is configured to store a liquid release setting for the mobile controller, to receive a selection of the vehicle, and to issue a liquid release command including the liquid release setting to the mobile controller corresponding to the selected vehicle. The mobile controller corresponding to the selected vehicle is configured to initiate a release of the liquid directed to one or more wheels of the selected vehicle to reduce traction of the selected vehicle according to the liquid release setting.
FILED Friday, September 30, 2016
APPL NO 15/281853
ART UNIT 3715 — Amusement and Education Devices
CURRENT CPC
Systems for Controlling or Regulating Non-electric Variables
G05D 7/0623 (20130101)

Educational or Demonstration Appliances; Appliances for Teaching, or Communicating With, the Blind, Deaf or Mute; Models; Planetaria; Globes; Maps; Diagrams
G09B 9/042 (20130101) Original (OR) Class
G09B 19/167 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Transportation (USDOT) 

US 09858816 Cook et al.
FUNDED BY
Department of Transportation (USDOT)
APPLICANT(S) Regents of the University of Minnesota (Minneapolis, Minnesota)
ASSIGNEE(S) Regents of the University of Minnesota (Minneapolis, Minnesota)
INVENTOR(S) Douglas J. Cook (Maple Grove, Minnesota);  Vassilios Morellas (Plymouth, Minnesota);  Theodore L. Morris (Saint Paul, Minnesota);  Nikolaos Papanikolopoulos (Minneapolis, Minnesota)
ABSTRACT Systems and methods for determining park stall occupancy are disclosed herein. The systems and methods include receiving a three dimensional representation of a parking stall in a parking lot. The systems and methods also include processing the three dimensional representation to determine occupancy of the parking stall. The parking stall has a boundary relative to the area.
FILED Thursday, May 21, 2015
APPL NO 14/718914
ART UNIT 2667 — Image Analysis; Applications; Pattern Recognition; Color and compression; Enhancement and Transformation
CURRENT CPC
Recognition of Data; Presentation of Data; Record Carriers; Handling Record Carriers
G06K 9/0063 (20130101)
G06K 9/00771 (20130101)

Image Data Processing or Generation, in General
G06T 7/85 (20170101)
G06T 7/579 (20170101)
G06T 7/593 (20170101)
G06T 2207/10021 (20130101)
G06T 2207/30236 (20130101)

Traffic Control Systems
G08G 1/14 (20130101) Original (OR) Class
G08G 1/144 (20130101)
G08G 1/146 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Federal Reserve Bank (FED) 

US 09858553 Davis et al.
FUNDED BY
Federal Reserve Bank (FED)
APPLICANT(S) Federal Reserve Bank of Minneapolis (Minneapolis, Minnesota)
ASSIGNEE(S) Federal Reserve Bank of Minneapolis (Minneapolis, Minnesota)
INVENTOR(S) Peter A. Davis (Plymouth, Minnesota);  Keith Pierce (Lauderdale, Minnesota);  Stephen P. Hanten (Minneapolis, Minnesota);  Erik Tennant (Apple Valley, Minnesota);  Jennifer Larson (Elk River, Minnesota)
ABSTRACT Efficiently processing ACH payments by processing batches of ACH payments in parallel. A processing system of an ACH operator receives an ACH file including multiple batches of ACH items. Each batch includes at least one ACH item. A control module of the processing system organizes data in the ACH file into multiple partitions according to a selected strategy. Each partition includes at least one of the batches. A processing module of the processing system separately processes each partition in parallel, validating the batches and ACH items and creating at least one output batch for each partition. If the control module determines that the ACH file is acceptable, based on this parallel processing, then the processing module settles the ACH items in the output batches and creates at least one new ACH file for transmitting the settled ACH items to one or more corresponding receiving depository financial institutions.
FILED Thursday, December 18, 2014
APPL NO 14/575291
ART UNIT 3696 — Business Methods - Finance/Banking/ Insurance
CURRENT CPC
Data Processing Systems or Methods, Specially Adapted for Administrative, Commercial, Financial, Managerial, Supervisory or Forecasting Purposes; Systems or Methods Specially Adapted for Administrative, Commercial, Financial, Managerial, Supervisory or Forecasting Purposes, Not Otherwise Provided for
G06Q 20/023 (20130101) Original (OR) Class
G06Q 20/401 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

National Geospatial Intelligence Agency (NGA) 

US 09858656 Young
FUNDED BY
Department of Defense (DOD)
National Geospatial Intelligence Agency (NGA)
APPLICANT(S) Raytheon Company (Waltham, Massachusetts)
ASSIGNEE(S) Raytheon Company (Waltham, Massachusetts)
INVENTOR(S) Darrel L. Young (Falls Church, Virginia)
ABSTRACT According to embodiment, an interpretability and quality estimation method includes generating an interpretability or quality estimate for an image or frame using one or more feature characteristics of a reference image when a reference image associated with an image is available or partially available, and generating an interpretability or quality estimate for the image or frame using one or more feature characteristics of the image when a reference image associated with the image is not available.
FILED Wednesday, March 13, 2013
APPL NO 13/801549
ART UNIT 2665 — Image Analysis; Applications; Pattern Recognition; Color and compression; Enhancement and Transformation
CURRENT CPC
Image Data Processing or Generation, in General
G06T 7/0002 (20130101) Original (OR) Class
G06T 2207/30168 (20130101)

Pictorial Communication, e.g Television
H04N 17/004 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Office of the Director of National Intelligence (ODNI) 

US 09858531 Monroe et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Office of the Director of National Intelligence (ODNI)
Intelligence Advanced Research Projects Activity (IARPA)
APPLICANT(S) UNIVERSITY OF MARYLAND (College Park, Maryland);  DUKE UNIVERSITY (Durham, North Carolina);  UNIVERSITY OF BRITISH COLUMBIA (Vancouver, Canada)
ASSIGNEE(S) University of Maryland (College Park, Maryland);  Duke University (Durham, North Carolina);  University of British Columbia (Vancouver, British Columbia, Canada)
INVENTOR(S) Christopher Monroe (Ellicott City, Maryland);  Jungsang Kim (Chapel Hill, North Carolina);  Robert Raussendorf (Vancouver, Canada)
ABSTRACT A modular quantum computer architecture is developed with a hierarchy of interactions that can scale to very large numbers of qubits. Local entangling quantum gates between qubit memories within a single modular register are accomplished using natural interactions between the qubits, and entanglement between separate modular registers is completed via a probabilistic photonic interface between qubits in different registers, even over large distances. This architecture is suitable for the implementation of complex quantum circuits utilizing the flexible connectivity provided by a reconfigurable photonic interconnect network. The subject architecture is made fault-tolerant which is a prerequisite for scalability. An optimal quantum control of multimode couplings between qubits is accomplished via individual addressing the qubits with segmented optical pulses to suppress crosstalk in each register, thus enabling high-fidelity gates that can be scaled to larger qubit registers for quantum computation and simulation.
FILED Friday, August 01, 2014
APPL NO 14/449477
ART UNIT 2122 — AI & Simulation/Modeling
CURRENT CPC
Devices or Arrangements, the Optical Operation of Which Is Modified by Changing the Optical Properties of the Medium of the Devices or Arrangements for the Control of the Intensity, Colour, Phase, Polarisation or Direction of Light, e.g Switching, Gating, Modulating or Demodulating; Techniques or Procedures for the Operation Thereof; Frequency-changing; Non-linear Optics; Optical Logic Elements; Optical Analogue/digital Converters
G02F 1/113 (20130101)

Electric Digital Data Processing
G06F 15/76 (20130101)
G06F 2015/768 (20130101)

Computer Systems Based on Specific Computational Models
G06N 99/002 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 

Small Business Administration (SBA) 

US 09855376 Bluvshtein et al.
FUNDED BY
Department of Health and Human Services (HHS)
U.S. Public Health Service (USPHS)
Small Business Administration (SBA)
Small Business Innovation Research (SBIR)
APPLICANT(S) Minnetronix, Inc. (Saint Paul, Minnesota)
ASSIGNEE(S) MINNETRONIX, INC. (Saint Paul, Minnesota)
INVENTOR(S) Vlad Bluvshtein (Plymouth, Minnesota);  Lori Lucke (Rosemount, Minnesota);  William Weiss (Mechanicsburg, Pennsylvania)
ABSTRACT Disclosed are systems and methods for measuring and calculating parameters to control and monitor a power transfer in an implanted medical device, including operating the device in a plurality of scalable power modes and/or coupling modes. The system may shift between or among power and/or coupling modes based on input such as data received over system communication lines, programmable timers, or electrical loading information. The system may also shift between or among power and/or coupling modes based on calculated amounts of coupling, levels of detected heat flux, and/or amounts of estimated temperature changes.
FILED Friday, July 24, 2015
APPL NO 14/808540
ART UNIT 3766 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Devices for Introducing Media Into, or Onto, the Body; Devices for Transducing Body Media or for Taking Media From the Body; Devices for Producing or Ending Sleep or Stupor
A61M 1/12 (20130101)
A61M 1/101 (20130101)
A61M 1/122 (20140204)
A61M 1/127 (20130101) Original (OR) Class
A61M 1/1086 (20130101)
A61M 2205/3368 (20130101)
A61M 2205/8243 (20130101)

Magnets; Inductances; Transformers; Selection of Materials for Their Magnetic Properties
H01F 38/14 (20130101)

Circuit Arrangements or Systems for Supplying or Distributing Electric Power; Systems for Storing Electric Energy
H02J 7/025 (20130101)
H02J 50/12 (20160201)
VIEW PATENT @ USPTO:  Full Text   PDF 

U.S. State Government 

US 09855233 Rahbar et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
U.S. State Government
State of California
California Breast Cancer Research Program (CBCRP)
APPLICANT(S) CITY OF HOPE (Duarte, California);  Mahin Rahbar (Beverly Hills, California)
ASSIGNEE(S) CITY OF HOPE (Duarte, California)
INVENTOR(S) Samuel Rahbar (Beverly Hills, California);  Timothy W. Synold (Monrovia, California);  John Termini (Altadena, California)
ABSTRACT Methods of quantifying a N2-carboxyethyl-2′-deoxyguanosine (CEdG) levels in biological samples and comparing those levels to known normal levels can diagnose a number of disorders, including diabetes and cancer. Methods can also determine whether therapies for disorders are effective by measuring CEdG levels before and after treatment. Measurement of CEdG levels occurs using liquid chromatography electrospray ionization tandem mass spectrometry.
FILED Friday, November 07, 2014
APPL NO 14/536299
ART UNIT 1634 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/195 (20130101) Original (OR) Class
A61K 45/06 (20130101)

Electrotherapy; Magnetotherapy; Radiation Therapy; Ultrasound Therapy
A61N 5/10 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 30/7233 (20130101)
G01N 30/7266 (20130101)
G01N 2030/045 (20130101)
G01N 2030/8827 (20130101)
G01N 2030/8868 (20130101)
G01N 2800/042 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Government Rights Acknowledged 

US 09855225 Eisenstein et al.
FUNDED BY
APPLICANT(S) Toby K. Eisenstein (Wyndmoor, Pennsylvania);  Rebecca R. Hartzell (Indian Rocks Beach, Florida);  Martin W. Alder (Warrington, Pennsylvania);  Joseph J. Meissier (Ardmore, Pennsylvania)
ASSIGNEE(S) TEMPLE UNIVERSITY OFFICE OF TECHNOLOGY TRANSFER (Philadelphia, Pennsylvania)
INVENTOR(S) Toby K. Eisenstein (Wyndmoor, Pennsylvania);  Rebecca R. Hartzell (Indian Rocks Beach, Florida);  Martin W. Alder (Warrington, Pennsylvania);  Joseph J. Meissier (Ardmore, Pennsylvania)
ABSTRACT The present invention includes methods and compositions for treating a transplant recipient by administration of a CB2 receptor agonist either alone or in combination with one or more active pharmaceutical ingredients to block the rejection of foreign tissue and prolong grafted organs, tissues and cells.
FILED Friday, August 17, 2012
APPL NO 14/239413
ART UNIT 1627 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/09 (20130101) Original (OR) Class
A61K 31/35 (20130101)
A61K 31/095 (20130101)
A61K 31/352 (20130101)
A61K 31/404 (20130101)
A61K 31/415 (20130101)
A61K 31/454 (20130101)
A61K 39/3955 (20130101)
A61K 45/06 (20130101)

Peptides
C07K 16/244 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09856824 Lerg et al.
FUNDED BY
APPLICANT(S) Rolls-Royce North American Technologies, Inc. (Indianapolis, Indiana)
ASSIGNEE(S) Rolls-Royce North American Technologies Inc. (Indianapolis, Indiana)
INVENTOR(S) Bryan H. Lerg (Westfield, Indiana);  Stephen A. Bergeron (Indianapolis, Indiana);  Benjamin R. Harding (Greenwood, Indiana)
ABSTRACT A nozzle is provided that is capable providing flowpaths for a combined cycle aircraft propulsion system that in one form includes a gas turbine engine and a ramjet. The gas turbine engine produces an exhaust flow that is offset from an exhaust flow from the ramjet. The two streams can be flowed independent of each other or together depending on the application and relevant portion of a flight envelope. The nozzle includes a movable portion that can selectively open and close an exhaust flowpath for the gas turbine engine. The nozzle includes a surface that provides expansion for both low speed (gas turbine engine) flow and high speed (ramjet) flow.
FILED Thursday, March 06, 2014
APPL NO 14/199612
ART UNIT 3741 — Thermal & Combustion Technology, Motive & Fluid Power Systems
CURRENT CPC
Jet-propulsion Plants
F02K 1/42 (20130101) Original (OR) Class
F02K 7/16 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09858304 Marcus et al.
FUNDED BY
APPLICANT(S) RAYTHEON COMPANY (Waltham, Massachusetts)
ASSIGNEE(S) RAYTHEON COMPANY (Waltham, Massachusetts)
INVENTOR(S) Eran Marcus (Culver City, California);  David U. Fluckiger (Allen, Texas);  Brian F Boland (Redondo Beach, California)
ABSTRACT A method for computing a cross-correlation between a first sequence and a second sequence includes: generating a first index vector based on the first sequence, the first index vector including a plurality of first elements, the first index vector excluding indices of zero valued elements of the first sequence; generating a second index vector based on the second sequence, the second index vector including a plurality of second elements, the second index vector excluding indices of zero valued elements of the second sequence; computing, on a processor, a plurality of pairwise differences between each of first elements of the first index vector and each of the second elements of the second index vector; and binning, on the processor, the plurality of pairwise differences to generate the cross-correlation of the first sequence and the second sequence.
FILED Friday, March 27, 2015
APPL NO 14/671614
ART UNIT 2163 — Data Bases & File Management
CURRENT CPC
Radio Direction-finding; Radio Navigation; Determining Distance or Velocity by Use of Radio Waves; Locating or Presence-detecting by Use of the Reflection or Reradiation of Radio Waves; Analogous Arrangements Using Other Waves
G01S 7/486 (20130101)
G01S 17/10 (20130101)

Electric Digital Data Processing
G06F 17/15 (20130101)
G06F 17/142 (20130101)
G06F 17/3053 (20130101)
G06F 17/30336 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09858640 Earl et al.
FUNDED BY
APPLICANT(S) HRL Laboratories, LLC (Malibu, California)
ASSIGNEE(S) HRL Laboratories, LLC (Malibu, California)
INVENTOR(S) Darren J. Earl (Los Angeles, California);  Heiko Hoffmann (Simi Valley, California);  Ryan M. Uhlenbrock (Calabasas, California)
ABSTRACT A method for merging 3D point clouds from sparsely distributed viewpoints includes collecting a plurality of 3D point cloud data sets using a 3D sensor, each 3D point cloud data set in a local reference frame of a viewpoint of the 3D sensor, downsampling the 3D point cloud data sets, registering the downsampled 3D point cloud data sets to a global reference frame using an initial transform Tv for rotating and translating each downsampled 3D point cloud data set from the local reference frame to the global reference frame, deriving estimated transforms Tv until the last derived transform Tv converges to a stable transform Tv, registering the plurality of 3D point cloud data sets to the global reference frame using the stable transform Tv, and deriving second estimated transforms Tv until the last derived transform Tv converges to a second stable transform Tv.
FILED Wednesday, July 15, 2015
APPL NO 14/800078
ART UNIT 2669 — Image Analysis; Applications; Pattern Recognition; Color and compression; Enhancement and Transformation
CURRENT CPC
Image Data Processing or Generation, in General
G06T 3/0075 (20130101) Original (OR) Class
G06T 7/0032 (20130101)
G06T 11/60 (20130101)
G06T 17/005 (20130101)
G06T 17/05 (20130101)
G06T 2200/04 (20130101)
G06T 2207/10028 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09859178 Morel et al.
FUNDED BY
APPLICANT(S) BAE SYSTEMS INFORMATION AND ELECTRONIC SYSTEMS INTEGRATION INC. (Nashua, New Hampshire)
ASSIGNEE(S) BAE Systems Information and Electronic Systems Integration Inc. (Nashua, New Hampshire)
INVENTOR(S) Yannick C. Morel (Falls Church, Virginia);  Sheila J. Konecke (Leesburg, Virginia);  Santos Nazario-Camacho (Woodbridge, Virginia);  Clint J. Novotny (Washington, District of Columbia);  Keith K. Sturcken (Nokesville, Virginia)
ABSTRACT A microwave module is described. The microwave module includes a base bracket, a window plate and a lid. The base bracket is configured to contain a photoconductive switch, a radio-frequency transformer and dielectric oil. The window plate, which is transparent to optical light, covers a first portion of the base bracket in which the photoconductive switch is located. The window plate is sealed to the base bracket. The lid, which includes a cutout to allow the radio-frequency transformer to pass through the lid, covers a second portion of the base bracket in which the radio-frequency transformer is located. The window plate is sealed to the base bracket, and the lid is sealed to the window plate, the base bracket and the radio-frequency transformer to contain the dielectric oil within the microwave module.
FILED Wednesday, October 07, 2015
APPL NO 14/876886
ART UNIT 2835 — Electrical Circuits and Systems
CURRENT CPC
Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 21/50 (20130101)
H01L 23/04 (20130101) Original (OR) Class
H01L 23/10 (20130101)
H01L 2924/00 (20130101)
H01L 2924/0002 (20130101)
H01L 2924/0002 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09860106 Gerecke
FUNDED BY
APPLICANT(S) Raytheon Company (Waltham, Massachusetts)
ASSIGNEE(S) Raytheon Company (Waltham, Massachusetts)
INVENTOR(S) William L. Gerecke (Stow, Massachusetts)
ABSTRACT Systems and methods for data stream virtualization are generally described herein. One or more embodiments of such a system can include a stream processing node, a physical sensor stream, a management node, a virtual sensor stream, or pairing logic.
FILED Tuesday, September 10, 2013
APPL NO 14/022665
ART UNIT 2448 — Computer Networks
CURRENT CPC
Transmission of Digital Information, e.g Telegraphic Communication
H04L 29/0602 (20130101) Original (OR) Class
H04L 65/80 (20130101)
H04L 65/605 (20130101)
H04L 65/4069 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

How To Use This Page 

THE FEDINVENT PATENT DETAILS PAGE

Each week, FedInvent analyzes newly granted patents and published patent applications whose origins lead back to funding by the US Federal Government. The FedInvent Patent Details page is a companion to the weekly FedInvents Patents Report.

This week's information is published in the FedInvent Patents report for Tuesday, January 02, 2018.

The FedInvent Weekly Patent Details Page contains a subset of patent information to provide a deeper dive into the week’s taxpayer-funded patents to help the reader better understand where a patent fits in the federal innovation ecosphere.

HOW IS THE INFORMATION ORGANIZED?

Patents are organized by the funding agency. Within each group, the patents are organized in numeric order. A patent funded by more than one agency will appear in the section of each of the agencies that funded the research and development that resulted in the invention. This approach gives the reader a complete view of the department or agency activity for the week.

WHAT INFORMATION WILL I FIND?

THE PANEL
There is a panel for each patent that contains the patent number and the title of the patent. When you click the panel, it opens to reveal the following information:

FUNDED BY
The agencies that funded the grants, contracts, or other research agreements that resulted in the patent. FedInvent includes as much information on the source of the funding as possible. The information is presented in a hierarchy going from the Federal Department down to the agencies, subagencies, and offices that funded the work. Here are two examples:

Department of Health and Human Services (HHS)
     National Institutes of Health (NIH)
         National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Department of Defense (DOD)
     Defense Advanced Research Projects Agency (DARPA)
         Army Research Office (ARO)

We do our best to provide detailed information about the funding. In some cases, the patent only reports limited information on the origins of the funding. FedInvents presents what it can confirm. We add the patents without the information required by the Bayh-Dole Act to our list of patents worthy of further investigation.

APPLICANT(S) and ASSIGNEES
FedInvent includes both the Applicants and the Assignees because having both provides more information about where the inventive work was done and by what organizations. Many organizations — universities, corporations, and federal agencies — standardize the Assignee/Owner information by the time a patent is granted. In the case of federal patents, many of the patents use the agency headquarters information for patent assignment.

Showing just the headquarters address would make Washington, DC the epicenter of all taxpayer-funded research and development. Providing both the applicant information and the assignee information provides a more accurate picture of where important taxpayer funded innovation is happening in America. Here are two examples from two different patents:

APPLICANT: U.S. Army Research Laboratory, Adelphi, MD
ASSIGNEE: The United States of America as represented by the Secretary of the Army Washington, DC

APPLICANT: Optech Ventures, LLC (Torrance, California)
ASSIGNEE(S): The Regents of the University of California (Oakland, California); Optech Ventures, LLC (Torrance, California)

INVENTOR(S)
The inventors appear in the same order as they appear on the patent. FedInvents presents the names in first name/last name order because they are easier to read than the last name/first name order of the names on the USPTO patent documents.

ABSTRACT
The abstract as it appears on the patent.

FILED
The date of the patent application including the day of the week.

APPL NO
This is the patent application serial number. If you’d like to learn more about how application serial numbers work you can go to the Lists Page.

ART UNIT
Patent data includes the Art Unit where a patent was examined. (The Art Unit isn’t available for published patent applications.) The Art Unit provides insight into what group of patent examiners prosecuted the patent application and the subject matter that the examiners work on. For example:

3793 — Medical Instruments, Diagnostic Equipment, and Treatment Devices

You can learn more about ART UNITS on the FedInvent Patents Weekly panel called About Tech Center or you can find information on the FedInvent Lists Page.

CURRENT CPC
Current CPC provides a list of the Cooperative Patent Classification symbols assigned to the patent. These are the CPC symbols assigned at the time the patent was granted.

The FedInvent Project is a patent classification maximalist endeavor or put another way, we believe that more you understand about patent classification the more you'll learn about the nature of the invention and the types of work that the federal government is funding.

The symbol presented in BOLD is the symbol identified as the "first" classification which is the most relevant classification on the patent. The date that follows the symbol is the date of the most recent revision to the art classed there.

  • A61B 1/149 (20130101)
  • A61B 1/71 (20130101)
  • A61B 1/105 (20130101)

The CPC symbols match the classifications found on the PDF version of the patent. Over time, the classifications on the full-text version of the patent change to reflect how USPTO organizes patent art to support its examiners. The two sets of CPCs don’t always match.

VIEW PATENT
As of June 2021, we include two ways to view a patent at USPTO. FedInvent provides a link to the Full-Text Version of the patent and a link to the PDF version of the patent.

HOW DO I FIND A SPECIFIC PATENT ON A PAGE?

You can use the Command F or Control F to find a specific patent you are interested in.

HOW DO I GET HERE?

You navigate to the details of a patent by clicking the information icon that follows a patent on the FedInvent Patents Weekly Report.

You can also reach this page using the weekly page link that looks like this:

https://wayfinder.digital/fedinvent/patents-2018/fedinvent-patents-20180102.html

Just update the date portion of the URL. Tuesdays for patents. Thursdays for pre-grant publication of patent applications.

Download a copy of the How To Use This Page

HAVE MORE QUESTIONS?

info@wayfinder.digital